Trafficking motifs in potassium channels by Karnik, Rucha
  
Trafficking motifs in potassium channels 
 
 
Rucha Karnik 
 
 
 
Submitted in accordance with the requirements for the degree of  
Doctor of Philosophy 
 
 
The University of Leeds 
Multi-disciplinary Cardiovascular Research Centre 
& 
Institute of Membrane Systems and Biology 
 
 
October 2010
1 
 
 
 
 
 
 
 
The candidate confirms that the work submitted is her own, except where work which 
has formed part of jointly-authored publications has been included. The contribution of 
the candidate and the other authors to this work has been explicitly indicated below. 
The candidate confirms that appropriate credit has been given within the thesis where 
reference has been made to the work of others.” 
 
“This copy has been supplied on the understanding that it is copyright material and that 
no quotation from the thesis may be published without proper acknowledgement.” 
© 2010 The University of Leeds and Rucha Karnik 
 
2 
 
 
ACKNOWLEDGMENTS 
 
Firstly, I would like to thank my supervisor Professor Asipu Sivaprasadaro for giving me 
the opportunity to work in his lab and for his guidance and help throughout my studies 
at the Leeds University. I would also like to thank Jon Lippiat and Stan White for their 
assessment of my work during the last three years and providing valuable feedback.  
Many thanks to Andrew Smith, Jamel Mankouri, David Elliott and Tarvinder Taneja, 
past members of the Rao lab for their contributions to the project and for preparing 
some of the constructs used in this study and to Edd for his advice about making it 
through the postgraduate years. For their help in the lab I must thank Chris, Tim and 
Lin. Special thanks to Matthew Hardy, for his expertise in isolation of cardiac myocytes. 
Thanks to Mandeep and Judith as well as others in the department for all the 
chocolates and cakes that make it a happy place to be. 
My studies and stay in the UK were funded by Overseas Research Students Awards 
Scheme (ORSAS), University of Leeds Tetley and Lupton Scholarship and 
International Research Scholarship (2007-2010). I am extremely grateful to the British 
Government and University of Leeds for the same. 
Last but not the least I thank my parents, my kid bro and Sak for being there for me 
always and supporting me in all my endeavours.  
  
3 
 
 
ABSTRACT  
The pancreatic ATP-sensitive potassium (KATP) channels couple glucose metabolism to 
excitability of the pancreatic β-cells to regulate insulin secretion. The channel 
subunits, Kir6.2 and SUR1, are encoded by the KCNJ11 and ABCC8 genes 
respectively. Genetic polymorphisms in these genes, which reduce channel activity, 
cause congenital hyperinsulinism (CHI) characterized by insulin hyper-secretion and 
hypoglycemia. The hERG (human ether-a-go-go related gene) potassium channels, 
encoded by the KCNH2 gene, contribute to the rapidly activating delayed rectifier K+ 
current (IKr), which is responsible for rapid repolarisation of the cardiac action potential. 
Decreased hERG channel function causes the Long QT syndrome 2 (LQTS2) and life 
threatening cardiac arrhythmias. Several mutations in these two clinically important 
potassium ion channels alter their surface density leading to disease. Therefore, it is of 
fundamental importance to investigate the trafficking mechanisms that regulate the 
surface density of these channels.  
Techniques in cell biology, molecular biology and biochemistry were employed to 
identify the molecular basis of Sar1-GTPase dependent ER exit of the KATP and hERG 
channels in COPII vesicles. Blocking the cargo binding sites on the Sec24 protein of 
the COPII coat with membrane-permeable synthetic peptides prevented ER exit of both 
these channels. While the diacidic 280DLE282 sequence on the Kir6.2 subunit of KATP 
channels was found to be the ER exit motif required for entry of the channels into 
COPII vesicles at the ER exit sites, such a motif was found to be absent on hERG C-
terminus. Further, endocytic trafficking mechanism of hERG channels was studied in 
recombinant (HEK MSRII and HeLa) and native (neonatal rat cardiac myocytes) 
systems using cell biological and pharmacological tools. hERG channels were found to 
be internalised by a dynamin-independent, raft-mediated, and ARF6-dependent 
pathway. A prolonged block of this pathway revealed that the channels could also 
undergo internalisation by an alternate dynamin-mediated pathway. Internalised hERG 
channels were found to recycle back to the cell surface and undergo lysosomal 
degradation. Degradation of the channels was enhanced when Rab11a-GTPase 
function was disrupted leading to reduced surface density indicating that recycling is 
crucial to maintain cell surface density of the channels. Thus this study investigated 
and compared the previously unknown mechanisms of biosynthetic and endosomal 
trafficking of the KATP and hERG potassium channels with a conclusion that these 
processes play an important role in maintaining surface density and thereby in the 
function of these channels in physiological and patho-physiological conditions.  
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1.1 Ion Channels in Health and Disease 
1.1.1 Ion channels - a general introduction 
Ion channels are transmembrane proteins that are crucial components of living cells 
which facilitate and regulate passage of specific ions such as potassium (K+), sodium 
(Na+), calcium (Ca2+) and chloride (Cl-) across cellular and organelle membranes. Ion 
channels, like enzymes, are highly substrate specific and are stringently regulated. For 
example, K+ channels are 100–1,000 times more permeable to K+ than Na+, although 
the Na+ ion are smaller (Hille, 2001). The opening or closing of ion channels alters the 
electrical potential across the plasma membrane, which is critical for several 
physiological processes of the cell such as nerve and muscle excitation, hormone 
secretion, cell proliferation, sensory transduction, learning and memory, regulation of 
blood pressure, salt and water balance, fertilisation and cell death (Ashcroft, 2006a). 
More than 300 types of ion channels have been identified in living cells which differ 
from each other in their gating (opening or closing of pores) and selectivity (in terms of 
which ions they allow to pass through) giving them the ability to carry out diverse 
physiological roles. Ion channels can be classified depending on their functional 
properties or structure. Classification of ion channels based on the ions that they 
conduct and their properties is as follows (Hille, 2001): 
• Chloride channels - involved in regulation of pH, volume homeostasis, organic 
solute transport, cell migration, cell proliferation and differentiation. 
• Sodium channels - include voltage-gated (Nav) channels which are involved in 
the firing of action potential in myocytes and neurons and non-neuronal 
epithelial ligand-gated sodium channels (ENaC). 
• Calcium channels - include both voltage-gated (Cav) and ligand-gated channels 
involved in diverse physiological functions. 
• Potassium channels - have diverse functions and tissue distribution. Can be 
classified as: voltage gated (Kv), inward-rectifier (Kir), calcium activated (KCa) 
two-pore domain (K2P). 
• Proton channels - are voltage-gated and sensitive to pH, known to function in 
phagocytes.  
• Non-selective ion channels – for example TRP channels, which allow many 
types of cations, mainly Na+, K+ and Ca2+ to pass through and the cyclic 
nucleotide- gated (CNG) channels which conduct Na+, K+, Mg2+ and Ca2+ ions.  
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1.1.2 Ion channels and disease 
Basic ion channel structure includes one or more α-subunits that form the ion 
conducting pore with the selectivity filter. Some channels have one or more accessory 
subunits also called as the β-subunits. Ion channel function depends on the number of 
channels in the membrane, the fraction of time they remain open (the open probability) 
and the conductance of the single channel and therefore alteration of any of these 
could disrupt channel function (Hille, 2001). 
 
Both genetic mutations and pharmacological compounds can alter channel function 
leading to disease; for example the delta F508 mutation that causes retention of the 
chloride channel, Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), in 
the ER causes cystic fibrosis (Cheng et al., 1990); several drugs bind to and inhibit the 
cardiac voltage-gated potassium channels Kv11.1 and produce the acquired long QT 
syndrome (LQTS). This disease can also be caused due to mutations that alter channel 
function and trafficking (Sanguinetti et al., 1995). Loss-of-channel function can occur 
due to mutations that lead to decrease in channel density by preventing channel 
protein synthesis or correct membrane targeting or due to drugs that may block the 
channels. Similarly mutations and drugs can also cause gain-of-function in ion 
channels leading to disease. For example, gain-of-function and loss-of-function 
mutations in the pancreatic ATP-sensitive potassium channels can produce distinct 
clinical disorders: neonatal diabetes (due to too little insulin secretion) and 
hyperinsulinemia (Ashcroft, 2005, Ashcroft, 2006a). Thus absence or mutation of one 
or more of the contributing channel subunits can result in channelopathies (defined as, 
diseases that result from impaired channel function). Table 1.1, adapted from (Ashcroft, 
2006a), lists some of the channelopathies.  
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Table 1.1 Channelopathies caused due to mutations in ion channel genes 
Protein Mutation type Channelopathies 
Kir1.1 (ROMK) 
KCNJ11 (loss of 
function) 
Bartter’s syndrome  
Kir 2.1  
KCNJ2 (loss of 
function) 
Andersen’s syndrome 
SUR2 (cardiac KATP β 
subunit) 
SUR1 (loss of function) Dilated cardiomyopathy 
Kv1.1, neuronal α-
subunit 
KCNA1 (loss of 
function) 
Neuromuotonia 
KVLQT1 
KCNQ1 (loss of 
function) 
(gain of function) 
LQTS1, Atrial fibrillation 
Short QT syndrome  
MinK, cardiac β-subunit 
KCNE1 (loss of 
function) 
LQTS5 
TRPP2  TRPP2 
Autosomal dominant 
polycystic kidney disease 
TRPC6 
TRPC6 (gain of 
function) 
Defective Mg2+ reabsorbtion 
BK channel α-subunit 
(KCa) 
KCMNA1 (gain of 
function) 
Generalised epilepsy  
Nav1.1, neuronal α-
subunit 
SCN1A (gain of 
function) 
(loss of function) 
Generalised epilepsy 
Severe myoclonic epilepsy 
of infancy 
Nav cardiac muscle α-
subunit. 
SCN5A (gain of 
function) 
LQTS2, Brugada syndrome, 
congenital heart block 
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1.1.3 Ion channels as drug targets 
Since ion channels control a wide range of physiological functions and alteration in 
channel function causes disease, they have been identified as important drug targets. 
Over the years several compounds that modulate the activity of ion channels have 
been discovered and commercialised. However, early ion channel drug discovery was 
based on screening for drugs that cured disease in simulated animal models where 
nature of the molecular target was unclear. Modern age drug research is directed 
towards development of drugs that have ion channels as targets (Garcia and 
Kaczorowski, 2005, Kaczorowski et al., 2008). For example, human genetics and gene 
ablation studies in rodents have identified a number of new ion channel targets 
including Nav1.7, Nav1.4, Cav2.2, KCNMA1, Kir1.1, Kir6.2-SUR2 and KCNQ (Lifton et 
al., 2001, Ashcroft and Gribble, 2000b, Yu and Catterall, 2004, Gribkoff, 2008, Garcia 
Protein Mutation type Channelopathies 
Nav, skeletal muscle α-
subunit. 
SCN4A (loss of 
function)  
Hypokalemic periodic 
paralysis 
CLC5 (Cl- transporter in 
kidney) 
CLCN5 (loss of 
function) 
Dent’s disease  
CLC7, (Cl- transporter) CLC7 (loss of function) 
Osteopetrosis (dense 
bones), blindness 
GABAA receptor neuronal 
α1-subunit. 
GABRA1 (loss of 
function) 
Juvenile myoclonic epilepsy 
AChR skeletal muscle 
α1-subunit 
CHRNA1 (gain of 
function) 
Congenital myasthenia 
CFTR (epithelial Cl- 
channel) 
CFTR (loss of function) Cystic fibrosis 
Epithelial Na+ channel 
(ENaC) β- and γ-subunit 
SCNN1B and SCNN1G 
(gain of function) 
Hypertension (Liddle’s 
syndrome) 
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and Kaczorowski, 2005). Apart from the traditional pharmacological drugs, new 
therapeutic agents that could be the future of medicine include modulation of channel 
expression by regulation of promoter activity, siRNA technology, or the employment of 
dominant-negative interference strategies as well as small peptides. For example a 
peptide which is a synthetic analogue of peptides contained in the cone snail venom is 
being developed clinically as a treatment for acute pain. The peptide is a potent blocker 
of the neuronal voltage-gated calcium channel, Cav2.2 (Miljanich, 2004). Similarly, the 
spider toxin peptide GxTX that targets the pancreatic β-cell delayed rectifying 
potassium channel, Kv2.1 (KCNB1), is a potential candidate for enhancing glucose-
dependent insulin secretion (GSIS), and thus for the treatment of type II diabetes 
(Herrington et al., 2006). 
 
Drug discovery and development is a costly and time consuming process which meets 
with limited success. For example, toxicity due to interaction with unrelated channels 
such as the cardiac Kv11.1 which leads to life threatening arrhythmias (Witchel, 2010), 
is a major cause of drug failure. Success in development of new therapeutic 
approaches that target ion channels depends on the knowledge about how the ion 
channels function with respect to their ion conductance as well as trafficking of the 
channels in the cells. Also, understanding of the molecular mechanism underlying 
diseases caused by mutations in ion channels would help in the design of therapy. 
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1.2 Potassium Ion Channels 
1.2.1 Potassium channels - a general introduction 
K+ channels regulate movement of the K+ ions down the electrochemical gradient and 
maintain the cellular membrane potential. These channels are critical for membrane 
potential dependent functions of the cell such as regulation of cardiac action potential, 
regulation of insulin secretion and neural signal transduction (Aidley, 2008). K+ is one 
of the predominant monovalent cation in mammalian cells, and extracellular K+ 
concentrations are low. Opening of K+ channels favours an outward flow of these 
positively charged ions which shifts the voltage across the cell membrane towards the 
equilibrium reversal potential where the tendency for K+ ions to move outwardly (down 
their concentration gradient) is balanced by their tendency to move inward (down their 
electrical gradient). By this mechanism open K+ channels mediate recovery after 
activity in excitable tissue and stabilize cellular potential (Hille, 2001). 
 
1.2.2 Basic structure of potassium ion channels 
Potassium channels are made of pore-forming subunits (α-subunit) and may be 
associated with auxiliary subunits (denoted as β-subunit or γ-subunit) which could be 
involved in channel regulation or trafficking (Pongs, 1999). The α-subunits have 
transmembrane α-helices with a membrane re-entering pore (P) loop. The pore-loop 
structure lines the top of the pore that is responsible for potassium selective 
permeability through the selectivity filter. K+ channels display high selectivity towards K+ 
(1.33 Å) and exclude smaller alkali metal cations Li+ (radius 0.60 Å) and Na+ (0.95 Å) 
but allow permeation of the larger ions such as rubidium Rb+ (1.48 Å) and Cs+ (1.69 Å) 
(Hille, 2001, Doyle et al., 1998). Ion selectivity occurs at the narrowest part of the 
channel pore due to the presence of the selectivity filter located in the P-loop of the 
channel which consists of a highly conserved sequence (TVGYG). Prior to entry into 
the selectivity filter, K+ ion is dehydrated and this loss is compensated by the backbone 
carbonyls of the VGYG residues that contribute to the four oxygen rings. The ion 
moves through the filter by slipping from one binding site to the next in a single file at a 
very high rate of about 107-108 ions per second (MacKinnon, 2003). Since the carbonyl 
oxygen atoms in the channel pore are too far apart to enable them to interact intimately 
with dehydrated Na+ ions, Na+ is effectively excluded from the selectivity filter (Doyle et 
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1.2.3 Inwardly rectifying potassium ion channels 
Introduction 
Inwardly rectifying potassium channels (Kir) are an important class of K+ channels that 
have been shown to regulate membrane excitability, heart rate, vascular tone, insulin 
release and salt flow across epithelia (for a comprehensive review see (Bichet et al., 
2003). They can conduct higher inward K+ currents at membrane voltages negative to 
the K+ equilibrium potential than outward currents, even when K+ concentrations on 
both sides of the membrane become equal. 
 
The analysis of amino acid sequences of the transmembrane domains (M1 and M2) of 
the Kir channels suggested that these domains are equivalent to the S5 and S6 
transmembrane domains of the Kv channels (MacKinnon, 1991). In light of the 
structural information available for the voltage-gated ion channels, it was considered 
that the membrane re-entrant loop between M1 and M2 formed the ion channel 
conduction pore (Heginbotham et al., 1994). The selectivity filter in the Kir channels is 
lined by residues TXGYGFR and a pair of highly conserved cysteine residues flanks 
the pore region of the channel. The elucidation of the chicken Kir2.2 crystal structure 
(Tao et al., 2009) has provided a better understanding of the biophysical basis of 
inward rectification. Inward rectification is attributed to the selective interaction of the 
channels with cytoplasmic Mg2+ ions and polyamines that block K+ efflux at membrane 
potentials more positive than the reversal potential (Isomoto et al., 1997, Hille and 
Schwarz, 1978, Lu, 2004). The degree or strength of inward rectification within the Kir 
family depends on the binding affinity of the channel for blocking cations such as 
polyamines and Mg2+, which plug the conduction pathway upon depolarisation and 
impede the outward flow of K+ (Horie and Irisawa, 1987, Lopatin et al., 1994). Other 
regulators of Kir channels include extracellular K+ concentration, the membrane 
anchored phospholipid, phosphatidylinositol 4,5-bisphosphate (PIP2), ATP and protein-
protein interactions (see Figure 1.2.A adapted from (Tao et al., 2009), and Figure 1.2.B 
adapted from (Hibino et al., 2010).  
  
 
 
Figure 1.2 Regulators of Kir channel function
showing the transmembrane domain, cytoplasmic domain (in grey) and ion binding 
sites for Rb+. The ions are shown as spheres and 
et al., 2009). (B) Kir channels can be regulated by small substances such as H
Na+; polyamines, phosphorylation and membrane phospholipids. Interactions with 
proteins such as the sulfonylurea receptor (SUR), G
and anchoring protein can also play a critical role in Kir channel regulation 
al., 2010).  
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Classification 
About fifteen Kir subunit genes have been identified and the channels are divided into 
seven distinct subfamilies (Kir1-7) that exhibit variations in strength of rectification and 
response to cellular signals (Isomoto et al., 1997, Doring et al., 1998). These seven 
families of the Kir channels are functionally classified into four groups (Ashcroft et al., 
1987, Krapivinsky et al., 1998, Hille, 2001, Hibino et al., 2010) as follows: 
• Classical Kir channels (Kir2.x) that are constitutively active 
• G-protein gated Kir channels (Kir3.x) that are regulated by G protein-coupled 
receptors (GPCRs) 
• ATP-sensitive K+ channels (Kir6.x) are tightly linked to cellular metabolism 
• K+ transport channels (Kir1.x, Kir4.x, Kir5.x, and Kir7.x) 
Kir channels are found in multiple cell types, including macrophages, cardiac and 
kidney cells, leukocytes, neurons, pancreatic β-cells and endothelial cells where they 
have varying physiological functions. For example, in endothelial cells, Kir (Kir2.x) 
channels are involved in regulation of nitric oxide synthase while in kidneys Kir 
channels export surplus potassium into collecting tubules for removal in the urine 
(Chilton and Loutzenhiser, 2001). In cardiac tissue, G-protein activated Kir channels 
(Kir3.1 + Kir3.4) are important for heart rate modulation (Corey et al., 1998) and in 
pancreatic β-cells, the ATP-regulated Kir channels (KATP) are involved in glucose 
regulated insulin release (Ashcroft et al., 1984, Ashcroft et al., 1987). 
 
Cloning and identification 
The ATP-dependent Kir channels ROMK1/Kir1.1 (Ho et al., 1993) and the IRK1/Kir2.1 
(Kubo et al., 1993) were the first Kir channels to be isolated and cloned in 1993. 
Architecture of the transmembrane domain of Kir channels was determined from the 
crystal structure of a bacterial homolog KirBac1.1 (Kuo et al., 2003). These studies 
showed that structurally, Kir channels are tetramers, each subunit having two 
transmembrane segments (TM1 and TM2), which are linked by an extracellular pore 
loop (P) and cytoplasmic amino (NH2) and carboxyl (COOH) terminal domains (Figure 
1.B). Since the channels lack the S4 voltage sensor region found in voltage-gated 
channels, the Kir channels are insensitive to membrane voltage. The Kir channel 
subunits are capable of both homomeric and heteromeric combinations to form 
functional Kir channels which display distinct properties. Heteromerisation generally 
occurs between members of the same subfamily, for example Kir2.1 can associate with 
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Kir2.2, Kir2.3, or Kir2.4 and Kir3.1 forms heteromeric complexes with Kir3.2, Kir3.3 or 
Kir3.4. An exception is where Kir4.1 assembles with Kir5.1 (Hibino et al., 2010, Hille, 
2001).  
1.2.4 Voltage gated potassium channels 
Voltage-gated potassium (Kv) channels sense changes in the cellular membrane 
potential. Owing to the concentration gradient for K+ that exists across cellular 
membranes, the opening of Kv channels results in an efflux of positive charge which 
results in membrane repolarisation. In excitable cells such as neurons or cardiac 
myocytes, Kv channels are therefore often expressed together with voltage-gated Na
+ 
(Nav) and/or Ca2+ (Cav) channels which cause membrane depolarisation. Activation of 
Kv channels thus reduces excitability of the cells after action potential firing (Hille, 
2001).  
Structures of the bacterial KvAP and the mammalian Kv1.2 channels (both thought to 
be in the open state) have been solved; however structure of a channel with a drug 
molecule bound is not available till date. This has made understanding of the 
pharmacology of the channels difficult. About 40 Kv channels encoded by the human 
genome are known and they are involved in diverse physiological processes ranging 
from repolarisation of neuronal and cardiac action potentials, to regulating Ca2+ 
signalling and cell volume, to driving cellular proliferation and migration (Hille, 2001). 
The first Kv channel to be cloned was the Drosophila Shaker channel (Papazian et al., 
1987). Like the Shaker channel, all mammalian Kv channels are homo-tetramers or 
hetero-tetramers of 6-TM domain α-subunits (Figure 1.1.C). The six transmembrane α-
helical segments, S1–S6 and P-loop are arranged circumferentially to form the channel 
central pore. The four S1–S4 segments, each containing four positively charged 
arginine residues in the S4 helix, act as voltage sensor domains and 'gate' the pore by 
'pulling' on the S4–S5 linker (Long et al., 2005a). The Kv channel α-subunits are 
classified into 12 subfamilies (Kv1-12) based on their homology. The channels can be 
grouped according to their function as follows: 
• Delayed rectifiers (belong to the shaker family) - (Kv1.x, Kv2.x, Kv3.x, Kv7.x, 
Kv10.x) 
• A-type potassium channels - Kv1.4  
• Outward-rectifying - Kv10.2  
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• Inward-rectifying - that pass current more easily into the inwards direction (Into 
the cell) - Kv11.1, Kv11.2, Kv11.3 
• Slowly activating - Kv12.1, Kv12.2, Kv12.3  
• Modifier/silencer - Unable to form functional channels as homo-tetramers but 
instead hetero-tetramerise with Kv2 family members to form conductive 
channels- Kv5.1, Kv6.1, Kv6.2, Kv6.3, Kv6.4, Kv8.1, Kv8.2, Kv9.1, Kv9.2, Kv9.3  
 
K+ channel β-subunits represent a diverse molecular group, which includes cytoplasmic 
proteins (Kvβ1-3, KChIP and KChAP) that interact with the intracellular domains of the 
Kv channels, single transmembrane spanning proteins, such as minK and minK-related 
proteins (MiRPs) encoded by the KCNE gene family. Co-expression of the β-subunits 
with α-subunits regulates cell surface expression, gating kinetics and drug-sensitivity of 
the Kv channels (Hanlon and Wallace, 2002, Martens et al., 1999).  
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1.3 ATP-Sensitive Potassium Channels 
1.3.1 Tissue localisation of KATP channels 
ATP-sensitive potassium (KATP) channels are weakly inwardly rectifying potassium 
channels which play the central role of coupling cell metabolism to changes in cell 
membrane potential. These channels were first identified in cardiac myocytes and were 
found to be inhibited by intracellular ATP but stimulated by Mg-ADP (Noma, 1983, 
Ashcroft et al., 1984, Ashcroft et al., 1987). The KATP channels are found in cardiac 
myocytes (Noma, 1983), pancreatic β-cells (Ashcroft et al., 1984), skeletal muscle 
(Spruce et al., 1985), vascular smooth muscle (Beech et al., 1993) and neurons 
(Ashford et al., 1988). They are located either at the plasma membrane, at the inner 
mitochondrial membrane (mitoKATP) (Szewczyk et al., 1996) or in secretory granules 
(Geng et al., 2003). 
 
1.3.2 Structure and stoichiometry 
The KATP channel expressed on the cell surface is an octamer of two distinct subunits: 
a pore-forming α-subunit, which belongs to the K+ inward rectifier family (Kir6.x), and a 
regulatory β-subunit, the sulfonylurea receptor (SURx), see Figure 1.3.A. The Kir 
subunits are responsible for ATP inhibition and the SUR proteins for nucleoside 
diphosphate (NDP) activation.  
 
Three isoforms of Kir6.x cloned till date includes the mammalian Kir6.1 (Inagaki et al., 
1995), Kir6.2 (Sakura et al., 1995) and the Kir6.3 found in zebra fish (Zhang et al., 
2006). The sulfonylurea receptor SUR belongs to the ATP-binding cassette (ABC) 
family of proteins. Unlike other ABC proteins such as CFTR, it has neither active nor 
passive intrinsic transport function. SUR associates with the pore forming potassium 
channel subunits, Kir6.x to form the KATP channel, where it serves as a regulatory 
subunit which fine-tunes the gating of Kir6.x in response to alterations in cellular 
metabolism (Clement et al., 1997, Lorenz et al., 1998). Transcripts of SUR1 occur most 
abundantly in neurons, brain, and pancreatic β-cells (Aguilar-Bryan et al., 1995). Other 
members of SUR family identified include SUR2 which has splice variants SUR2A and 
SUR2B. Transcripts of SUR2A are primarily detected in heart and secondly in skeletal 
muscles while the SUR2B transcripts are mainly detected in smooth muscle, and 
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present nearly ubiquitously in many tissue types (Chutkow et al., 1996). Combinations 
of different SURx and Kir6.x subunits form distinct types of KATP channels found in 
different tissues. Kir6.1 is present ubiquitously in many tissue types and its transcripts 
are abundantly present in heart, ovary, adrenal tissues (Inagaki et al., 1995). The 
transcripts of Kir6.2 are present in high levels in skeletal muscle, heart, pancreatic 
islets, lung, liver, brain, stomach (Sakura et al., 1995). The β-cell KATP channels are an 
octameric complex made of four pore forming Kir6.2 and four regulatory SUR1 
subunits. Cardiac KATP channels are made of Kir6.2 and SUR2A subunits while those in 
smooth muscles are made of Kir6.1 and SUR2B (Inagaki et al., 1995, Aguilar-Bryan et 
al., 1995, Surah-Narwal et al., 1999). The zebra fish Kir6.3 subunits associate with 
SUR1 to form functional channels (Zhang et al., 2006).  
 
The pore forming Kir6.x subunits have two transmembrane domains and the 
membrane re-entering pore-loop like typical Kir channels. The ATP-binding site present 
on the Kir6.x subunit (Tucker et al., 1997), is essentially a binding pocket made of five 
residues, R50 in the NH2 terminus and I182, K185, R201, and G334 in the COOH 
terminus (Antcliff et al., 2005, Hibino et al., 2010). The SURx subunits contain 17 
transmembrane regions grouped into three transmembrane domains TMD0, TMD1 and 
TMD2. Each SUR unit has two nucleotide-binding domains between TMD1 and TMD2 
(NBD1) and in the COOH terminus following TMD2 (NBD2), see Figure 1.3.B. SUR2A 
and SUR2B differ only in 42 amino acids of the COOH-terminal. The TMD0 of SUR has 
been implicated in controlling both channel gating (Babenko et al., 1999) and 
association with Kir6.2 and is thus vital for KATP channel trafficking (Sharma et al., 1999, 
Zerangue et al., 1999). Co-expression of the Kir6.2 and SUR1 subunits in both 
Xenopus oocytes and mammalian cells results in KATP current identical to those of 
native β-cell currents (Sakura et al., 1995); however, the channel subunits expressed 
on their own failed to give functional currents in Xenopus oocytes (Zerangue et al., 
1999, Hough et al., 2000). Therefore, association of the KATP subunits is considered to 
be critical for expression of functional KATP channels on the cell surface. 
 
1.3.3 Regulation of Kir6.x 
KATP channel activity is regulated by intracellular nucleotides and by various 
pharmacological agents. The physiological and pharmacological control of KATP 
channels depends on the conformational changes in the Kir6.x pore by interaction with 
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ATP or through interaction with the SURx subunit. Physiologically the key feature of the 
KATP channel is its regulation by ATP in presence of Mg2+. The KATP channel stays 
closed as long as ATP is bound to the channel. In native pancreatic β-cells, ATP in its 
free acid form is a more potent inhibitor of the channel while Mg-ATP has little inhibitory 
effect (Ashcroft and Kakei, 1989). In smooth muscle cells, Mg-ATP is also less effective 
(Kajioka et al., 1991, Nelson and Quayle, 1995).  
 
However, cardiac KATP channels are inhibited by both ATP and Mg-ATP in a similar 
manner (Findlay, 1988). ADP is essential for the physiological opening of the KATP 
channels and they are thought to bear two distinct sites for channel gating, an inhibitory 
ATP-binding site and a stimulatory NDP-binding site (Tung and Kurachi, 1991). The 
stoichiometry of ATP binding in one Kir6.2 subunit provides one high-affinity ATP-
binding site, and therefore, one functional KATP channel bears four ATP-binding sites. 
However, binding of single ATP to any of the identical ATP-binding sites is sufficient to 
cause channel closure (Markworth et al., 2000, Craig et al., 2008). PIP2 binds to the 
cytoplasmic region of the Kir6.2 subunit which is close to the ATP-binding site and 
stabilizes the open state of the channel. The competition between PIP2 and ATP 
regulates channel closure by ATP-binding (Baukrowitz et al., 1998).  
 
Activation of the KATP channels is caused by binding of Mg-ADP to SUR subunit 
through the cytoplasmic nucleotide binding domains (NBD) which results in 
conformational change in the subunits. The NBD2 domain has ATPase activity and 
hydrolyses Mg-ATP to Mg-ADP with a twofold higher rate compared to NBD1 in 
presence of Mg2+ (Matsuo et al., 1999). Binding of Mg-ADP to NBD2 stabilises the 
binding of ATP to NBD1, which then stimulates channel activity (Bienengraeber et al., 
2000). Upon removal of Mg-ADP from NBD2, ATP dissociates from NBD1 and channel 
activity is reduced. The ATP/ADP ratio therefore dictates channel activity and when the 
ATP/ADP ratio is high, ATP inhibition predominates. Conversely, when the ratio is low, 
Mg-ADP stimulation dominates, the channel is activated directly and the channel 
sensitivity to ATP is reduced. Thus, the KATP channel complex functions not only as a 
K+ conductor, but also as an enzyme regulating nucleotide-dependent channel that is 
gated through an intrinsic ATPase activity of the SUR subunit. Mutations such as 
K1348A and D1469N in NBD2 reduce its ATPase activity and produce channels with 
increased sensitivity to ATP while KATP channel openers, which bind to SUR, promote 
ATPase activity (Bienengraeber et al., 2000). 
  
 
 
Figure 1.3 Structural 
to show the octameric assembly of the K
assemble to form the K
subunits of SUR1. (B) Schematic representation of Kir6.2 and SUR1 subunits showing 
the configuration of transmembrane domains (TMD) and
the nucleotide binding domains (NBD) on SUR. (C) Top and side views of the EM 
density along with models of Kir6.2 (blue) and SUR1 with TMD0 (red), TMD0 (yellow) 
and ATP (green) shown, image from 
 
37 
organization of KATP channel and its subunits
ATP channel. Four subunits of the Kir6.x 
+ ion permeable channel pore which is surrounded by
 the approximate location of 
(Mikhailov et al., 2005). 
 
 
. (A) Schematic 
 the four 
38 
 
 
KATP channels can also be regulated through phosphorylation by PKA signalling 
pathways particularly in smooth muscles (Lin et al., 2000). PKA phosphorylation sites 
include S385 in Kir6.1 and T633 and S1465 in SUR2B (Quinn et al., 2004), and S1387 
in NBD2 of SUR2B (Shi et al., 2007). Kir6.2 can be phosphorylated at T224 by PKA 
(Lin et al., 2000) and at T180 by PKC (Light et al., 2000). How phosphorylation of these 
residues activates the channels is not well understood. Gating of the atrial KATP channel 
is mechano-sensitive, and mechanical pressure applied to a cardiac cell leads to an 
increase in their activity. Disruption of actin filaments with DNase I or cytochalasin B 
antagonises ATP-mediated inhibition of KATP channels. Although this mechanism is not 
well understood, it is considered that mechano-sensitive modulation of the KATP 
channels may help to open the cardiac KATP channels during ischemia or hypoxia when 
mechanical disturbances of the cytoskeleton can occur (Van Wagoner and Lamorgese, 
1994, Terzic and Kurachi, 1996). 
 
1.3.4 Pharmacology of KATP channels 
Sulfonlyureas such as acetohexamide, tolbutamide, glipzide, glebenclamide and 
glimepriride affect SUR subunits resulting in block of KATP channels. In pancreatic β-
cells, binding of sulphonylurea drugs blocks the KATP channels which inhibits K
+ efflux, 
resulting in membrane depolarisation, opening of voltage dependent Ca2+ channels, 
Ca2+ influx and insulin secretion. Therefore these drugs are used to stimulated insulin 
secretion in patients suffering from type 2 diabetes mellitus. The sensitivity of different 
types of KATP channels to sulfonlyureas is variable; for example gliclazide and 
tolbutamide block the KATP channels in the β-cells, but not the cardiac or smooth 
muscle cells owing to the different SURx subunits in these tissues. Glibenclamide 
however blocks all types of the KATP channels with similar affinity. Effect of tolbutamide 
and gliclazide on the KATP channels is reversible however the block of glibenclamide is 
reversible on cardiac, but not β-cell, KATP channels (Ashcroft and Gribble, 2000a, 
Ashcroft and Gribble, 2000b). Potassium channel openers include drugs such as 
cromakalim, pinacidil, nicorandil, diazoxide, and minoxidil sulfate. These drugs have 
considered of potential use for a broad range of therapeutic applications including 
treatment of hypertension and congenital hyperinsulinism (CHI). KATP channels in 
vascular smooth muscles are opened by KATP channel opener drugs which cause 
relaxation of the muscles resulting in reduced blood pressure. In pancreatic β-cells KATP 
channel opener drug diazoxide has been clinically used to treat hyper-secretion of 
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insulin associated with CHI (Ashcroft and Gribble, 2000a). Since native KATP channels 
in different tissue are made of different SUR subunits, i.e. SUR1 in pancreatic, SUR2A 
in cardiac and SUR2B in smooth muscle tissue, they show different sensitivity to the 
channel opener drugs that affect the SUR subunits of the KATP channel. Therefore, the 
pancreatic KATP channels are readily activated by diazoxide, weakly activated by 
pinacidil, and unaffected by cromakalim or nicorandil (Ashcroft and Gribble, 2000a) and 
the cardiac KATP channels are activated by pinacidil, cromakalim, and nicorandil but not 
by diazoxide (Ashcroft and Gribble, 2000a, Reimann et al., 2000), while the smooth 
muscle channels are activated by all these drugs. 
 
1.3.5 Physiological roles of pancreatic KATP channels 
Insulin-secreting pancreatic β-cells express KATP channels (Inagaki et al., 1995) which 
couple blood glucose concentration to insulin secretion (Ashcroft and Kakei, 1989, 
Ashcroft and Rorsman, 1990). The report (Tokuyama et al., 1996) showed that 
expression of Kir6.2 mRNA was reduced by >70% in islets from diabetic rats, and this 
indicated that the channel function was important for β-cell function and depletion of 
Kir6.2 could cause diabetes mellitus. Mice lacking either Kir6.2 or SUR1 showed 
transient neonatal hypoglycemia (Seghers et al., 2000, Miki et al., 1998).  
 
Hypoglycemia is defined by low blood glucose concentration below 1-2 mM. It results in 
the brain being deprived of its main energy source causing rapid loss of 
consciousness. This condition can lead to brain damage and even death if untreated. 
Hyperglycemia is an opposite condition where there is elevation of blood glucose levels 
(>7 mM) and it can lead to complications of diabetes such as neuropathy, retinopathy 
and cardiovascular disease. Hence it is important for blood glucose levels to be 
maintained within narrow limits and this is achieved by glucose homeostasis in the 
fasting and fed states. When food is consumed, liver synthesizes glycogen and 
triglycerides. Triglycerides are diverted to the adipose tissue as energy stores. When 
glucose levels decrease during fasting conversion of glycogen by hepatic 
glycogenolytic enzymes releases glucose. These metabolic processes regulate blood 
glucose levels through regulation by key endocrine hormones insulin and glucagon. 
They influence directly or indirectly the enzymes which regulate liver carbohydrate and 
fatty acid metabolism, and thereby orient metabolic fluxes towards either energy 
storage or substrate release. Insulin hormone alone is capable of decreasing plasma 
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glucose concentration, both by inhibiting glucose release from the liver and by 
increasing glucose uptake in the muscle and adipose tissues (Dunne et al., 2004). 
Insulin secretion is stimulated by high blood glucose levels by the pancreatic β-cells 
when the KATP channels are closed whilst at sub-stimulatory blood glucose levels, the 
channels are open and no insulin is secreted. As blood glucose levels increase, 
glucose uptake into the pancreatic β-cell by glucose transporter GLUT2 is followed by it 
being metabolised to generate ATP. As a result of this metabolic process within the β-
cells there is an increase in concentration of ATP while the concentration of ADP is 
reduced. The property of the KATP channels to be blocked by ATP underlies the glucose 
stimulated insulin secretion (GSIS) by the pancreatic β-cells as follows: as the 
ATP/ADP ratio in the cell increases, ATP concentration increases in the cell and the 
Mg-ADP concentration decreases. Binding of ATP to Kir6.2 causes channel closure as 
mentioned before, and the movement of K+ ions from the cell is reduced and the cell 
membrane becomes depolarized. Membrane depolarization causes the opening of the 
depolarization activated Ca2+ channels. Ca2+ influx into the cell occurs and the resulting 
high Ca2+ levels trigger the insulin granules stored inside the cell to fuse with the 
plasma membrane and insulin is released into the blood stream (Antcliff et al., 2005, 
Ashcroft, 2005, Ashcroft, 2006a) and Figure 4). Insulin facilitates glucose uptake from 
blood. When the blood glucose levels fall, the metabolism in the cell decreases and the 
ATP/ADP ratio decreases and the ATP bound to the KATP is displaced by PIP2. The 
channel opens and K+ ions move out of the cell causing membrane hyperpolarisation 
(Hille, 2001, Ashcroft and Kakei, 1989, Ashcroft and Rorsman, 1990, Nichols, 2006). 
The net activity of KATP depends on the number of open channels present on the cell 
surface. The density of KATP channels increases sharply in presence of low glucose and 
decreases when blood glucose levels rise in cells that carry out GSIS (Smith et al., 
2006). Owing to the key roles of the KATP channels especially in pancreatic β-cells, any 
anomalies in the channel function lead to diseases of abnormal insulin secretion.  
  
 
 
Figure 1.4 Schematic representation of events 
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1.3.6 Pathophysiology of the pancreatic KATP channels 
Polymorphisms in Kir6.2 and SUR1 subunits that alter channel trafficking or function, 
cause disorders of insulin secretion. The channels have therefore been studied in order 
to find a cure for affected individuals. Channel function can be altered by mutations in 
the genes encoding Kir6.2 (KCNJ11) and SUR1 (ABCC8) that affect channel properties 
or expression on cell surface (Ashcroft, 2005, Ashcroft, 2006b, Ashcroft and Gribble, 
1999, Dunne et al., 2004). Certain mutations lead to the loss-of-channel function by 
altering channel gating by decreasing the affinity for Mg-nucleotides for SUR1 due to 
which there is excessive insulin secretion even at sub-stimulatory concentrations of 
glucose, while others cause defects in trafficking of the functional channels to cell 
surface (Cartier et al., 2001, Partridge et al., 2001, Smith et al., 2007).  
 
Loss of function mutations 
Loss of pancreatic KATP channel function can cause persistent hyperinsulinaemic 
hypoglycemia of infancy (PHHI), also known as congenital hyperinsulinism (CHI) which 
is characterised by excessive secretion of insulin despite hypoglycemia. More than 100 
mutations in the SUR1 gene have been reported, some of which cause loss of surface 
expression of functional KATP channels (Cartier et al., 2001, Partridge et al., 2001), 
while others alter channel function. For example, mutations in the NBD of SUR1 lead to 
formation of KATP channels that do not open in response to Mg-ADP (Nichols et al., 
1996, Ashcroft, 2006a, Gribble et al., 1997). Similarly, several mutations in the Kir6.2 
subunits result in channels that remain closed and do not regulate GSIS (Ashcroft, 
2005). Although numerous CHI-causing mutations have been identified not many have 
been characterised to understand how they affect channel trafficking and function. 
 
Apart from the mutations that cause altered channel function, some PHHI causing 
mutations affect trafficking of the channels to the cell surface thereby reducing surface 
channel density and thereby channel function leading to increased insulin secretion. 
For example, mutation delta F1388 in SUR1 prevents normal trafficking of the channels 
to the cell surface but does not affect channel function. Lack of the channels on cell 
surface causes disease (Cartier et al., 2001). Another mutation R1394H in SUR1 
causes retention of the channels in the trans-Golgi network (TGN), which reduces 
surface expression of the channels. However, treatment with diazoxide rescues the 
mutant channels to the cell surface where they form functional channels (Partridge et 
al., 2001). Some mutations in the transmembrane domains (TMD0, TMD1 and TMD2) 
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of SUR1 affect trafficking of the channels to the cell surface. Interestingly, mutations of 
TMD0 domain of SUR1 which cause trafficking defects in the mutant channels respond 
to treatment with channel blocker sulfonylurea drugs but not to diazoxide. The mutant 
channels pharmacologically rescued to the cell surface were found to be functional 
(Yan et al., 2007).  
 
CHI occurrence is rare in general populations with about 1 in 50,000 individuals 
affected but in certain Finnish and Saudi Arabian people it has a high occurrence of 1 
in 2,500 (Smith et al., 2007). The patients require treatment with high glucose to 
prevent brain damage and are responsive to therapy using exogenous glucagon which 
stimulates glycogen degradation and gluconeogenesis (Arnoux et al., 2010). Some of 
the patients are cured by treatment with diazoxide (Dunne et al., 2004) but the majority 
of the acute cases of hyperinsulinism require subtotal pancreatectomy (Christesen et 
al., 2007). About 40% of the patients suffering from CHI suffer from the disease of a 
focal nature where only certain regions of the pancreas are affected and secrete 
excessive insulin. A near total pancreatectomy is required to cure the CHI in patients 
with diffuse lesions (Ashcroft, 2005, Verkarre et al., 1998).  
 
Gain-of-function mutations 
Gain-of-function mutations in either Kir6.2 or SUR1 cause permanent neonatal 
diabetes mellitus (PNDM) characterised by reduced insulin secretion and resultant 
hyperglycemia (Ashcroft, 2005). Mutations in Kir6.2 gene that reduce the sensitivity of 
the KATP channels to ATP cause PNDM, while in most extreme cases patients may 
suffer from severe developmental delay, epilepsy and permanent neonatal diabetes 
(DEND) syndrome, characterised by marked developmental delay, muscle weakness, 
epilepsy, dysmorphic feature, and neonatal diabetes (Proks et al., 2004, Gloyn et al., 
2004). Mutations such as I182V or R201C/H in Kir6.2, which are located in close 
vicinity of the putative ATP-binding site, directly impair ATP binding and cause NDM 
alone (Proks et al., 2004, Gloyn et al., 2004). Mutations including Q52R, V59M/G, and 
I296L in Kir6.2, indirectly reduce the sensitivity of the channels to ATP as they affect 
the channel gating properties which increase channel opening. These mutations cause 
DEND syndrome along with severe NDM (Trapp et al., 1998). NDM can also be caused 
due to mutations that affect channel trafficking. For example mutations Y330C and 
F333I in Kir6.2 increase surface density of the KATP channels by reducing their 
internalisation the cell surface (Mankouri et al., 2006). Most patients suffering from 
NDM respond to sulfonylurea therapy (Ashcroft, 2005, Smith et al., 2007).  
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1.3.7 Physiological roles of cardiac KATP channels 
Cardiac KATP channels have been implicated in the maintenance of cellular functions 
and stress adaptation to protect the heart from arrhythmia. Kir6.2-knockout mice show 
an increased vulnerability to sympathetic stress and acute stress caused arrhythmia 
and sudden death (Zingman et al., 2002). Native cardiac KATP channels are considered 
to be formed of subunits Kir6.2 and SUR2A, although recent reports suggest that in 
mice Kir6.2 may be expressed with SUR1 in atrial myocytes and with SUR2A in 
ventricular myocytes (Flagg et al., 2008). Since cardiac tissue has a high concentration 
of ATP, cardiac KATP channels are closed under physiological conditions and metabolic 
insult such as increased cardiac work load, hypoxia, or ischemia causes channel 
opening (Kane et al., 2005).  
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1.4 Kv11.1 Potassium Channels 
1.4.1 Kv11.1 channels in normal activity of the heart 
Normal electrical activity of the heart depends on the co-ordinated generation of action 
potentials in individual cardiomyocytes which result from the opening and closing 
(gating) of ion channels that are expressed on cardiomyocyte cell membranes. Gating 
of ion channels allows movement of ions that created different phases of the cardiac 
action potential which include the resting phase, a depolarisation phase and the 
repolarisation phase. Different regions of the heart possess ion channels which have 
distinct pharmacological and gating properties and they function in co-ordination to 
keep the heart beating in rhythm. Alteration of the ion channel function due to inherited 
genetic mutations or drugs that modify channel gating properties or expression in the 
cell surface causes disorders such as cardiac arrhythmias (Sanguinetti and Tristani-
Firouzi, 2006, Amin et al., 2010).  
 
In mammalian cardiac ventricular myocytes, the action potential has five phases 0-4 
(Figure 1.5.A). In general, the resting potential of atrial and ventricular myocytes during 
resting phase is stable and negative (approximately -85 mV) due to the high 
conductance for K+ of the Kir channels. Upon excitation by electrical impulses from 
adjacent cells, Na+ channels activate (open) and permit an inward Na+ current leading 
to phase 0 depolarisation (initial upstroke). This is followed by phase 1 (early 
repolarisation), accomplished by transient outward flow of K+ ions due to opening of 
voltage-gated K+ channels. Next stage is the phase 2 (plateau) which is a balance 
between the depolarising L-type inward current from inflow of Ca2+ ions through Ca2+ 
channels and the repolarising opening of K+ channels. Currents from the channels that 
play a role in phase 2 can be categorised as ultra-rapid (Ikur), rapid (Ikr), and slow (Iks) 
activating. Phase 3 (repolarisation) comprises of the closing of the L-type Ca2+ 
channels and outflow of K+ ions due to opening of K+ channels. Phase 4 represents a 
return of the action potential to baseline (Amin et al., 2010).  
 
The voltage gated Kv11.1 channels encoded by KCNH2 in humans are also known as 
the human ether a go-go-related gene (hERG) channels, which have been identified as 
the potassium channels responsible for the IKr currents (also designated as ERG 
currents) that are a part of the cardiac action potential (Sanguinetti et al., 1995).  
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The hERG channels are also important for the pace-making activity of the sinoatrial 
(SA) and atrioventricular (AV) nodes of the heart and achieving the resting potential in 
neurons, smooth muscles and tumour cells. 
 
ERG currents have also been recorded in many other excitable cells or neuroendocrine 
cells, smooth muscle fibres of the gastrointestinal tract, where they contribute to the 
maintenance of the resting potential related to cell-specific functions like increase in 
hormone secretion, frequency adaptation or increase in contractility (Gullo et al., 2003, 
Schwarz and Bauer, 2004).  
 
The channels were first cloned from a hippocampal cDNA library in 1994 and belong to 
the conserved family of genes related to Drosophila eag, which encodes a distinct type 
of voltage-activated K+ channels (Warmke and Ganetzky, 1994). The history behind the 
name of the channel is that Drosophila geneticist studying the fly behaviour found that 
mutant flies, when anaesthetized with ether, exhibited a twitching behaviour that 
resembled the action of a go-go dancer; hence the mutant phenotype was named as 
ether-a-go-go (EAG) (Warmke and Ganetzky, 1994). The encoded EAG polypeptide is 
related both to voltage-gated K+ channels and to cyclic nucleotide-gated cation 
channels. Homology screens identified a family of eag-related channel polypeptides, 
highly conserved from nematodes to humans, comprising three subfamilies: EAG, ELK, 
and ERG. The human analogue of EAG gene was named HERG derived from the 
name human EAG-related gene. Since HERG or KCNH2 encodes the human Kv11.1 
potassium channel it is also known as hERG (Sanguinetti, 2005). The Kv11.1 channels 
found in mammals other than humans that have been studied include mouse, rat, 
guinea pig, rabbit and canine channels. In humans, the hERG channels are expressed 
in tissues throughout the body such as the heart, neurons and smooth muscles but 
their expression in cardiac tissue is quite high. Role of the channels in many other 
tissues is unknown. 
 
The mammalian ERG family of genes includes three genes ERG1, ERG2 and ERG3. 
The cardiac ERG has two N-terminal alternatively spliced variants of ERG1; ERG1a 
and ERG1b while the ERG2 and ERG3 are found to express in nervous system in rat 
(Guasti et al., 2005). The ERG1b protein is similar to ERG1a except that it has a 
shorter N-terminus and is found to express in mouse and human heart (London et al., 
1997). Functional ERG channels have been shown to be homo- as well as hetero-
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tetramers of both ERG1a and ERG1b proteins in human cancer cells (Crociani et al., 
2003) and in rat, human and canine ventricular myocytes (Jones et al., 2004).  
 
The ERG alpha subunits are reported to associate with single transmembrane-domain 
proteins MinK and MiRP1 (minK-related protein1) and are considered to affect channel 
function and trafficking (McDonald et al., 1997). For example interaction of hERG α-
subunits with β-subunit MiRP1 in heterologous expression systems, causes decreased 
trafficking of channels to the cell surface and a more rapid rate of deactivation. 
However looking at the tissue distribution of these subunits as well as the comparisons 
between hERG currents in presence or absence of MiRP1, it is considered unlikely that 
the protein has any physiologically critical role in the formation of functional hERG 
channels (Weerapura et al., 2002). 
 
1.4.2 Stoichiometry and structure of hERG channels 
Stoichiometry of hERG 
Homomeric channels encoded by HERG1a have been used as a model for studying 
the cardiac Ikr currents. The X-ray crystal structure of the hERG channels is not 
available till date. Gating properties of the hERG channels have been determined (for 
detailed review see(Tristani-Firouzi and Sanguinetti, 2003), based on the crystal 
structures of the bacterial KcsA, KvAP and MthK channels and a mammalian channel, 
Kv1.2, solved by Rod MacKinnon and his colleagues (Long et al., 2005b). 
 
Structure of hERG 
hERG channels are tetramers of ERG and each α-subunit is a six transmembrane 
protein like a typical Kv channel that forms the K+ selective channel pore where the S4 
domain serving as the main voltage sensor. The channels have a Per-Arnt-Sim (PAS) 
domain in the N-terminus (Morais Cabral et al., 1998) and a cyclic nucleotide binding 
domain (cNBD) within the C-terminus. 
 
Gating of hERG 
The channel pore is asymmetrical and its dimensions change as the channel gates 
open and close. The extracellular end of the narrow channel pore in hERG has the K+ 
selectivity filter that allows the passage of dehydrated K+ ions as a single file. The 
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highly conserved sequence Thr-Val-Gly-Tyr-Gly of amino acids line the channel pore in 
Kv channels but hERG has the Thr and Tyr residues substituted with Ser and Phe. 
Below the selectivity filter, the pore widens into a water-filled region, called the central 
cavity, which is lined by the S6 α-helices.  
 
The four S6 domains of the closed channels form a criss-cross near the cytoplasmic 
interface. This prevents the entry of K+ ions from the cytoplasm into the channel pore. 
When the cellular membrane depolarises, the S6 α-helices splay outwards allowing 
passage of ions into the channel. The S6 domain forms a hinge at the Ile-Phe-Gly motif 
which allows gating of the channel between the open and inactivated state which 
cannot close. This is unlike the gating seen in Kv1-Kv4 channels where the channels 
hinge at the Pro-Val-Pro motif. The bacterial KcsA, MthK, KirBac1.1 and KvAP 
channels have a conserved Gly residue in S6 is proposed to serve as the hinge which 
is located two helical turns above the Pro-Val-Pro motif in Kv channels (Sanguinetti and 
Tristani-Firouzi, 2006). The hERG channels undergo rapid C-type inactivation, deduced 
by study of Kv channels other than hERG, mediated by a slight constriction of the 
selectivity filter that may only occur when the outermost K+ binding site is not occupied 
by an ion (Kiss and Korn, 1998). The role of the PAS domain in the N-terminus of 
hERG in channel gating is not well understood although deletion of this domain results 
in rapid deactivation of the channel. Binding of cAMP to the CNBD domain has a 
relatively minor effect on channel gating but it is found to be critical for processing of 
the channels in the ER and disruption of this domain results in lack of functional 
channels expressed on cell surface (Akhavan et al., 2005). See Figure 1.6. 
 
Drug binding properties of hERG channels 
The hERG channels have been shown to be directly blocked in the intracellular pore, 
leading loss of Ikr currents, by a variety of drugs with diverse structures that include 
several anti-arrhythmic, psychiatric, anti-microbial and anti-histamine drugs (Fermini 
and Fossa, 2003). Drug binding is also reported to interfere with trafficking of the hERG 
channels to the cell surface resulting in reduced channel function leading to acquired or 
drug induced LQTS (for detailed review see (Dennis et al., 2007). This unique property 
of hERG channels is attributed to their structural features that can more effectively 
accommodate the binding of drugs as compared to other K+ channels. Lack of 
complete understanding of the channel structure limits the predictability for drugs that 
could bind hERG.   
 
 
 
Figure 1.6 Structure and gating of hERG
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Two polar residues (Thr623 and Ser624) located at the base of the channel pore helix 
and two aromatic residues (Tyr652 and Phe656) located in the S6 domain of the hERG 
subunit were found to be important for interacting with several drugs such as cisapride 
and terfenadine. The S6 residues (Tyr652 and Phe656) are unique to hERG since 
most Kv channels have an Ile and a Val in homologous positions. The binding of drugs 
to the channels is likely to be possible only when the channels are open (Sanguinetti et 
al., 1995, Sanguinetti and Tristani-Firouzi, 2006, Mitcheson, 2008). The occurrence of 
drug induced LQTS has resulted in the withdrawal of several blockbuster drugs from 
the market. Pharmaceutical companies are therefore required to screen compounds for 
hERG-channel activity early during preclinical safety assessment adding to the 
developmental costs. 
 
1.4.3 Pathophysiology of hERG channels 
The Long QT Syndrome (LQTS) 
The rhythmic changes in cardiac action potential are recorded in the electrocardiogram 
(ECG). A typical ECG tracing of the cardiac cycle (heartbeat) consists of a P wave, a 
QRS complex, a T wave, and a U wave; the baseline voltage of the electrocardiogram 
is known as the isoelectric line (Figure 1.5.B). The LQTS is commonly characterised by 
prolongation of the ventricular action potential duration during cardiac repolarisation, 
measured as the QT interval on the electrocardiogram (Figure 1.7.A-B). LQTS can lead 
to life-threatening torsade de pointes (TdP), see Figure 1.7.C. The inherited or 
congenital LQTS is mainly caused by mutations in genes that code for protein subunits 
of cardiac ion channels. Several genotypes of LQTS are known (LQTS1-10) of which 
LQTS1-3 have most common occurrence. Mutations in HERG (KCNH2) are found to 
cause the long QT syndrome 2 (LQTS2) which suggests that the channels play a 
critical role in myocellular repolarisation in the heart (Curran et al., 1995). More than 
200 HERG mutations have been identified and most of these are located in the hERG 
channel pore thereby affecting channel gating while others affect the intracellular 
trafficking of the channels (Anderson et al., 2006, Modell and Lehmann, 2006). Altered 
channel trafficking causes a reduction in the number of channels expressed on cell 
surface leading to decreased hERG currents (Ikr). The channels have also been 
implicated in drug induced LQTS2 where block of hERG channel pore by drugs results 
in decreased hERG currents (Sanguinetti et al., 1995).   
 
 
 
Figure 1.7 ECG traces in health and disease
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Both cardiac drugs as well as non-cardiac medications, antipsychotics (e.g., 
thioridazine), methadone, antimicrobials (e.g., erythromycin), the gastrointestinal 
stimulant cisapride, and antihistamines (e.g., terfenadine), may induce LQTS2 and TdP 
(Modell and Lehmann, 2006). Severity of this form of LQTS varies depending on the 
drug, dose and individual. In rare instances, drugs may also interfere with trafficking of 
the hERG channels. Conditions such as hypocalcemia, hypokalemia and 
hypomagnesemia related to diet, medical conditions and diuretic use can also cause 
LQTS (Massaeli et al., 2010, Modell and Lehmann, 2006). 
 
The Short QT Syndrome  
Short QT syndrome (SQTS) is a disease characterised by a shortened QT interval of 
the ECG and is associated with cardiac tachyarrhythmia including sudden cardiac 
death. It usually affects young and healthy people who may have no structural heart 
disease. SQTS is caused due to mutations in genes that encode for cardiac potassium 
ion channels. Gain-of-function mutations in HERG lead to SQTS (Brugada et al., 2005, 
Hong et al., 2005). For example, the inherited mutation hERG-N588K causes severely 
compromised inactivation abilities and faster deactivation kinetics of the mutant 
channels leading to SQTS (Grunnet et al., 2008). 
 
hERG channels and disorders of insulin secretion 
Majority of the patients suffering from diabetes mellitus, characterised by impaired 
insulin secretion leading to high blood sugar levels, are affected by cardiovascular 
diseases such as LQTS and show an increased risk of sudden cardiac death. Cardiac 
disorders are a major cause of death in diabetic patients. Though several ionic currents 
are found to be depressed in diabetic hearts, any decrease of hERG currents which are 
required for normal function of the heart (Veglio et al., 2004) would led to cardiac 
arrhythmia. The channels are also found to be down regulated by hyperglycemia, 
tumour necrosis factor-alpha (TNF-α), ceramide and the cellular metabolites 
accumulating in diabetic tissue and this may be due to over production of reactive 
oxygen species (ROS) which are known to decrease hERG function (Wang et al., 
2004a, Nanduri et al., 2008).  
 
A lot remains to be understood about the link between the disorders of insulin secretion 
and their effect of hERG. It has been reported that expression of the channel protein is 
reduced in diabetic hearts but not the levels of hERG mRNA which was attributed to 
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the over-expression of micro-RNA miR-133. This study indicates that apart from 
trafficking, expression of the channels on cell surface could also be regulated by 
miRNAs at translational levels (Xiao et al., 2007), However, trafficking of ion channels 
remains to be a major determinant of the number of channels expressed on the cell 
surface and is therefore important for understanding channelopathies (Delisle et al., 
2004).   
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1.5 Trafficking of Membrane Proteins 
 
This is an overview of trafficking mechanisms of membrane proteins. The trafficking of 
the KATP and hERG channels is discussed in the relevant chapters. 
1.5.1 General overview of membrane protein trafficking 
Cellular membrane proteins destined for the plasma membrane or for secretory and 
endocytic organelles are synthesised by ribosomes in the endoplasmic reticulum (ER). 
Newly formed proteins fold with the help of chaperones into the correct conformation in 
the ER membrane. Proteins are transported from the ER to an ER-Golgi intermediate 
compartment (ERGIC) and then are further sorted to the cis-Golgi. ER resident proteins 
are recycled back from ERGIC. For proteins that are multimers of same or different 
proteins, retention/retrieval to the ER ensures that only properly assembled multimers 
are transported to the cell surface (Figure 1.8). Misfolded or incorrectly assembled 
proteins in the ER are generally targeted for degradation through ER-associated 
degradation (ERAD) pathway. The trans-Golgi Network (TGN) serves as a sorting 
station that either sends proteins to the cell surface or diverts them to endosomes for 
further distribution within the cell (Ashcroft, 2006a, Bannykh et al., 1998, Bannykh and 
Balch, 1998).  
 
Thus the ER and Golgi are locations of quality control of the newly synthesised 
proteins. This includes a general surveillance system that screens for broad 
conformational characteristics such as appropriate membrane partitioning of 
hydrophobic domains or unpaired cysteine residues and a more selective mechanism 
that requires specific motifs interacting with transport proteins that help trafficking of 
correctly folded/assembled proteins from the ER or Golgi. These motifs are located on 
the proteins being transported or the ‘cargo proteins’ and are recognised/bound by the 
proteins involved in the forward trafficking of these proteins but till date only a limited 
number of these motifs have been identified (Ellgaard and Helenius, 2003) for 
particular classes of proteins. Membrane proteins expressed on cell surface by means 
of forward or biosynthetic trafficking pathways may be removed from the cell surface 
(internalisation or internalisation), transported back to the cell surface after 
internalisation (recycling) or transported to endosomes for degradation (Bonifacino and 
Traub, 2003, Maxfield and McGraw, 2004, Mayor and Pagano, 2007).  
  
 
 
Figure 1.8 Schematic showing forward trafficking of membrane proteins.
Membrane proteins are synthesised in the ER membrane and following vesicular 
transport they enter the ER
regulated transport of proteins out of the ER. Unassembled and ER resident proteins 
are transported back to the ER in COPI vesicles. Following processing in the Golgi, the 
membrane proteins ar
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Like in the biosynthetic pathway, motifs on the cargo proteins can play an important 
role in endosomal trafficking of the proteins. Identification and study of these trafficking 
motifs is critical for understanding the mechanism of trafficking of membrane proteins 
and is of fundamental importance to cell biology.  
 
1.5.2 Trafficking vesicles 
Transport of secretory and membrane proteins between intracellular compartments is 
generally vesicular, involving proteins of the coat complexes that direct the selection of 
cargo through recognition of signal motifs (Gorelick and Shugrue, 2001). The vesicles 
carrying the protein cargo pinch off from donor organelle membrane and then reach 
recipient organelle to deliver the cargo by fusing with the membrane of the recipient 
organelle (Aridor and Balch, 1996, Scales et al., 2000, Schekman et al., 1995). These 
coat complexes include (Bonifacino and Glick, 2004): 
• Coat protein complex II (COPII), which exports proteins from the ER. Proteins 
are sorted by recognition of specific motifs such as DXE on the cargo proteins.  
• Coat Protein Complex I (COPI), which binds di-leucine (LL) motifs and functions 
to direct retrograde transport of proteins from pre-Golgi and Golgi 
compartments to the ER.  
• Clathrin coated vesicles (CCV), which mediate sorting of receptors containing 
Tyr-based motifs from the TGN and the cell surface.  
Vesicular transport generally involves several mediator proteins that act in a cascade. 
Of several trafficking mediators known, such as the adaptor proteins (AP1, AP2), Sar 
proteins, Sec proteins and Rab-GTPases, it is evident that these proteins are more or 
less specific with reference to the site of their action and the kind of cargo they 
recognize (Doherty and McMahon, 2009, Barlowe, 2003).  
 
1.5.3 Endosomal trafficking of membrane proteins 
Changes in the distribution as well as the protein and lipid composition play a key role 
in regulation of several cell biological processes. Endosomal trafficking mechanisms 
control the lipid and protein composition of the plasma membrane, thereby regulating 
how cells interact with their environments (Steinman et al., 1983). Endosomal 
trafficking processes include: 
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• internalisation, which allows removal of membrane proteins expressed on cell 
surface or uptake of proteins into the cell; 
• endosomal recycling, which allows the transport of internalised proteins back to 
the cell surface; and 
• degradation, which diverts proteins internalised from the cell surface for 
degradation. 
These interactions can also have patho-physiological implications; for example, 
alteration of surface density of proteins such as an ion channel can lead to disorders 
caused by altered channel function (Steele et al., 2007a). Pathogens, such as viral 
proteins, have been shown to hijack the cellular endocytic mechanisms for entry into 
the cells and cause infection (Marsh and Helenius, 2006). Therefore, it is important to 
understand the basic cell biology of endosomal trafficking mechanisms and their 
regulation.   
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1.6 Forward Trafficking of Membrane Proteins 
1.6.1 ER exit of membrane proteins – COPII vesicles 
Some membrane proteins can leave the ER by bulk flow where the ER export is via 
non-selective vesicle transport while others are transported by a concentrated flow of 
proteins where proteins leave the ER after being selectively packaged into COPII 
vesicles that are rich in the protein cargo (Balch and Farquhar, 1995). This selective 
anterograde pathway involves coat assembly which begins through activation of a 
small G-protein, Sar1 which recycles between cytosolic and membrane-associated 
pools, with GTP binding generating the active, membrane-bound state (Barlowe et al., 
1994). Several types of ER-exit signals which play a role in transport of specific cargo 
from the ER exit sites (ERES) have been identified. These include the diacidic motifs 
[(D/E)X(D/E)], di-hydrophobic motifs (FF, YY, LL or FY), YXXXNPF and LXXLE motifs 
(Nishimura et al., 1999).  
 
Formation of the COPII transport vesicle begins with selective sorting and recruitment 
of correctly folded cargo proteins and the components of the COPII vesicle at the 
ERES and the formation of the COPII vesicles that bud off from the ER. It consists of 
proteins Sar1, Sec23–Sec24 and Sec13–Sec31 that are sequentially recruited to ER 
membrane surface. Sar1 is a small 21 KDa GTPase, whereas Sec23–Sec24 and 
Sec13–Sec31 are large heteromeric protein complexes. Activation of Sar1-GDP to 
Sar1-GTP is thought to regulate COPII coat assembly. Activation of Sar1-GDP to Sar1-
GTP is catalysed by a membrane-bound GDP–GTP exchange factor, Sec12 (a Sar1 
specific GDP dissociation stimulator), which is localised to ER (Barlowe and 
Schekman, 1995). To assemble COPII coat, membrane-bound Sar1-GTP binds to 
Sec23–Sec24, which in turn attracts Sec13–Sec31 that leads to clustering of the COPII 
vesicle proteins. Sec24 has several cargo recognition sites through which it binds the 
transmembrane cargo that is packaged into COPII vesicles. Cargo recognition by 
Sec24 is due to the specific ER exit motifs present on proteins that get concentrated at 
the ERES during export (Barlowe, 2003, Nishimura and Balch, 1997, Nishimura et al., 
1999, Bi et al., 2002). The cargo containing vesicles pinch off from the membrane 
following hydrolysis of Sar1-GTP to Sar1-GDP causing their release from the vesicle 
(Figure 1.9). 
  
 
 
Figure 1.9 Schematic showing the COPII vesicle
proteins. The assembly of the vesicle begins with the Sec12
GTP for GDP on Sar1 and recruitment of Sar1
followed by the sequential recruitment of the hetero
recognition and binding to Sec24 cargo and finally the recruitment of Sec13/31 coat 
proteins which lead to the assembly of the cargo loaded COPII vesicle 
sites. This assembly leads to the formation of a pre
formed is released into the cytoplasm as a COPII
Golgi apparatus. Hydrolysis of GTP to convert Sar1
the release of the COPII vesicle f
Nakano, 2007b).  
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The vesicles fuse at the Golgi membrane to deliver the cargo proteins to their 
destination. GDP/GTP exchange of Sar1 catalysed by Sec12 is critical for initiation of 
COPII coat assembly (Barlowe and Schekman, 1995).  
 
1.6.2 ER retrieval - COPI vesicles and 14-3-3 
Proteins that are returned back to the ER via the COPI vesicles include the ER resident 
proteins (for example, vSNAREs, ERGIC53/p58, the KDEL receptor), nucleus localised 
proteins (for example, the epidermal growth factor receptor family protein) and the 
proteins that do not get transported beyond the cis-Golgi (for example, unassembled 
protein complex components (Wang et al., 2010, Lee and Goldberg, 2010). 
 
Additionally, COPI coat proteins have complex functions in intra-Golgi trafficking and in 
maintaining the normal structure of the mammalian interphase Golgi complex. COPI-
coated vesicles form on the Golgi apparatus by the sequential recruitment of an ADP 
ribosylation factor 1 (ARF1) protein and coatomer, a 550 KDa cytoplasmic complex of 
seven COPs α-, β-, β0-, γ-, δ-, 3-, and ζ-COP (Waters et al., 1991, Yang et al., 2002). 
Budding of the cargo containing COPI vesicles is initiated by the exchange of GDP for 
GTP on ARF catalysed by a Golgi-localised guanine nucleotide exchange factor (GEF). 
See Lee et al., 2010 for a detailed review. 
 
The coatomer COPI proteins are reported to recognise and bind an arginine based 
RXR motif, where X could be any amino acid, on their cargo (McMahon and Mills, 
2004). It was originally suggested that the 14-3-3 proteins bind to the RXR motif; for 
detailed review see (Michelsen et al., 2005). It was considered that in unassembled 
KATP channels the RXR motif on the Kir6.2 and SUR1 subunits is bound by the 14-3-3 
protein which causes their ER retention. With further research on the 14-3-3 proteins, it 
was found that the 14-3-3 proteins bind only dimeric or tetrameric ‘RXR’ motifs 
following which the proteins are returned to the ER via COPI vesicles. It was 
considered that the proteins bind to partially assembled KATP channel subunits and 
probe the assembly state of the channel (Heusser et al., 2006, Mrowiec and 
Schwappach, 2006, Nufer and Hauri, 2003).  
The TASK-1 and TASK-3 potassium channels have also been shown to bind to 14-3-3 
through tri-basic motif, KRR, which differs in several important aspects from canonical 
arginine-based (RXR) or lysine-based (KKXX) ER retention signals. Interaction with 14-
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3-3 has no significant effect on the dimeric assembly of the channels (Zuzarte et al., 
2009). In case of the Major Histocompatibility Complex II (MHCII) protein, 14-3-3 binds 
to the phosphorylated membrane protein enabling its forward trafficking (Mrowiec and 
Schwappach, 2006).  
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1.7 Internalisation of Membrane Proteins 
1.7.1 Introduction 
Endocytic mechanisms essentially require selection of the cargo protein at the cell 
surface followed by budding off of the region of the plasma membrane containing the 
endocytic cargo and tethering of the cargo containing vesicles to their destination 
endosomal compartment within the cell where the vesicle can fuse to deliver its cargo. 
Several different endocytic mechanisms have been identified which vary in the cargoes 
they transport and may use distinct protein machinery, but owing to their complexity a 
lot still needs to be understood regarding these cellular processes.  
 
Classification of endocytic mechanisms can be based on the requirement for dynamin- 
pathways that use dynamin-mediated scission mechanism (dynamin-dependent), and 
those that require other processes (dynamin-independent). Two major classes of 
dynamin-dependent pathways use either clathrin or caveolin coat proteins. Another 
basis of classification is pathways that use clathrin (clathrin mediated) or all other 
pathways (clathrin independent). Clathrin independent mechanisms are classified 
according to requirement of the small GTPases- CDC42, RhoA and ARF6 (Doherty 
and McMahon, 2009, Mayor and Pagano, 2007); see Figure 1.10. 
 
Study of endocytic mechanisms of proteins is complicated as the same endocytic cargo 
may be internalised by different mechanisms in different cell types or may switch 
pathways in a single cell type under different conditions. For example; albumin is 
internalised in caveolae in some cell types such as human skin fibroblasts and 
endothelial cells, whereas in Chinese Hamster Ovary (CHO) cells it is internalised by a 
RhoA-dependent mechanism (Singh et al., 2003). Another example is cholera toxin 
(CT), which bind to GM1 at the plasma membrane and is internalised to the Golgi and 
then transported to the ER. In the ER, catalytic subunits of CT are translocated to the 
cytosol causing toxicity. CT has been found to be internalised by multiple endocytic 
pathways which include the clathrin-, caveolin-, ARF6- and CDC42- dependent 
pathways. Simultaneous block of all these pathways does not prevent toxicity which 
suggests that additional pathways may exist for internalisation of the CT into the cells 
(Massol et al., 2004). Choice of endocytic mechanism has also been shown to regulate 
the fate of its cargo. For example, epidermal growth factor receptors (EGFR) that 
undergo clathrin mediated endocytosis (CME) have longer life while EGFR receptors 
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that undergo clathrin independent internalisation (CIE) are diverted for degradation. 
Thus CME is important for some EGFR-activated signalling pathways and EGF-
dependent biological responses, such as DNA synthesis (Torgersen et al., 2001, 
Sigismund et al., 2008). 
1.7.2 Clathrin mediated endocytosis 
Clathrin mediated endocytosis (CME) is one of the most common and well studied 
endocytic mechanisms. It is mediated by the formation of clathrin coated vesicles 
(CCV) at the cell membrane. CCV can also bud from membranes of intracellular 
compartments and assist in cargo transfer within the cell. Adaptor and accessory 
proteins coordinate formation of CCV at the plasma membrane by facilitating 
membrane curvature and constriction of the vesicle neck. Release of the CCV from the 
plasma membrane into the cell is mediated by the membrane scission protein, the 
large GTPase dynamin, which forms a helical polymer around the constricted neck of 
the CCV (Praefcke and McMahon, 2004). The clathrin coat is removed from the vesicle 
by auxilin and hsc70 allowing the targeting of the vesicle to its destination within the 
cell to deliver its cargo by fusion with the cell membrane (Lee and Goldberg, 2010).  
 
Membrane proteins that are endocytosed via the CME have di-leucine (LL) or tyrosine-
based (YXXΦ, where Φ is a hydrophobic amino acid) motifs which act as signals that 
are recognised by adaptor protein-2 (AP2), which form a link between the cargo and 
the clathrin molecules. For example, the classical CME cargo transferrin receptor has 
the YTRF motif which is found to be critical for internalisation of the receptor (Collawn 
et al., 1990); CME of the pancreatic KATP channels requires an intact YSKF motif in the 
carboxyl-terminus of Kir6.2 subunits. Mutations Y330C and F333I that disrupt this motif 
have been shown to abrogate internalisation of reconstituted mutant channels causing 
permanent neonatal diabetes mellitus (Mankouri et al., 2006). Considering the varied 
cargoes that are internalised by CME it is being considered that more than one kind of 
adaptor and accessory proteins are involved in the formation of different subtypes of 
CCVs that are directed to specific locations within the cell (for detailed review see 
Doherty and McMohan, 2009). 
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1.7.3 Clathrin independent endocytosis 
Endocytic pathways that do not use clathrin are generally classified as clathrin 
independent endocytic (CIE) mechanisms. CIE pathways are mostly mediated by lipid-
rafts and may or may not require dynamin for membrane fission (Doherty and 
McMahon, 2009). Rafts are small platforms in membranes and are composed of 
sphingolipids, phospholipids and cholesterol in the lipid bilayer. Lipid-rafts are present 
on both the plasma membrane as well as in the membranes of the ER, Golgi and 
endosomes. Raft components including cholesterol, ceramide and the hydrophobic 
backbone of sphingolipids are synthesised in the ER and sphingolipid head groups are 
attached to ceramide in the Golgi complex for the assembly of lipid-rafts which then 
spread into the endosomal recycling compartments. Cholesterol partitions between the 
raft and the non-raft phases of the membranes and has higher affinity to raft 
sphingolipids than to unsaturated phospholipids. Cholesterol molecules act as spacers 
between the hydrocarbon chains of the sphingolipids and maintains raft structure 
(Simons and Toomre, 2000). Removal of raft cholesterol using methyl-β-cyclodextrin or 
saponin, generally leads to dissociation of most proteins from rafts and renders them 
non-functional. Since the rafts are not solubilised by Triton X-100 or with CHAPS at 
4°C they are also referred to as detergent-resistant membranes (DRMs) (Simons and 
Ehehalt, 2002). The partitioning of proteins into and out of rafts can be tightly regulated. 
For example; peripheral membrane protein such as non-receptor tyrosine kinase, can 
be reversibly palmitoylated and can lose its raft association after depalmitoylation 
(Zacharias et al., 2002). Raft mediated membrane trafficking mechanisms are 
discussed below: 
 
Caveolin-mediated internalisation 
Caveolins are coat proteins that have been implicated in the formation of caveolin 
coated vesicles known as ‘caveolae’. Caveolae are 50–80 nm flask shaped 
invaginations of the cholesterol rich lipid raft membranes (caveolar rafts) that are 
involved in caveolar internalisation. There are three isoforms of mammalian caveolin 
proteins, caveolin1-3. Caveolin1 is considered to be muscle specific while caveolin1 
and caveolin2 are expressed in most non-muscle cells (Rothberg et al., 1992). Several 
cargoes such as the SV40, cholera toxin (CT) have been shown to internalise in a 
caveolin dependent manner to large intracellular structures called as caveosomes. 
Caveolins have been shown to associate with cholesterol and glycosphingolipid GM1. 
Cholesterol depletion and phosphorylation of caveolin1 flattens the caveolae. Studies 
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using phosphomimetic mutant (S80A) of Caveolin1 suggest that dephosphorylation of 
the protein at ER/Golgi, where the formation of caveolae initiates, may regulate the 
formation of caveolar micro-domains (Schlegel et al., 2001).  
  
 
 
 
Figure 1.10 Schematic of different endocytic mechanisms
and dynamin-independ
and Pagano, 2007). CME
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Endocytic nature of caveolae is not well understood and it is considered that caveolae 
may or may not pinch off from the cell membrane. Apart from internalisation, caveolins 
have been implicated as being anchors for signalling molecules and caveolae are 
considered to act as signalling platforms (Krajewska and Maslowska, 2004). For 
example, localisation of Kv1.5 channels to caveolar rafts has been shown to be critical 
for regulating the channel function (Martens et al., 2001, Martinez-Marmol et al., 2008).  
 
Flotillin-mediated internalisation 
 
Flotillin proteins (also called reggie proteins) are homologous to caveolin1 and are 
found to oligomerise and associate into clusters that form scaffolds for membrane 
micro-domains. The caveolin independent flotillin micro-domains are considered to 
have a role in facilitating dynamin-dependent internalisation of proteoglycans as well 
the as epidermal growth factor receptor (EGFR), cellular prion-related protein (PrPc), 
GFP-GPI and CT (Stuermer et al., 2001, Payne et al., 2007), for review see (Mayor 
and Pagano, 2007, Sandvig et al., 2008). They form hairpin structures in the plasma 
membrane and have been shown to undergo cycling to and from the plasma 
membrane. Scission factors for flotillin based carriers are unknown but their trafficking 
within the cell is regulated by Rab5. Besides the plasma membrane, flotillin is localised 
to various intracellular compartments; however, the trafficking pathways used by them 
is not very clear and they are even considered to act upstream of the clathrin-
independent pathways (Langhorst et al., 2008, Langhorst et al., 2005, Stuermer et al., 
2004).  
 
CDC42-regulated internalisation 
Internalisation of caveolin1-associated cargoes overlap with those of the clathrin-
independent carrier (CLIC) and glycoslyphosphatidylinositol anchor protein (GPI-AP) 
enriched early endosomal compartment (GEEC) pathway. These are examples of 
clathrin- and caveolin-independent pathways that require lipid-raft domains, also 
designated as non-caveolar lipid-rafts. Cargoes of non-caveolar raft domains include 
extracellular fluid, SV40 virions, CT, GM1, GPI-linked proteins, as well as receptors for 
IL2, growth hormone, AMF and many other molecules (Mayor and Pagano, 2007).  
 
CDC42-regulated endocytic pathway is one of the main routes for non-clathrin, non-
caveolar uptake of cargoes such as CT, plant protein ricin, and Helicobacter pylori 
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vacuolating toxin (VacA). GPI-AP are localised to lipid-raft membranes and undergo 
internalisation via this cholesterol-dependent, clathrin-independent pathway to GEEC 
instead of the conventional Rab5 positive early endosomal compartments. Membrane 
constituents are believed to cause membrane budding that is independent of dynamin 
and requires the small G protein CDC42. Internalisation into GEECs is considered to 
require CDC42-regulated recruitment of the actin polymerisation machinery. The 
CDC42-regulated endocytic carriers that bud from the cell surface have long and 
relatively wide surface invaginations which also allow internalisation of large volume of 
fluid phase markers in a single budding event compared to clathrin and caveolin 
mediated mechanisms of internalisation (Chadda et al., 2007, Mayor and Pagano, 
2007).  
 
Rac and RhoA-regulated internalisation 
A class of CIE pathways are regulated by RhoA GTPase which is considered to cause 
rearrangement of the actin cytoskeleton. These endocytic processes can be 
independent of coat proteins and dynamin, and are mediated by cholesterol rich lipid 
raft membrane regions or use dynamin as a scission factor. The dynamin-dependent, 
RhoA regulated pathway includes the IL-2 pathway where Rab5 and Rab7 are involved 
in trafficking within the cell.  
 
Phagocytosis and macropinocytosis 
Phagocytosis is the means of internalisation of large particles into the cell which are 
generally diverted to lysosomes in a Rab7 dependent manner for degradation. It is 
considered to be mediated by factors such as Rac1 or PKC and involves actin and 
microtubule rearrangement (Swanson and Baer, 1995).  
 
Macropinocytosis is an actin-mediated endocytic process involving plasma membrane 
ruffles and internalisation of fluid and particles in large, uncoated, endocytic vacuoles 
known as macropinosomes (Swanson and Watts, 1995). The ruffles can take the form 
of lamellipodia or filopodia and are irregular in shape as they are independent of coat 
proteins and can be up to 10 µm in diameter. It is a clathrin- and caveolin-independent 
mechanism for uptake of fluids and is considered to be regulated by tyrosine kinases, 
Ras, Rac1, and Rab34, Na+ /H+ exchange factors, CDC42 and cholesterol. For detailed 
review see (Mayor and Pagano, 2007, Mercer et al., 2010, Swanson and Watts, 1995).  
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ARF6-mediated endocytic pathway 
ADP-ribosylation factor 6 (ARF6) localises to the plasma membrane in its GTP state 
and to a tubulovesicular compartment in its GDP state (Macia et al., 2004). It is 
expressed widely in different cell types and has been implicated in dynamin- and 
clathrin-independent, raft-mediated internalisation and recycling of membrane proteins 
through its GTPase cycle. Apart from membrane trafficking, ARF6 has been shown to 
function in a variety of biological events, including chromaffin granule exocytosis, Fc-
receptor-mediated phagocytosis, epithelial cell migration and adherens junction (AJ) 
turnover (Sabe, 2003). ARF6 alters the cortical actin cytoskeleton and the lipid 
composition at the PM through activation of phosphatidylinositol 4-phosphate 5-kinase 
[PI(4,5)P2] and phospholipase D (PLD) and can facilitate clathrin-dependent as well as 
clathrin-independent internalisation of ligands (Aikawa and Martin, 2003). ARF6-
regulated CME requires AP-2. 
 
ARF6-regulated CI endocytic cargos include MHCI, β1integrin, E-cadherin, GPI-AP, IL-
2R-α (Tac) (Eyster et al., 2009). After internalisation, ARF6-GTP and cargo containing 
endosomal compartments are separate from the classical early endosomal 
compartments but have been shown to fuse with Rab5 associated early endosomes 
following hydrolysis of ARF6-GTP. Recycling vesicles derived from clathrin-dependent 
and independent internalisation might eventually converge in a common endosomal 
recycling compartment (ERC). For example, after internalisation, MHCI eventually 
enters the transferrin-positive endosomal compartments from where it can be recycled 
back to the cell surface (Donaldson and Williams, 2009). Aluminium fluoride (AlF) 
treatment redistributes ARF6 to the PM and stimulates the formation of actin-rich 
surface protrusions that prevents internalisation and recycling. ARF6 activation is 
required for recycling of MHCI from the endosomal membrane back to the PM which 
can be regulated by Rab11, Rab22, Rab35 and CDC42 (D'Souza-Schorey and 
Chavrier, 2006, Donaldson, 2003, Donaldson et al., 2009, Eyster et al., 2009),  see 
Figure 1.11. 
  
 
 
Figure 1.11 Schematic of 
clathrin-independent 
mediated by ARF6 (red star) is shown using MHCI (pink triangle) as an example 
compared to dynamin (orange circles) and clathrin mediated 
the transferrin receptor (green oval) as an ex
ruffling due to activation or Src, clathrin coated vesicles fusion with Rab5 (blue bar), 
EEA1-positive, “classical” early endosomes (EE) containing the CME cargo. From 
here, CIE cargo may go on to late endosomes (LE)
reaches the endosomal recycling compartment (ERC) either directly or after fusion with 
EE and may be recycled back out to the plasma membrane. 
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1.8 Endosomal Recycling of Membrane Proteins 
 
Proteins internalised from the cell surface are targeted to specific endosomal 
compartments from where they may be recycled back to the cell surface or undergo 
lysosomal degradation by means of vesicular transport. These endosomal recycling 
processes are regulated by the Rab-GTPases which have been implicated principally 
in the control of vesicle docking and fusion (Gonzalez and Scheller, 1999).  
 
1.8.1 Rab proteins 
Rab proteins are members of the Ras super family of GTPases and are key regulators 
of intracellular vesicular transport. They undergo a cycle of GTPase activity which 
allows a cycle of reversible attachment of the Rabs to endosomal membranes. 
Transport vesicles contain Rab-GTP which is hydrolysed to Rab-GDP when the 
vesicles fuse with membranes of endosomal compartments. Rab-GDP is then recycled 
back to their membranes of origin. After delivery to their respective membranes Rab-
GDP is activated to Rab-GTP, which allows it to interact with a wide variety of effectors 
that help in vesicular transport by promoting docking of transport vesicles to their 
specific target membranes. At steady state most of the Rabs are membrane-
associated, however about 10-50% can be detected in the cytosol (for a detailed 
review see (Schimmoller et al., 1998). 
 
Several Rab proteins have been identified and in most cases they are specifically 
associated with a particular organelle or pathway. They are tightly regulated by 
accessory proteins through membrane association, nucleotide binding and hydrolysis. 
Table 1.2 lists different Rab proteins and their role in endosomal trafficking (for a 
detailed review see(Somsel Rodman and Wandinger-Ness, 2000, Goody et al., 2005, 
Pfeffer and Aivazian, 2004). 
 
Loss of Rab function due to mutations in the GTPases have been implicated as the 
cause of several disease conditions such as bleeding and pigmentation disorders 
(Griscelli syndrome), mental retardation, neuropathy, kidney disease (tuberous 
sclerosis) and blindness (choroideremia). Altered function of regulatory molecules of 
Rabs can cause cancers (prostate, liver, breast) as well as vascular, lung, and thyroid 
diseases (for detailed review see(Stein et al., 2003).  
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Table 1.2 Rab proteins and functions mediated by them in endocytic trafficking.  
Rab protein Function mediated by Rab 
Rab4 Regulation of sorting and recycling, localised on EE and RE 
Rab5 Formation of CCV for internalisation of cargo proteins from 
PM and facilitating fusion of the CCV with EE or EE with EE 
Rab6 Budding and trafficking of vesicles arising from the TGN to 
recycle cargo such as Shiga toxin to cell surface. 
Rab7 Transport from EE to LE and fusion of compartments from LE 
for fusion with lysosomes for degradation 
Rab9 Transport of cargo from LE to TGN 
Rab10 Basolateral trafficking 
Rab11 Regulation of recycling from the perinuclear ERC, and 
transport from TGN to PM 
Rab14 Internalisation, lysosomal fusion and phagocytosis 
Rab20 Internalisation and recycling in epithelial cells 
Rab22 Localised to EE and LE, also implicated in recycling from LE 
Rab32 Localised to lysosomes related organelles 
Rab34 Formation of macropinosomes and lysosomal distribution 
Rab35 Slow endocytic recycling through recycling endosomes 
Rab38 Localised to lysosomes related organelles 
Rab39 Internalisation 
 
EE, early endosomes; LE, late endosomes; ERC, endosomal recycling compartments; 
CCV, clathrin coated vesicles; (Barr and Lambright, 2010, Stein et al., 2003, Valente et 
al., 2010) 
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1.8.2 Rabs and post endocytic trafficking of membrane proteins 
Endosomal trafficking of CME cargo 
During internalisation, Rab5 facilitates segregation of cargo (for example, the human 
transferrin receptor) into clathrin coated vesicles (CCV) and together with a number of 
effector molecules, promotes fusion with early endosomes (EE). Hence Rab5 positive 
early endosomal compartments are the first destination of post endocytic cargoes of 
CME (Zerial and McBride, 2001). Generally, proteins from the EE are subsequently 
sorted for recycling back to the plasma membrane or transported to lysosomes for 
degradation. EE micro-domains containing Rab4 molecules promote rapid recycling of 
the proteins back to the cell surface. Rab15 inhibits recycling from early endosomes 
(Zuk and Elferink, 2000, Zuk and Elferink, 1999). Membrane proteins that do not 
recycle back from the EE are transported to late endosomes (LE) and recycling 
endosomes (RE) from where they undergo recycling back to the plasma membrane in 
a Rab11 and Rme1 dependent manner (Schlierf et al., 2000). Proteins destined for 
degradation are diverted to lysosomes in a Rab7 dependent transport. Some proteins 
such as the mannose 6-phosphate receptor (M6PR) are transported to the TGN from 
LE with the help of Rab9. Apart from the Rabs described here, other cell specific Rabs 
are also known; for example, Rab25 is involved in the apical recycling of proteins from 
the LE to TGN (see Figure 1.12).  
 
Endosomal trafficking of CIE cargo 
Proteins internalised through the CIE have been shown to enter compartments 
separate from the EE. These vesicles may bypass entry into EE and fuse with 
endosomes containing CME cargo and are diverted to distinct tubular endosomes that 
recycle the proteins back to the PM or get diverted to LE and subsequently to 
lysosomes for degradation. Some examples of CIE cargo include the MHCI protein, 
GPI-AP, the cation channel protein mucolipin-2 and E-cadherin. Recycling can be 
mediated by Rab11, Rab22, Rab35, extracellular signal regulated kinase Erk, CDC42 
and Par3 (for a detailed review see(Eyster et al., 2009).  
 
ARF6 is one of the key regulators of dynamin and clathrin-independent endocytosis. 
After internalisation ARF6-GTP and cargo containing endosomal compartments bind 
phosphatidylinositol 3-phosphate (PI3P) which allows fusion with Rab5 associated 
early endosomes containing clathrin cargo. Thus endosomal vesicles derived from 
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clathrin-dependent and independent endocytic events eventually converge in a 
common recycling compartment (Naslavsky et al., 2003). For example, after 
internalisation, ARF6 endocytic cargo MHCI eventually enters transferrin positive 
endosomal compartments from where it enters the tubular recycling compartments 
(ERC) from where they can be recycled back to the cell surface (Donaldson and 
Williams, 2009). Expression of a constitutively active form of ARF6, ARF6-Q67L, 
stimulates CIE and causes accumulation of internalised cargo in enlarged vacuolar-
type structures that are coated with actin and PIP2 which prevents further traffic to 
Rab5 endosomes and recycling. ARF6 cargoes such as CD55, Glut1 and CD59 are 
transported to the ERC by bypassing entry into EE and recycled back to the cell 
surface in a Rab22 dependent manner. The ‘GDP on’ mutant of ARF6 (T27N), has 
been shown to localise mainly to the ERC, and can block recycling of proteins back to 
the cell surface. Proteins such as the GPI-AP and the fluid phase markers are 
internalised by an ARF6-independent mechanism into GEECs which subsequently 
acquire Rab5 and EEA1 following which they either fuse with other GEECs or with 
endosomes carrying the CME cargo in a Rab5 dependent manner (Kalia et al., 2006), 
see Figure 1.13. 
 
Caveolae containing dynamin-dependent cargoes and CIE cargoes are internalised to 
endocytic caveolar carriers or caveosomes, both of which can fuse back to the cell 
membrane allowing recycling of the proteins. SV40 virus is transported to the LE from 
the caveosomes in a Rab5 dependent manner from where they can traffic to the TGN 
(Parton and Simons, 2007).  
  
 
 
Figure 1.12 Schematic of endosomal trafficking of membrane proteins 
internalised by CME
membrane proteins are shown along with the different 
process. 
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Figure 1.13 Schematic of endosomal trafficking of membrane proteins 
internalised via dynamin and clath
Different routes of post endocytic trafficking and recycling of membrane proteins are 
shown along with the different Rab proteins that help in the process. (
endosomes; LE, late endosomes; ERC, endosomal recyc
trans-Golgi network; GEEC, GPI
phosphatidylinositol 4,5
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1.9 Aims of the Study 
 
The aim of this study was to investigate the trafficking mechanisms of the pancreatic 
KATP and the cardiac hERG ion channels and compare the underlying mechanisms. 
Although the endosomal trafficking of KATP channels is better understood, not much is 
known about the trafficking of hERG channels. 
 
In Chapter 3, the mechanistic details of ER export of the KATP channels will be 
investigated using cell biological approaches. A mutation, E282K, in the C- terminus of 
the Kir6.2 subunit of the KATP channel has been reported to cause congenital 
hyperinsulinism (CHI) and previous studies from the group suggested that this mutation 
causes abrogation of the diacidic ER exit motif on Kir6.2. In this chapter, it will be 
investigated if E282 on the Kir6.2 is a part of the canonical DXE motif required for 
assembly of the channels into COPII vesicles. Using epitope-tagged constructs for the 
wild type and the E282K mutant subunits, the molecular basis of the disease 
phenotype will be examined.  
 
In Chapter 4, it will be investigated if hERG channels are also exported out of the ER in 
COPII vesicles like KATP channels. In addition, using C-terminal truncations, the location 
of the ER exit motifs in hERG will be investigated.  
 
In Chapter 5, the endocytic trafficking mechanism of hERG channels will be 
investigated using functional, biochemical, pharmacological and cell biological 
approaches. The mechanism of hERG internalisation will be compared to the clathrin 
mediated endocytosis of KATP channels. The mode of hERG internalisation, if 
understood could help in gaining an insight into how this process may be regulated in 
health and disease.  
 
In Chapter 6, the endocytic recycling process will be investigated. It will be determined 
whether internalised hERG channels also recycle back to the cell surface. Factors that 
may be involved in the regulation of endocytic trafficking of the channels will be 
investigated using functional, pharmacological and cell biological approaches. 
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CHAPTER 2 
 
General materials and methods 
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2.1 Materials 
2.1.1 Cell lines 
The mammalian human embryonic kidney (HEK293) cells were purchased from the 
European Collection of Cell Cultures (ECACC, Cambridge, UK). The HEK293-MSRII 
(HEK-MSRII) cell line, a derivative of the HEK293 cell line with improved adhesion 
properties was a kind gift from Dr. SP Yusaf, Glaxo-Smith Kline (GSK), Stevenage, 
UK. HeLa cells were a gift from Dr. Vas Poonambalam, University of Leeds.  
2.1.2 Tissues 
Neonatal rat hearts were obtained from sacrificed 3-7 day old Wistar rat pups provided 
by members of Dr. Gamper’s lab. Guinea pigs were obtained from the University of 
Leeds animal house and handled, sacrificed and dissected to obtain hearts by Dr. 
Matthew Hardy, University of Leeds, following the UK Home Office guidelines. All 
experimental protocols requiring the use of animals conformed to the Animals Scientific 
Procedures Act, 1986. 
2.1.3 General materials 
Sterile plastic-ware for tissue culture was purchased from Sarsted. All solutions for 
other experimental procedures were prepared using sterile deionised Milli-Q water (18 
MΩ, Milli-Pore). Sterile tubes and tips and solutions were used for construction of 
mutant constructs and general amplification of plasmid DNA. Solution stocks were 
sterilised by autoclaving. Heat labile solutions were filter-sterilized using 0.2 µm 
Acrodisc PF filters (Gelman Science).  
2.1.4 Tissue culture media 
Basal media for tissue culture, DMEM/F-12 with GlutaMax™ was purchased from 
Invitrogen (Cat: 31331). Medium supplement fetal bovine serum (Cat# F524) and 
antibiotics penicillin-streptomycin were purchased from Sigma chem. co., G-418 
disulphate (Cat# G0175) and Blasticidin (Cat# R210-01) were purchased from Melford. 
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2.1.5 Growth media 
Bacto-tryptone and yeast extract were purchased from Amersham and Difco 
laboratories. Bacterial agar was purchased from Oxoid, ampicillin sodium salt (Cat# 
A0104) was purchased from Melford.  
2.1.6 DNA cloning – reagents for DNA modification 
Restriction endonucleases were purchased from New England Biolabs (NEB). 
PfuTurbo® DNA polymerase was purchased from Stratagene. Electrophoresis grade 
agarose was purchased from Life Technologies. 
2.1.7 Oligonucleotides or DNA cloning 
Oligonucleotide primers were designed for site-directed mutagenesis, PCR or DNA 
sequencing and were from Invitrogen Life Technologies. Primers were reconstituted in 
sterile deionised water to the concentration of 1 nmol/µl for long-term storage at -20ºC. 
2.1.8 Bacterial strains 
For general amplification of plasmids competent E.coli DH5α cells were prepared. The 
cells were grown in LB media and incubated in a 37ºC orbital shaking-incubator at 200-
250 rpm. 
2.1.9 Chemicals and solutions 
Laboratory reagents and chemicals were purchased from Sigma, BDH and the 
Anachem Chemicals Company unless otherwise stated. Isopropanol and ethanol were 
purchased from BDH. 
2.1.10 Plasmid vectors 
Most of the constructs used in the study are in mammalian expression vectors pcDNA3 
(+), pcDNA6/HIS™A or pEGFP from Invitrogen / Life Technologies. The constructs for 
expression of the KATP and hERG channels used in this study are as follows: the HA-
tagged Kir6.2 is in pcDNA3 and the myc- and HIS6-tagged SUR1 are in 
pcDNA6/HIS™A (Figure 2.1 & Figure 2.2), (Mankouri et al., 2006). hERG cDNA 
(accession number Q12809) was a kind gift from Prof. SA Goldstein (University of 
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Chicago) and was cloned into pcDNA3 along with the insertion of an HA-tag to 
generate HA-hERG-pcDNA3 plasmid (Figure 2.3) by Dr. Elliott, a member of the Rao 
lab. All other plasmid constructs are described in the relevant chapters.  
2.1.11 DNA transfection 
Transient transfection of cells with plasmids for expression of the required proteins was 
carried out using Fugene® 6 transfection reagent (Roche) and Optimem® for dilution of 
reagents (Invitrogen).  
2.1.12 Antibodies 
Primary antibodies: Anti-HA (YPYDVPDYA) high affinity rat monoclonal antibodies 
(clone 3F10) were obtained from Roche. Anti-Kv11.1 (hERG) antibodies against 
extracellular epitope (AFLLKETEEGPPATEC) on hERG channels, raised in rabbit, 
were purchased from Sigma, mouse monoclonal antibodies against the Myc-tag 
epitope (EQKLISEEDL) of human c-Myc residues 410-419, clone 9B11 were from Cell 
Signalling Technology. 
Secondary antibodies: Anti-rat, rabbit and mouse fluorescein isothiocyanate (FITC) - 
conjugated and anti-cyanine-3 (Cy3) - conjugated antibodies were purchased from 
Jackson Immuno Research Laboratories. Anti-rat and mouse Alexa-488 and Alexa-633 
conjugated secondary antibodies were purchased from Invitrogen.  
Other antibodies used in the study are described in the relevant chapters. 
2.1.13 Materials and reagents for western blotting 
All chemicals for polyacrylamide gel electrophoresis (PAGE) were obtained from 
Sigma. Nitrocellulose membranes (Cat# 162-0115); blotting paper (Cat# 170-3960) and 
apparatus for gel electrophoresis and western blot transfer (Trans-blot) were 
purchased from BIORAD. Pre-stained protein ladders were purchased from Fermentas 
(Cat# SM1811, SM0671).  
  
 
 
Figure 2.1 Map of 
(YPYDVPDYA) and an additional 11 amino
introduced into an extracellular loop of mouse Kir6.2 (accession number D50581) by 
PCR (Zerangue et al,1999) to produce this construct cloned in
expression vector pcDNA3, with ampicillin as 
geneticin as selection marker in mammalian cells. Plasmid map
PlasMapper (Dong et al., 2004)
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Figure 2.2 Map of 
prepared by cloning hamster SUR1 
et al, 2001). HIS6-SUR1
epitope into the first extracellular loop of 
(Sharma et al, 1999); the resultant
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Figure 2.3 Map of
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Chicago). A HA (hemagglutinin A) epitope and an additional 8
introduced into an extracellular loop of hERG by polymerase chain reac
described by (Ficker et al., 2003)
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Plasmid map prepared using PlasMapper 
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2.2 General Solutions 
2.2.1 Mammalian cell culture medium 
HEK-MSRII, HeLa and KATP stable cells were cultured in DMEM/F12 containing L-
glutamine, supplemented with 10% fetal bovine serum (Sigma) and 1X penicillin-
streptomycin (Sigma). HEK-MSRII were maintained in 400 µg/ml G-418 and KATP 
stable cells were maintained in 500 µg/ml G-418 and 10 µg/ml blasticidin.  
 
2.2.2 Bacterial culture medium 
LB Medium (1L) Autoclaved and cooled before use.  
Tryptone 16.0 g 
Yeast Extract 10.0 g 
NaCl 5.0 g 
pH7.2 Adjusted 
Water Made up volume to 1L with water. 
Relevant antibiotic as selection marker for plasmid being amplified were added. 
For preparation of LB Agar plates, LB medium was mixed with 2g of agar and 
autoclaved. The medium was cooled to ~40°C and mixed with appropriate antibiotic 
as required before pouring into sterile Petri-dishes and allowed to set. LB Agar plates 
were stored at 2-8°C. 
 
SOB Medium (1L)  
Tryptone 20.0 g 
Yeast Extract 5.0 g 
NaCl 0.5 g 
250 mM KCl 10.0 ml 
pH 7.0 Adjusted 
Water Made up volume to 1L with water. 
Autoclaved and 5 ml sterile 2M MgCl2 was added immediately before use. 
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2.2.3 Antibiotic stock solutions 
All antibiotic solutions were prepared as concentrated stocks in water and diluted prior 
to use. Blasticidin was prepared in DMSO. Stock solutions were filter sterilised and 
stored as aliquots at -20°C. 
 
Antibiotic Stock concentration Working concentration 
Ampicillin  50 mg/ml 50 µg/ml 
Kanamycin  35 mg/ml 50 µg/ml 
G-418 50 mg/ml 500 µg/ml 
Blasticidin 10 mg/ml 10 µg/ml 
 
2.2.4 Solutions for preparation of competent cells 
0.5 M PIPES (100 ml) Filter sterilised, stored at -20°C 
Piperazine-1,2-bis(2-ethane-sulfonic acid) 15.1 g 
Water ~ 60 ml 
Adjusted pH 6.7 and final volume made up to 100 ml with water. 
 
Inoue transformation buffer (1 L) Filter sterilised, stored at -20°C 
MnCl2. 4H2O 10.88 g 
CaCl2. 2H2O 2.20 g 
KCl 18.65 g 
0.5M PIPES, pH 6.7 20 ml 
Final volume made up to 100 ml with water.  
 
2.2.5 Solutions for DNA preparation  
Plasmid DNA amplified in E.coli cells was isolated using the alkaline lysis method and 
purified by phenol-chloroform extraction as described by Sambrook & Russell (2001). 
Solutions for DNA isolation were prepared as follows:  
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Solution I (100 ml) Stored at 2–8°C, stable for 6 months. 
Glucose 1.8 g 
1M Tris (pH 8.0) 2.5 ml 
0.5 M EDTA 2.0 ml 
Water Made up to 99 ml 
RNAse A (10 mg/ml) 1.0 ml 
 
Solution II (100 ml) Prepared fresh before use. 
10 M NaOH 2.0 ml 
10% SDS 10.0 ml 
Water 88.0 ml 
 
Solution III (100 ml) 3M Potassium acetate, pH 5.2. Stored at 2–8°C, stable for 
6 months. 
Potassium acetate 29.4 g 
Acetic acid 11.6 ml, more added if required to adjust to pH 5.2 
Water Made up volume to 100 ml 
 
PEG Solution (25 ml) Stored at RT, stable for 6 months. 
Polyethylene glycol 8000 5.0 g 
Water Dissolved in about 15 ml water, made up volume to 25 ml 
 
TE Buffer, pH 8.0 10 mM Tris-Cl, pH 8.0, 1 mM EDTA. Sterile filtered. 
 
Phenol: Chloroform: 
Isoamyl alcohol 
Stored at 2-8°C 
Phenol 25 ml 
Chloroform 24 ml 
Isoamyl alcohol 1 ml 
Phenol phase equilibrated with 10 mM Tris, pH 8.0, 1 mM EDTA. 
 
Chloroform: 
Isoamyl alcohol 
Stored at RT 
Chloroform 24 ml 
Isoamyl alcohol 1 ml 
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2.2.6 Electrophoresis solutions 
 DNA electrophoresis 
Agarose gel running 
buffer (1L) 
Tris-acetate-EDTA (TAE) buffer, 50X. Diluted to 1:50 in 
sterile water prior to use. 
Tris base 242.0 g 
Glacial acetic acid 57.1 g 
0.5 M EDTA (pH 8.0) 100.0 ml 
Distilled water Made up volume to 1L 
 
Protein electrophoresis 
Polyacrylamide Gel 
running buffer (1L) 
Tris-glycine-SDS buffer, 10X. Diluted to 1:10 to get working 
solution. 
Tris base 30.3 g 
Glycine 144.0 g 
SDS 10.0 g 
Water Made up volume to 1L 
2.2.7 Other commonly used buffers 
10 X Phosphate 
buffered saline 
(PBS) (1L) 
Autoclaved and stored at RT. For working solution stock 
was diluted 1:10 in water (used for western blotting).  
KH2PO4 2.1 g 
Na2HPO4.7H2O 7.3 g 
NaCl 9.0 g 
Dissolved in ~800 ml water, adjusted to pH 7.2. Made up final volume to 1L with 
water. For washing of cells during immunostaining, tissue culture grade D-PBS was 
used.  
 
5X TNE buffer (250 
ml) 
Autoclaved and stored at RT. For working solution stock 
was diluted 1:5 in water. 
NaCl 10.9 g 
Tris base 7.6 g 
90 
 
 
0.5 M EDTA 5 ml 
Dissolved in ~200 ml water, adjusted to pH 7.4. Made up final volume to 250 ml with 
water. 
 
2.2.8 Solutions for immunocytochemistry 
 
Antibody dilution buffer (100 
ml) 
Stored at -20°C as 1 ml aliquots, thawed on ice 
before use. 
Chicken egg albumin (Sigma) 1.0 g 
DMEM/F12 Medium 100 ml 
Adjusted to pH 7.2 
 
2% Paraformaldehyde 
(PFA), 1L 
Stored at -20°C. Thawed on ice before use. 
Water  800 ml (warmed to about 60°C) 
PFA (solid) 20.0 g, dissolved in hot water, cooled to RT 
10XPBS 100 ml 
Adjusted to pH 7.2 using 10 N NaOH.  
 
RIPA Buffer (100 ml) For cell lysis. Solution was stored at -20°C as 
aliquots. 
1M Tris-HCl, pH 7.4 1.0 ml 
0.5M EDTA 40 µL 
NaCl 0.9 g 
Sodium deoxycholate 1.0 g 
10% SDS 1.0 ml 
Nonidet P40 1.0 ml 
Water Made up final volume to 100 ml 
Protease inhibitor (Roche) 10 tablets, added before use 
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2.2.9 Primers for QuikChange® mutagenesis PCR 
The following primers were designed to introduce mutation by QuikChange® PCR and 
synthesised by Invitrogen.  
E282KFwd 5’ CACCACCAGGACCTGAAGATCATTGTCATC 3’ 
E282KRev 5’ GATGACAATGATCTTCAGGTCCTGGTGGTG 3’ 
 
2.2.10 Reagents for transfection 
2.5 M CaCl2 (10X), 10 ml Stored in aliquots at -20°C 
CaCl2.2H2O (Sigma, tissue culture grade) 3.7 g 
Sterile water to final volume 10 ml 
Solution was filter sterilised. 
 
BBS (2X), 250 ml BES- buffered solution, stored in aliquots at -20°C 
BES Na2 salt (Calbiochem) 2.94 g  
NaCl 4.091 g 
150 mM Na2HPO4, pH 6.95 2.5 ml 
Sterile water 230 ml 
pH adjusted to 6.97 
Final volume made up to 250 ml with sterile water. Solution was filter sterilised. 
 
2.2.11 Reagents for PAGE and Western blotting 
Resolving gel (8%)- 10 ml APS and TEMED added just before casting 
5% Glycerol 4.6 ml 
30% Acrylamide: bis acrylamide, 
30:1 (Sigma) 
2.7 ml 
1.5 M Tris-HCl, pH 8.8 2.5 ml 
10% SDS 0.1 ml 
10% Ammonium persulphate (APS) 0.1 ml 
TEMED (Sigma) 4.0 µL 
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3.4 ml of the resolving gel was poured in between the gel plates (BIORAD). The top 
of the gel was gently layered with water saturated butanol and the gel was allowed to 
set for 30-60 min at RT. The butanol was poured out before pouring the stacking gel. 
 
Stacking gel (5%) -10 ml APS and TEMED added just before casting 
5% Glycerol 6.8 ml 
30% Acrylamide: bis acrylamide, 
30:1 (Sigma) 
1.7 ml 
0.5 M Tris-HCl, pH 6.8 1.25 ml 
10% SDS 0.1 ml 
10% Ammonium persulphate  0.1 ml 
TEMED (Sigma) 10.0 µL 
The gel was poured to till the top and a well comb was inserted. The gel was allowed 
to set for 30-60 min at RT.  
 
10X SDS PAGE running buffer (1L)  Laemmli buffer diluted 1 in 10 before use. 
Tris base 30.3 g 
Glycine 144.0 g 
SDS 10.0 g 
Water final volume to 1L 
 
10X Transfer Buffer (1L)  Stored at 2-8 °C  
Glycine 144.0 g 
Tris base 30.3 g 
Water Final volume 1L 
Working transfer buffer 1X was prepared by mixing 1 part 10X buffer, 2 parts 
methanol and 7 parts water. 
 
SDS Sample Buffer (100 ml) For loading protein samples on SDS PAGE 
1M Tris-HCl, pH6.8 6.0 ml 
10% SDS 12.5 ml 
50% Glycerol 20 ml 
1M DTT 10 ml 
1M EDTA 0.8 ml 
Water 50.7 ml 
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2.3 General Molecular Biology Methods 
2.3.1 Competent cell preparation 
Untransformed E. coli DH5α cells were plated out on LB agar plates containing no 
antibiotics. A starting culture of 25 ml SOB medium was inoculated with one colony. 
After incubation for 6-8 hrs at 37°C, 3X 250 ml of SOB medium was inoculated with 10 
ml, 4 ml or 2 ml of the starting culture. Each culture was incubated at 18°C until the 
optical density at 600 nm (OD600) of the culture reached ~0.55 (requires about 12-16 
hours). The culture flasks were transferred to an ice-cold water bath for 10 min and the 
cultures centrifuged for 10 min at 2500 x g at 4°C [5000 rpm in J-10 rotor]. The medium 
was carefully removed and the cell pellet gently suspended in 80 ml of ice-cold Inoue 
transformation buffer. The culture was centrifuged for 10 min at 2500 x g at 4°C. The 
supernatant was removed carefully and the cells were re-suspended in 20 ml ice-cold 
Inoue transformation buffer and 1.5 ml of dimethyl sulfoxide (DMSO) was slowly 
swirled into the cell suspension. The culture was incubated for 10 min in a chilled ice 
bath. The cell suspensions was dispensed into chilled, sterile micro-centrifuge tubes 
and snap frozen by immersion in liquid nitrogen or dry ice before storing at -70°C. 
Competent cells obtained by this method typically showed efficiencies up to 3 x 108 
transformed colonies per µg of plasmid DNA.  
 
2.3.2 Transformation of E.coli with plasmid DNA 
For each transformation 100 µl of competent E. coli cells were thawed on ice, gently 
mixed with 25–50 ng of plasmid DNA to be amplified and incubated on ice for 30 
minutes. The DNA-cells mixture was then transferred to a 42°C water bath for 40 
seconds (heat shocked) and placed on ice for 1 minute following which 900 µl of LB 
medium was added to the cells and they were placed in a 37°C shaking incubator for 1 
hour. The cells were then spun at 7K rpm and 800 µl of the supernatant discarded. The 
pellet was then re-suspended into the remaining media and plated onto pre-warmed 
LB-agar plates (containing appropriate selection antibiotics) with a sterile glass 
spreader. The inoculated plates were then placed in a 37°C incubator and grown 
overnight. 
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2.3.3 Preparation of plasmid DNA 
The alkaline-lysis method was employed for isolating plasmid DNA from bacterial cells 
adapted from the protocols described in Sambrook and Russel (2001). (Russell, 2001).  
 
Mini-preparation of DNA 
5 ml of 2YT or LB medium supplemented with appropriate selection antibiotic was 
inoculated with a single bacterial colony transformed with the plasmid DNA or the 
product of QuikChange® PCR and incubated overnight at 37°C in a shaking incubator 
at 200 rpm. 1.5 ml of the culture was centrifuged (bench-top microfuge, 4400 g, RT) for 
1 minute and the supernatant discarded. This was repeated on more time and the cell 
pellet from 3 ml culture was then re-suspended in 200 µl of DNA prep Solution I by 
vortexing and the slurry was incubated at RT for 5 minutes. The cells were then lysed 
by addition of 400 µl of Solution II from the sides of the tube, gentle mixing by inversion 
and incubated at room temperature for no further than 5 minutes. 300 µl of Solution III 
was then added to the lysed cells and the after mixing vigorously the mixture incubated 
on ice for 10 minutes before spinning at 16000 g at room temperature for 15 minutes. 
The supernatant was transferred to a fresh tube and mixed with 750 µl isopropanol for 
10 minutes at room temperature prior to spinning at 16000 g for ten minutes. The 
supernatant was then discarded, the pellet washed with 70% ethanol and after drying 
at 37°C, re-suspended in 30 µl TE Buffer, pH 8.0. 1 µl of the DNA was then analysed 
by agarose gel electrophoresis to determine quality and approximate yield of the 
preparation. 
 
Large-scale preparation of DNA (Isolation and purification) 
5 ml of 2YT or LB media supplemented with appropriate antibiotic was inoculated with 
a single bacterial colony from a plate transformed with the plasmid DNA amplified. This 
seed culture was grown for 16 hrs at 37°C in a shaking incubator. This seed culture 
was then added to 400 ml 2YT containing appropriate antibiotic and grown at 37˚C in a 
shaking incubator for a further 16-24 hrs. The cell suspension was centrifuged 
(Beckman JA10 rotor, 4400 g, 4˚C, 15 min). The supernatant was decanted and the 
cell pellet re-suspended in 10 ml of Solution I. The cells were then lysed by the addition 
of 20 ml of Solution II, and gently mixed for one minute prior to incubating on ice for a 
further 10 min. 10 ml of Solution III (4˚C) was then added and after vigorous shaking 
the preparation was incubated on ice for 5 minutes prior to spinning as above. The 
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supernatant was filtered through filter paper and precipitated by the addition of 50 ml of 
isopropanol. Following centrifugation, the supernatant was then decanted; the pellet 
dried, and re-suspended in 2 ml TE buffer; pH 8.0. In order to remove all the RNA in 
the preparation, 50 µl RNase A (10 mg/ ml stock) and incubated at 37°C for 30 min. 
The plasmid DNA was purified by organic solvent extraction, once with phenol-
chloroform and twice with chloroform. The extraction step involved addition of equal 
volume of solvent to the DNA solution, vortexing and then centrifugation to separate 
the solvent phase from the DNA containing aqueous phase which was carefully 
collected and transferred to a new tube. After all steps of extraction, the DNA solution 
was precipitated by addition of 0.5 ml 20% PEG 8000 and 25 µl 1 M MgCl2. The DNA 
was then spun at 16000 g for 15 minutes, the pellet washed twice with 70 % ethanol, 
air-dried, and dissolved in TE buffer; pH 8.0. The DNA concentration was estimated by 
agarose gel electrophoresis of the DNA preparation.  
 
2.3.4 Agarose gel electrophoresis of DNA 
Gel preparation 
For 1 % agarose gels 100 ml of 1X TAE buffer was added to 1 g of electrophoresis 
grade agarose and heated until dissolved. The gel was allowed to cool to ~ 50˚C and 
7.5µl of 10 mg/ml ethidium bromide was added and mixed. The gel was then poured 
into a gel cast and allowed to set at room temperature. 
 
Sample preparation and electrophoresis 
The agarose gel was placed into the gel electrophoresis tank and immersed in TAE 
buffer. The DNA samples (1µl of 6X loading buffer and 5µl of the suitably diluted DNA) 
were loaded into individual wells and electrophoresed at 80 V for ~ 40 minutes. For 
size estimation of sample DNA, size marker DNA ladder (Fermentas) were run 
alongside. DNA were visualised on a UV trans-illuminator and the images captured 
using the Bio-Rad gel documentation system.  
 
2.3.5 QuikChange® mutagenesis 
Site-directed mutagenesis was performed using the QuikChange® (Stratagene) and 
with specifically designed primers which had the desired mutation in the centre of the 
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primer with ~10-15 bases on each side, (see Section 2.2.9 for primers used in this 
study). Primers were 25-40 bases in length and possessed a melting temperature of 
~10°C above the standard extension temperature of 68°C. Melting temperatures were 
calculated using the formula: Tm = 81.5 + 0.41(%GC) – 675/N - % mismatch, where N 
is the primer length in base pairs, %GC is the overall guanine and cytosine content. 
QuikChange® PCR reaction mix was prepared as follows: 
 
Ingredients per reaction Volume 
DNA template (Stock: 100 ng/µl) 1µl 
Forward primer (Stock: 10 nmol/µl) 1µl  
Reverse primer (Stock: 10 nmol/µl) 1µl  
dNTP mix (Stock 2 mM) 5µl 
10X Pfu reaction buffer 5µl 
Pfu Turbo DNA polymerase (2.5 U/µl) (Fermentas) 1µl 
DMSO  1µl 
Water 35µl 
 
Each reaction was overlaid with mineral oil (Fluka), placed in a DNA thermal cycler and 
subjected to the following temperature cycles:  
 
95°C for 30 seconds 
55°C for 1 minute  
68°C for X minutes (X depended on the length of the template, with each 1000 base 
pairs of template requiring 2 minutes of extension time at 68°C)  
 
Once the 16 cycles were completed, the DNA was extended for 7 minutes at 72°C. 
Once the PCR reaction was complete 1µl of DpnI restriction enzyme (20U) was added 
for 2 hours at 37°C to digest the parental super-coiled DNA. The PCR products were 
then transformed into competent DH5α cells. Plasmid mini-preps were prepared from 
the colonies obtained from the transformation and sent for sequencing to confirm 
success of the mutagenesis.  
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2.3.6 DNA sequencing 
All DNA sequencing was performed by Gene service, UK. Sequencing was used to 
confirm the authenticity of constructs used in the study. The sequences of the primers 
used for DNA sequencing in this study are as follows: 
Primer name Primer sequence (5’ - 3’) 
T7F  TAATACGACTCACTATAGGG 
T7R TAGTTATTGCTCAGCGGTGG 
Kir6.2 C-terminus seq.  GTGCAGAATATCGTCGGGCTG 
CMVF CGCAAATGGGCGGTAGGCGTG 
  
98 
 
 
2.4 Mammalian Cell Culture and Manipulation 
2.4.1 Growth and maintenance of cell lines 
Culture of HEK-MSRII, HeLa and KATP-stable cells 
Cells were grown in 25 cm2 or 75 cm2 culture flasks (Sarstedt) at 37˚C in a humidified 
atmosphere of 5 % CO2 / 95 % air. When ~70-80 % confluent the cells were passaged 
as follows: the medium in the flask was removed and the cells were washed with D-
PBS (Invitrogen), and detached from the surface of the flask by treatment with 1X 
Trypsin-EDTA solution [0.05 % (w/v), Invitrogen] for 3-5 min. For the more sticky HEK-
MSRII cells, 5 X Trypsin-EDTA solution was used. The detached cells were then re-
suspended in pre-warmed media and 1/5th part of the cell suspension was transferred 
to a new culture flask containing pre-warmed medium and antibiotics where necessary 
(concentrations as described in section 2.2.1). The cells were then returned to the 
incubator and allowed to attach and reach confluence for 3-4 days.  
 
Long-term storage of cell lines and their revival 
For long-term storage cells were frozen in liquid nitrogen (N2). Cells were trypsinised, 
suspended in growth medium and centrifuged at 1000 rpm for 5 minutes to obtain cell 
pellet. The medium was then decanted and the pellet re-suspended in cell freezing 
medium (10% DMSO, 80% FBS). The cell suspension was transferred to freezing vials 
as 1 ml aliquots and stored at -80˚C for 48 hours in cryo-freeze container (Nunc) to 
allow gradual freezing of the cells. The frozen vials were transferred into a liquid 
nitrogen storage container for long-term storage. The frozen cells were revived by 
thawing the frozen vial of cells in a 37°C water bath and inoculating in a 25 cm2 flask 
containing 10 ml warm medium. The flask was transferred to the incubator and after 
about 6-8 hours, the medium from the flask was discarded and new medium was 
added. The antibiotic selection marker was added as required to the revived cells after 
24 hrs of incubation. The cells were used for transfection after one passage.  
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2.4.2 Transfection methods for HEK MSRII and HeLa cells 
Transfection with anionic lipid transfection reagent 
Mammalian cells were transfected with plasmid DNA (constructs in pcDNA3, pcDNA6 
or pEGFP) using Fugene®6 transfection reagent (Roche diagnostics). Cells were 
plated at a density of about 30% onto 12 mm or 18 mm glass cover-slips placed in 
individual wells of a 12 well culture plate and incubated overnight to allow the cells to 
adhere. The medium was replaced with 2.0 ml of fresh pre-warmed growth media and 
incubated for 1 hour. The transfection mix was prepared as follows in a sterile micro-
fuge tube (per well): 
Optimem™ 20 µl (warm) 
Fugene®6 1 µl (2 µl for HeLa cells) 
Mixed by gently flicking the tube and incubated for 5 min at RT 
Plasmid DNA 150-300 ng 
Mixed by gently flicking the tube and incubated for 30-45 min at RT.  
The transfection mixture was then transferred to the cells on cover-slips.  
 
Calcium phosphate method 
Calcium phosphate method (adapted from (Jordan and Wurm, 2004) was used for 
transfection of cells in 25 or 75 cm2 flasks at a confluence of 50 - 60%. 2 hours prior to 
transfection the medium from the flask was replaced with new pre-warmed medium (10 
ml for 25 cm2 and 20 ml for 75 cm2 flasks). The calcium phosphate transfection mixture 
was prepared as follows in a micro-fuge tube: 
For 25 cm2 flask: 
Ingredient Quantity 
Plasmid DNA 20-30 µg  
2M CaCl2  50 µl  
Sterile water to a final volume 500 µl, mix well 
2X BBS 500 µl, mix 
 
The DNA-calcium phosphate mixture was incubated at RT for 20 min and slowly added 
drop wise to the flask of cells to be transfected with constant swirling to mix. The cells 
were incubated at 35°C for 24 hrs before the medium was removed and the cells 
washed thrice with warm D-PBS. New medium was added to the cells and cells were 
incubated for further 24 to 48 hrs before use.  
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2.5 General Immunostaining Methods 
 
All reagents used were purchased as cell culture grade or were prepared and 
autoclaved as required. 
2.5.1 Preparation of adherent cells for immunocytochemistry 
For immunostaining experiments involving multiple treatments, the cover-slips were 
treated with poly-L-lysine for increased adherence of the cells.  
 
Preparation of poly-L-lysine coated cover-slips 
Borosilicate glass cover-slips were washed in distilled water and soaked in 
concentrated hydrochloric acid for 3-6 hours. The cover-slips were rinsed several times 
in distilled water to remove all traces of HCl. The washed cover-slips were dipped in 
1% (w/v) high molecular weight poly-L-lysine solution (44000 to 100000, purchased 
from Sigma chem. co.), overnight at 4°C or 3 hrs at RT. The poly-L-lysine solution was 
then removed and stored at 4°C for re-use. The coated cover-slips were rinsed with 
sterile water 3-5 times and dipped in 70% ethanol.  
 
2.5.2 Immunofluorescence staining 
Cells were plated onto glass cover-slips in 12 well tissue culture plates and transfected 
as required ~40 hours prior to immunostaining. The growth medium was removed 
using a plastic Pasteur pipette and the cells were washed twice with chilled D-PBS. 
The D-PBS was removed and ~0.5 ml chilled 2% PFA solution was added to fix the 
cells for 6 min. The cells were washed thrice with D-PBS. For staining of the channels 
(or membrane proteins) expressed on cell surface at steady state, the cells were 
incubated with primary antibodies against extracellular epitope on the membrane 
proteins for 40 min at RT, followed by D-PBS and incubation with fluorophore 
conjugated secondary antibodies. For staining of total protein expressed in the cells, 
following fixing, the cells were permeabilised by treatment with methanol: acetone (1:1) 
solution (-20°C) for 6 min. Following washing with D-PBS, the cells were 
immunostained as above. For staining of cells on surface and internal separately, the 
membrane proteins expressed on the cell surface were first stained following which 
cells were permeabilised and the internal membrane proteins were stained. For 
101 
 
 
staining membrane proteins within the cells, the secondary antibody selected was with 
a different fluorophore to the one used for surface staining. The cells on cover-slips 
were washed, air dried, mounted on glass slides using Prolong Gold anti-fade reagent 
with DAPI (Invitrogen), and allowed to set for 24 hrs at RT, before imaging under a 
Zeiss 510-META laser scanning confocal microscope (LSCM).  
 
2.5.3 Confocal microscopy 
Confocal Laser Scanning Microscopy (CLSM) is an optical microscopy in which a 
focused laser beam is scanned laterally along the x and y axes of a specimen in a 
raster pattern. The emitted fluorescence (reflected light signal) is collected by the 
objective lens of the microscope and is focused through a small pinhole, which blocks 
any light, which originated from above or below the plane of focus. The light, which 
passes through the pinhole, is then collected by a photomultiplier tube and displayed 
as pixels on a computer monitor.  
 
Immunofluorescence stained cells were viewed using a Zeiss 510-META laser 
scanning confocal microscope (LSCM) under an oil-immersed 63× objective lens (NA = 
1.40). FITC (494 nm excitation: 519 nm emission) was excited using an argon laser 
fitted with 488 nm filters and Cy3 (550 nm excitation: 570 nm emission) was excited 
using a helium / neon laser fitted with 543 nm filters. Cy5 and Alexa 633 were excited 
using a He/Ne laser fitted with 633 nm filters. The settings of each image were adjusted 
so that the intensity of each pixel was within the range of sensitivity of the fluorescence 
detectors i.e. no pixel showed saturation of fluorescence. Images were processed for 
addition of Scale bars using LSM Image browser. Any adjustments for brightness or 
contrast on the images was done using LSM Image browser and applied equally on all 
the image panels without altering the basic information on the image.  
 
2.5.4 Chemiluminescence experiments 
Density of HA-KATP or HA-hERG channels on the cell surface was estimated
 by the 
chemiluminescence method as described previously (Mankouri et al., 2006). 
Transfected cells on cover-slips expressing the channels were fixed and channels on 
cell surface were labelled with rat anti-HA antibody followed by the HRP conjugated 
secondary antibody. The cells were washed several times in PBS and solubilised in 
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RIPA buffer containing Benzonase (5 units) and 1X Protease inhibitors (Roche) by 
incubation overnight at 4°C on a rocker. Duplicate aliquots (60 µL) of the lysates were 
transferred to white 96 well plates (Grenier) and 50 µL of Lumigen PS-Atto® substrate 
was added to each well for 30s and the luminescence was measured using PolarStar 
Optima (BMG Labteck, GmbH) at a 1 sec interval. Protein content in the lysates was 
measured on duplicate 60 µL aliquots using the bicinchoninic acid (BCA) assay (Smith 
et al., 1985). Luminescence values were normalised to the cell protein content. Data 
were obtained from three separate transfection experiments, each measured in 
duplicate. 
 
Protein Estimation by BCA Assay 
The Bicinchonic acid (BCA) assay was used to determine protein content in 
mammalian cell lysates. The BCA reagent was purchased from Pierce, Thermo Fisher 
Scientific. The cupric sulfate reagent was prepared by mixing 0.4 g of CuSO4.5H20 in 
10 ml distilled water. Working BCA reagent was prepared by mixing 10 ml of the BCA 
reagent with 100 µl of the cupric sulfate reagent. 60 µL of the lysates were mixed with 
200 µL of the working BCA reagent and incubated at 37°C for 30 min. The absorbance 
of the samples was read at 562nm. For preparation of the protein standard curve, 1 
mg/ml BSA standard protein solution (Sigma) was added to the lysis buffer to get 0.1-
0.6 µg of protein in 60 µL volume. The absorbance values for the protein standards 
were plotted against concentration to get standard curve and equation for best fit plot 
was obtained using the Origin software. 
2.5.5 Western Blotting  
Lysates of cells or raft fractions were mixed with the SDS sample buffer and loaded on 
8% SDS-PAGE gels along with a pre-stained protein molecular weight marker. The 
proteins were allowed to separate following electrophoresis in the SDS-PAGE running 
buffer (Figure 2.4.A). The separated proteins on the gel were transferred to a 
nitrocellulose membrane using Trans-blot apparatus and transfer buffer (Figure 2.4.B). 
Unbound sites on the membrane were blocked by incubation in 5% SM-PBST (5% 
skim milk powder, 0.5% Tween-20, PBS) for 2-3 hours and then the membranes were 
incubated with antibodies against the protein of interest overnight at 4°C followed by 
wash step using PBST (0.5% Tween-20 in PBS) to remove unbound antibodies. The 
membranes were then treated with appropriate HRP conjugated secondary antibodies. 
Working concentration of antibodies is detailed in relevant chapters. Following 
103 
 
 
incubation with Lumigen (substrate for HRP), blots were exposed to X-ray films 
(Kodak) and the films were subsequently developed. Positions of the protein bands 
relative to the molecular weight marker proteins were marked by carefully overlaying 
the developed X-ray films on the nitrocellulose membranes. For blots of raft fractions 
where more than one protein of interest were blotted, the membranes were stripped to 
remove the antibodies following developing for one protein using the western blot strip 
buffer (2% SDS, 100 mM β-mercaptoethanol, 50 mM Tris-HCl, pH 6.8). The 
membranes were blocked again 5% SM-PBST for 2-3 hours and blotting was repeated 
with the next set of antibodies as described above. Scans of relevant portions of the 
blots are shown.  
  
 
 
Figure 2.4 Schematic for Western blotting
proteins. (B) Transfer of separated proteins to nitrocellulose membrane for probing with 
relevant antibodies. Images prepared by Bensaccount were taken from the public 
domain at Wikipedia.org.
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2.6 Data and Statistical Analysis 
 
For immunocytochemistry experiments, ‘n’ numbers refer to the number of separate 
occasions on which the experiment was performed. For chemiluminescence 
experiments each experiment was performed three or more times where each n 
number represents the duplicate from individual experiments. The statistical 
significance of data was determined by performing the Student’s t-test or one way 
ANOVA test. Significance was deemed when the values were less than or equal to the 
0.05 P value when compared to the experimental control.  
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2.7 Electrophysiology 
 
HEK-MSRII cells were co-transfected with pcDNA3-HA-hERG and appropriate 
constructs (Chapter 4, 5 and 6). Borosilicate patch pipettes (2-3 MΩ resistance) were 
filled with a recording solution (in mM; 120 KCl, 5 MgCl2, 5 K2ATP, 5 EGTA, 10 
HEPES, pH 7.2 with KOH); the bath solution contained, in mM, 137 NaCl, 4 KCl, 1.8 
CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, pH 7.4 with NaOH. Whole currents were 
recorded at room temperature using an EPC10 patch clamp amplifier under the control 
of Patch master software (HEKA Electronik). Cells were held at -80 mV and 5 s 
depolarising pulses from -60 to +60 mV followed by a 5 s step to -60 mV were applied 
every 20 s. Current-voltage relationships were determined by plotting initial amplitudes 
of the tail currents at -60 mV against the applied voltage. The data were analysed using 
the Origin 7.0 software. Recordings in Chapter 4 were done by Paul Manna and all the 
electrophysiology experiments in Chapter 5 and 6 were carried out by Andrew Smith.  
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CHAPTER 3 
 
Sar1-GTPase dependent ER exit of pancreatic KATP channels revealed by a 
mutation causing congenital hyperinsulinism 
 
 
 
 
 
 
 
 
Most of the data presented in this chapter has been published in Human 
Molecular Genetics, 2009, Vol. 18, No. 13. 
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3.1 Introduction  
 
KATP channels regulate insulin secretion from the pancreatic β-cells in response to 
changes in blood glucose (Ashcroft, 2005, Minami et al., 2004) due to their 
characteristic property of being inhibited by ATP (Tucker et al., 1998) and activated by 
Mg-ADP (Shyng and Nichols, 1997). In healthy individuals, KATP channel function is 
regulated by the metabolic state of the cell (Miki et al., 1998, Nichols, 2006). Abnormal 
decrease in pancreatic KATP channel function has been implicated to be a cause of 
congenital hyperinsulinism (CHI), a disease characterized by unregulated insulin 
secretion and severe hypoglycemia (Aguilar-Bryan et al., 1998, Dunne et al., 2004, 
Ashcroft, 2005, Miki and Seino, 2005). The decrease in KATP channel activity is 
attributed to mutations in the genes encoding the KATP channel subunits. The molecular 
basis of the effect of these mutations could be classified as follows:  
• Mutations causing a decrease in channel function by increasing the sensitivity 
of the KATP channel to intracellular [ATP]/[ADP] ratio leading to severe 
hyperinsulinism (Tucker et al., 1998, Ashcroft, 2005, Burke et al., 2008, Dunne 
et al., 2004, Shyng et al., 1998).  
• Mutations that alter the normal trafficking of the channel leading to reduced or 
lack of surface channel expression (Cartier et al., 2001, Partridge et al., 2001, 
Christesen et al., 2007).  
 
The KATP channel subunits, the pore forming Kir6.2 and the sulphonylurea receptor 
(SUR1) have been shown to associate directly with each other (Lorenz et al., 1998). 
Moreover, assembly of the subunits is required for the expression of a functional 
channel on cell surface (Shyng and Nichols, 1997). Studies on trafficking of the KATP 
channel subunits reported that neither subunit were capable of exiting the ER when 
expressed alone due to the presence of dibasic ER retention/retrieval signal, RKR 
(arginine–lysine–arginine), present on both the subunits (Zerangue et al., 1999). It was 
proposed that assembly of the subunits into an octameric complex masks the ER 
retention signals enabling the channel to escape the ER. A recent study indicated that 
14-3-3 proteins play a role in masking these ER retention signals (Heusser et al., 
2006). However, the details of the ER exit pathway for the channel were not well 
understood.  
 
Since the KATP channel is a key player in regulating glucose-stimulated insulin secretion 
(GSIS) (Ashcroft, 2005, Nichols, 2006), studies to look at the KATP channels expressed 
in individuals suffering from insulin disorders have been undertaken in a quest to 
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understand the molecular nature of the disease and thereby look for possible cures. 
One such study reported a heterozygous mutation G844A in KCNJ11 gene, found in a 
Swedish baby suffering from a severe focal form of CHI (Christesen et al., 2007) . This 
mutation replaced glutamate (E) at position 282 with lysine (K) in the C-terminus of the 
KATP channel subunit Kir6.2 (hereafter referred to as Kir6.2
E282K). The patient was not 
responsive to therapy that employed the potassium channel activator drug, diazoxide 
(Arnoux et al., 2010, Christesen et al., 2007). The disease was focal in nature, wherein 
excessive insulin secretion was occurring only from certain clusters of the patient’s 
pancreatic β-cells (Sempoux et al., 2004). The focal nature of the disease is illustrated 
in Figure 3.1. Every individual inherits a set of chromosomes each from both parents. 
The Swedish patient had inherited from his father the heterologous G844A mutation in 
the KCNJ11 gene on chromosome 11. The patient’s pancreatic β-cells had the 
maternal chromosome 11 which had incurred a mutation that resulted in deletion in the 
11p15, an area containing the KCNJ11, ABCC8 and imprinted tumour suppressor 
genes such as the p57kip2 gene. Such deletion mutations can occur during cell division 
in early or later stage of development and result in hemizygosity for the mutant allele 
and β-cell hyperplasia in case of the patient. The p57kip2 gene is an imprinted gene for a 
tumour suppressor protein which is functional only when expressed off the maternal 
chromosome, therefore the cells in the patient’s pancreas with the truncated maternal 
chromosome 11 were tumorous and out-grew the population of cells without the 
mutation and expressed excessive insulin (Fournet and Junien, 2004, Fournet et al., 
2001, Fournet et al., 2000, Verkarre et al., 1998). Scission of the tumorous 
hyperinsulinaemic region of the patient’s pancreas resulted in the clinical cure of the 
patient (personal communication by Dr. Christesen).  
 
The study of mutations is often rewarding as it can give unique insights into the 
understanding of the disease at a molecular level. Previous members of the lab, (J. 
Mankouri and T. Taneja) initiated experiments to gain an insight into the role of the 
E282K mutation in the Kir6.2 subunit of the KATP channel in the cause of CHI in the 
patient. Constructs to express SUR1, HA-Kir6.2wt and HA-Kir6.2E282K (Kir6.2 with 
E282K mutation) were created for expression in heterologous eukaryotic expression 
systems.  
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Figure 3.1 Focal nature of disease in patient with E282K mutation in Kir6.2 
subunit. The blue cell represents the patient’s embryonic cell with the mutated 
chromosome 11 pair inherited one each from both the parents, destined to form the 
pancreas. The grey and pink cells represent the tumorous and non tumorous 
pancreatic β-cells respectively in the patient’s pancreas. These tumorous cells express 
only the E282K mutant channel subunits and out-grow the cells that express channels 
with heterogeneous wild type and mutant channel subunits. The grey cells clusters 
depict the focal regions in the patient’s pancreas that secrete excessive insulin.  
  
pancreas
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The extracellular hemagglutinin A (HA) epitope on an extracellular domain of Kir6.2 
subunit allowed the detection of the channel on cell surface and within the cell (Hu et 
al., 2003, Mankouri et al., 2006), see Chapter 2). The KATP channels were expressed in 
HEK-MSRII cells by co-transfection of SUR1 and HA-Kir6.2wt constructs. Staining of the 
channels on HEK-MSRII cell showed that the channels made of wild type Kir6.2 
subunits were expressed on cell surface, however the E282K mutant channels were 
absent from cell surface. The SUR1 subunit of KATP expressed on the cell surface is 
known to be glycosylated (Clement et al., 1997). Western blotting experiments 
described in (Taneja et al., 2009) showed that SUR1 co-expressed with HA-Kir6.2WT 
but not with HA-Kir6.2E282K matured. Further, anti-HA antibodies were able to co-
immunoprecipitate SUR1 from the lysates of cells co-expressing SUR1 and either the 
HA-tagged wild type or mutant (E282K) Kir6.2, but not SUR1 alone (Taneja et al., 
2009). Also when HEK-MSRII cells were co-transfected with HA-Kir6.2WT or HA-
Kir6.2E282K constructs along with SUR1 and stained to look at intracellular fluorescence 
the mutant showed almost complete co-localisation with the ER resident protein, 
calreticulin (Thesis of J. Mankouri). 
 
ER exit mechanisms of proteins are outlined in detail in the main introduction. 
Concentrated export of proteins from ER in COPII vesicles requires the small G protein 
Sar1 (Antonny et al., 2001, Sato and Nakano, 2007b), see Figure 1.9). The COPII 
cargo is recognised through specific motifs such as the diacidic motifs [(D/E) X (D/E)], 
di-hydrophobic motifs (FF, YY, LL or FY), YXXXNPF and LXXLE motifs which interact 
with proteins of the COPII machinery to facilitate their assembly into the COPII vesicle 
(Barlowe, 2003, Nishimura and Balch, 1997). Preliminary experiments of co-expression 
of KATP with dominant negative Sar1 construct (DN-Sar1
H79G) showed absence of 
surface expression of the channel (imaging) and lack of mature SUR1 band (western 
blotting). Moreover, sequence alignments for the Kir6.2 C-terminus indicated that E282 
could be a part of a conserved stretch that constituted a diacidic motif [(D/E) X (D/E)], 
where X= any amino acid (Nishimura et al., 1999), See Figure 3.2).  
 
Taken together, these data (Taneja et al., 2009) indicated that the E282K mutation 
could be responsible for a trafficking defect in the channel causing it to be retained in 
the ER. What remained and presented itself as an interesting subject of investigation 
was to confirm if E282 was part of a functional diacidic ER exit motif (DXE) and to 
determine the mechanistic details of ER exit of the KATP channel.  
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Figure 3.2 Residue E282 in Kir6.2 C-terminus could be a part of a conserved 
diacidic ER exit motif. Alignment of the partial Kir6.2 C-terminal amino acid sequence 
with proteins containing the diacidic ER exit motif (highlighted in red); numbers refer to 
positions in primary sequence. 
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In this chapter, Sar1-dependent ER exit of the KATP channels in COPII vesicles was 
investigated using a temperature sensitive mutant of VSV-G protein which is a reporter 
for COPII vesicles marking the ERES. The importance of the DXE motif on the Kir6.2 
C-terminus (Kir6.2-CT) in the recruitment of the KATP channels to the cell surface was 
investigated with the help of CD4-Kir6.2-CT fusion protein as a reporter. The interface 
of interaction of Kir6.2 with the Sec24 protein in the COPII complex was explored using 
membrane permeable HIV TAT fusion peptides. The study led to the new finding that 
KATP channels contain a diacidic ER exit signal, D
280L281E282, on Kir6.2, recognised by 
the COPII coat machinery for mediating ER exit of the channel via COPII vesicles and 
that the mutation E282K in Kir6.2 blocks ER exit of the channels by disabling the exit 
signal. Co-expression of the wild type subunit rescued the mutant subunit from ER 
retention and resulted in functional expression. These results explained the phenotype 
of the patient as well as response of the patient to resection of the focal area of the 
pancreas (see Discussion). 
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3.2 Materials and Methods 
3.2.1 Plasmid constructs 
HA-tagged Kir6.2 in pcDNA3 and myc-tagged SUR1 in pcDNA6 were transfected in the 
ratio of 3:1 for transient expression of the KATP channels in mammalian cell lines as 
described previously (Mankouri et al., 2006). Constructs of HA-Kir6.2-pcDNA3 with 
mutations E282K, D280N, L281N, E282N and W91R were generated by the 
QuikChange® PCR method by members of Rao lab. FLAG-tagged Kir6.2WT construct 
was without the HA-tag in pcDNA3. Wild type and mutants of hamster Sar1a (acc. 
AAB30321.1) in pcDNA3.1 were kindly provided by Prof. W.E. Balch, The Scripps 
Research Institute, La Jolla, CA, USA (Wang et al., 2004b). The constructs were sub-
cloned into pEGFP constructs to generate GFP-tagged- constructs GFP-Sar1WT, GFP-
Sar1H79G and GFP-Sar1T39N by members of the Rao lab. GFP-VSVGts045 was a gift from 
Kai Simons, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, 
Germany. Human CD4 (M12807) and CD4 containing the substitution of the C-terminal 
domain (residues 178– 364) of Kir6.2 (CD4-Kir6.2-CT), both in pCDNA3, are as 
described (Mankouri et al., 2006). CD4-Kir6.2E282K-CT was prepared as described later 
in the methods section.  
 
3.2.2 Antibodies 
All antibodies for immunofluorescence staining were diluted in the Antibody dilution 
buffer (section 2.2.8). Rat anti-HA antibodies (Roche) were diluted 1:500, mouse anti-
FLAG and anti-myc antibodies were diluted 1:250. AlexaFluor488-conjugated anti-rat 
secondary antibodies (Invitrogen Ltd, Paisley, UK), anti-rat FITC- and Cy3-conjugated 
secondary antibodies (Jackson Immuno Research, West Grove, PA) were diluted 
1:500 in antibody dilution buffer. Mouse anti-CD4 monoclonal antibodies (Q4120) were 
a gift from Dr P. Beverley (Edward Jenner Vaccine Research, Compton, UK), were 
diluted 1:100 in antibody dilution buffer for staining. For chemiluminescence assay, the 
HRP-conjugated anti-rat antibodies were diluted 1:500 in antibody dilution buffer.  
 
3.2.3 TAT- conjugated peptides 
TAT (YGRKKRRQRRR), TAT-DXE (YGRKKRRQRRRHHQDLEIIV) and TAT-DXK 
(YGRKKRRQRRRHHQDLKIIV) peptides were synthesized by Peptide 2.0, Chantilly, 
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VA. The lyophilised peptides were reconstituted as 1M solutions in sterile distilled 
water and stored as small aliquots in -20°C. HEK-MSRII cells were grown on cover-
slips in 12 well plates and pre-treated for 30 min with 1 ml of 1 µM peptide in 
Optimem®. 1 ml of cell growth medium was added to the wells and the cells were 
transfected with the desired constructs and incubated for 48 hours in the presence of 
0.5 µM peptide before analysis (immunofluorescence staining or chemiluminescence 
assay). For cells stably expressing HA-KATP channels, similar treatment protocol was 
used as described above without the transfection step.  
 
3.2.4 Preparation of CD4-Kir6.2E282K-CT construct 
The wild type CD4-Kir6.2-CT construct in pcDNA3 was used as a template for 
QuikChange® PCR method (described in Chapter 2, section 2.3.5) using primers (see 
Chapter 2, section 2.2.9) designed to mutate E to K in the DLE motif of the Kir6.2-CT 
region. The PCR product was analysed on DNA agarose gel (data not shown) and 
transformed into competent E. coli DH5α cells (prepared as described in Chapter 2, 
section 2.3.1). The resultant colonies were grown in 5 ml LB medium and plasmid DNA 
was isolated using the DNA mini-preparation method (as described in Chapter 2, 
section 2.3.3). The DNA preparations were sequenced using the Kir6.2 C-terminus 
seq. primer (described in Chapter 2, section 2.3.6). The construct with successful 
mutation in the sequence was used for large scale preparation of DNA (as described in 
Chapter 2, section 2.3.3) which was analysed using agarose gel electrophoresis for 
determination of quality of preparation and concentration of the DNA (data not shown). 
This plasmid DNA was used for transfection to transiently express the CD4-Kir6.2E282K-
CT protein in HEK-MSRII cells.  
 
3.2.5 Immunofluorescence staining 
Cells were stained for HA-KATP channels (wt or mutants) using antibodies against 
the HA-epitope, myc-SUR1 was stained using anti-myc antibodies and the CD4-
Kir6.2-CT constructs (wt or mutant) were stained using anti-CD4 antibodies in 
concentrations as described in the previous sections. Surface and total proteins 
were stained for immunofluorescence imaging using the protocols described in 
Chapter 2. Scale bars were shown for each image using the LSM image browser 
and zoomed sections of the image were added as insets into the main image.  
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3.2.6 Determination of surface density of channels 
(chemiluminescence assay) 
For quantification of cell surface density of the KATP channels, the 
chemiluminescence assay was used as described in Chapter 2, section 2.5.4. In 
the assay channels expressed on the cell surface were labelled with rat anti-HA 
antibodies followed by HRP-conjugated anti-rat antibodies. The concentration of 
the secondary antibodies is proportional to the number of channels on the cell 
surface. Addition of Lumigen™ reagent gives a chemiluminescence signal which 
was measured and this signal is directly proportional to the number of HRP- 
conjugated secondary antibodies. The luminescence value from each sample was 
normalized to the protein content in the lysates to equate the number of cells taken 
into account to obtain a measure of the surface density of the channels. Data were 
obtained from three separate transfection experiments, each measured in duplicate 
and expressed as mean ± SEM and represented as bar graphs for each treatment 
as compared to the control. Statistical significance of differences was determined 
using One-Way ANOVA and Bonferroni test; P <0.05 was accepted as significant.  
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3.3 Results 
3.3.1 Effect of mutation of D280L281E282 residues of the Kir6.2 subunit 
on surface expression of the channels 
The lack of surface expression of the KATP channel with E282K mutation in its Kir6.2 
subunit reported by previous members of the lab was confirmed (Figure 3.3 top panel). 
Sequence alignment for the C-terminus stretch (Figure 3.2) suggested that residue E282 
could be a part of a conserved diacidic ER exit motif DXE where X could be any amino 
acid. The authenticity of D280L281E282 as the DXE motif required to be tested. In order to 
understand if the KATP channel required an intact DLE sequence for surface expression, 
HEK-MSRII cells were co-transfected with SUR1 and each of the extracellular HA-
tagged Kir6.2 subunits: HA-Kir6.2WT and mutants HA-Kir6.2E282K, HA-Kir6.2D280N, HA-
Kir6.2L281N and HA-Kir6.2E282Q. The transfected cells were fixed and stained for 
channels expressed on cell surface (red) using the extracellular HA-epitope. The 
channels that were expressed within the cell but did not appear on the cell surface 
were stained (green) following permeabilisation of the transfected cells (see methods 
for details). The stained cells were visualised using immunofluorescence confocal 
microscopy (Figure 3.3).  
 
The wild type (WT) KATP channels express within the cell as well as on the cell surface 
while channels with the mutation E282K in the Kir6.2 subunit are expressed within the 
cell but do not appear on the cell surface. Similarly, mutation of the acidic D280 and E282 
residues to their neutral amide forms (D280N and E282N) in the Kir6.2 subunit 
prevented surface expression of the channels. Mutant L281N behaved like the wild 
type in terms of surface expression (Figure 3.3). These experiments confirmed the 
requirement of an intact D280L281E282 stretch in the Kir6.2-CT for surface expression of 
the KATP channels. It was however not clear if export of KATP channels from the ER was 
mediated by COPII vesicles. 
  
 Figure 3.3 Surface expression of the D
cells were co-transfected with wild type or mutant Kir6.2 and SUR1
were fixed and channels expressed on cell surface were stained with p
HA antibodies followed by Cy3
cells were permeabilised and the channels expressed within the cells were 
with anti-HA antibody followed by the Alexa
(green). Representative confocal images of four independent experiments are shown; 
Scale bars: 10 µm. 
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3.3.2 Sar1-dependent surface expression of KATP channels 
Lack of surface expression of the mutants of the acidic residues D280 and E282 had 
opened the possibility that the D280L281E282 sequence was an ER export motif on the 
Kir6.2-CT. The DXE is an ER exit motif recognised and bound by proteins of the COPII 
machinery that export proteins out of the ER. The formation of the COPII vesicle is 
dependent on Sar1 (Nishimura et al., 1999, Wang et al., 2004b), see introduction for 
details). If forward trafficking of the KATP channel was mediated by the COPII 
machinery, dominant negative (DN) mutants of Sar1 would prevent its surface 
expression. 
 
To test this hypothesis, GFP-tagged DN Sar1 mutants, GFP-Sar1H79G and GFP-
Sar1T39N were co-expressed with the KATP channel in HEK-MSRII cells. Both these 
mutants disrupt normal Sar1 function and prevent COPII vesicle mediated export of 
cargo proteins from the ER. Surface expression of KATP channels was absent in 
presence of both these mutants of Sar1 but not GFP-Sar1WT (see Figure 3.4.A). The 
GFP tag helped to visualise the expression of the Sar1 proteins in the cells. Further, to 
eliminate any possible role of the GFP tag in the observed inhibition of KATP surface 
expression, experiments were carried out to determine the surface expression of KATP 
channels in the presence of the non GFP-tagged versions of the Sar1 proteins (Figure 
3.4.B). The KATP channels were stained (red) on cell surface using the anti-HA antibody 
on the Kir6.2 subunit. The cells were fixed and permeabilised to stain the KATP channels 
expressed within the cells (green). In presence of Sar1WT, the channels are expressed 
on the cell surface and within the cells. However, in presence of the Sar1 mutants, 
there was no expression of the channels on cell surface (no red stain) although the 
channels were expressed within the cells (green stain). 
 
These experiments confirmed that Sar1 activity was necessary for surface expression 
of the KATP channels. Although the Sar1 protein has no known role apart from a role in 
the formation of the COPII coated vesicles that export cargo proteins out of the ER, 
experimental evidence was required to see if the KATP channels entered COPII vesicles 
prior to export out of the ER. 
  
 Figure 3.4 Surface expression of K
cells were transfected to co
tagged Sar1 constructs. Cells expressing K
control. The cells were stained with anti
on cell surface (red). GFP
GFP-tagged Sar1 proteins: Sar1
Kir6.2WT+SUR1. The K
on cell surface (red) and internal (green). Representative confocal images of three 
independent experiments are shown; 
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3.3.3 Entry of KATP channels into ERES 
GFP-VSVGts045 protein as a marker for COPII vesicles at ERES 
Packing of the COPII vesicles for selective export of cargo proteins from the ER occurs 
in specific regions of the ER designated as the ER exit sites (ERES) (Barlowe, 2003, 
Fromme et al., 2008, Miller et al., 2003, Mossessova et al., 2003). Therefore ERES are 
sites where COPII vesicles are formed. If the KATP channels are transported out of the 
ER in the COPII vesicles, they should enter the ERES. The entry of KATP channels into 
ERES could be confirmed by looking at co-localisation of the channels with a known 
ERES marker protein such as the temperature sensitive mutant of the vesicular 
stomatitis virus glycoprotein; VSVGts045 (Mezzacasa and Helenius, 2002). GFP-tagged 
VSVGts045 (GFP-VSVGts045) is expressed normally on cell surface at 37°C. However, if 
expressed in cells growing at 39.5°C, the protein misfolds and is not exported out of the 
ER and accumulates in the ER. If the cells are cooled to permissive growth 
temperatures (32°C or below), the protein rapidly folds into right confirmation and 
enters ERES for packing into COPII vesicles. Budding of the COPII vesicles from the 
ER can be prevented by cooling the cells to 10°C (Mezzacasa and Helenius, 2002). 
Further, since VSVG has a DXE motif and is known to exit the ER by the Sar1 
dependent COPII pathway (Nishimura and Balch, 1997), surface expression of the 
protein is prevented by the DN Sar1 mutant; GFP-Sar1H79G. This mutant of Sar1 is 
‘GTP on’ and allows COPII vesicle assembly but prevents vesicle budding from the 
ERES (Nishimura et al., 1999, Wang et al., 2004b). Figure 3.5 shows confocal imaging 
of cells expressing the GFP-VSVGts045 at regular growth temperature (37°C). For the 
temperature shift experiment, HEK-MSRII cells were transfected to transiently express 
GFP-VSVGts045 and grown at successive temperatures of 37°C, 39.5°C, 10°C as 
outlined in the legend to Figure 3.5. Immunofluorescence images of the cells showed 
the GFP-VSVGts045 protein in green punctate structures that mark the ERES close to 
the nuclear region and the protein was absent at the cell surface. Similar effect could 
be reproduced by co-expression of GFP-VSVGts045 with mutant Sar1H79G that prevents 
COPII vesicle budding (see Figure 3.5). Based on these data the punctate structures of 
GFP-VSVGts045 were used as markers for COPII vesicles at ERES and also as 
reporters for the activity of Sar1H79G.  
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E282K mutant KATP channels do not enter ERES 
Expression of KATP channels on cell surface is prevented following co-expression with 
DN Sar1 mutants (Figure 3.4). If Sar1 prevented COPII mediated ER exit of the 
channel, it should be able to enter ERES. Both temperature shift treatment and DN 
Sar1 co-expression approach was used on cells co-expressing WT or the E282K 
mutant KATP channels and GFP-VSVG
ts045; the latter was used as a marker of ERES. 
The wild type KATP channels co-localised with punctate GFP-VSVG
ts045 marking the 
ERES (Figure 3.6.A). In contrast, no co-localisation was apparent with the E282K 
mutant channels (Figure 3.6.B). These data indicated that the KATP channels enter 
ERES prior to export out of the ER. Moreover, since the E282K mutation prevented 
entry of the channels into ERES, D280L281E282 appeared to be the diacidic ER exit motif 
on the Kir6.2 subunit of KATP required for Sar1 dependent ER exit of the channel. 
Further, it was important to investigate if the SUR1 subunit has any role in this ER exit 
mechanism of the KATP channels. 
 Figure 3.5 GFP-VSVG
transfected with GFP
which they were shifted to 10°C for 5 hours and then fixed followed by nuclear stain by 
DAPI. At this temperature, the protein cannot leave the ER and accumulates at ERES. 
Cells transfected and grown a
GFP-VSVGts045 expressed in cells at 37°C along with Sar1
ERES in the COPII vesicle since it cannot dissociate from the ER. Nuclei were stained 
blue with DAPI. Representative 
are shown; Scale bars
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3.3.4 ER exit of Kir6.2 and SUR1 subunits expressed independently 
In the experiments looking at surface expression and ERES entry of the WT and 
E282K mutant KATP channels, the importance of the diacidic ER exit motif was 
apparent. However in these experiments, the SUR1 subunit was co-expressed with the 
WT or the E282K mutant Kir6.2 subunit as would be the case in native cells (Shyng 
and Nichols, 1997). Previous studies on trafficking of the KATP channel reported that the 
association of the Kir6.2 and SUR1 subunits was critical for masking the ER retention 
(RXR) motifs on both the subunits and therefore the subunits were thought to assemble 
in the ER (Zerangue et al., 1999). The subunit assembly was thus considered 
necessary for surface expression of the channel, yet there was no evidence of it being 
essential for the entry of the channel subunits into ERES. Moreover, when trafficking 
experiments with the Kir6.2 WT and E282K mutant subunits were conducted in 
presence of SUR1 subunit, the influence of the SUR1 subunit in the ER export could 
not be determined. To address this issue and to get a clearer idea of the ER exit and 
assembly mechanisms for the channel, the HA-Kir6.2WT, HA-Kir6.2E282K and myc-SUR1 
subunits were expressed independently to see if they could enter ERES. 
 
Punctate structures of GFP-VSVGts045 (co-expressed with Sar1H79G) were used as 
markers of ERES as shown before in Figure 3.5. Both HA-Kir6.2WT and myc-SUR1 co-
localised with GFP-VSVGts045 indicating that they are recruited to the ERES while the 
E282K mutant did not co-localise with GFP-VSVGts045 (Figure 3.7). These results were 
unexpected, based on the previous reports on the channel assembly where subunit 
assembly was considered to be a pre-requisite for ER exit (Clement et al., 1997, Shyng 
and Nichols, 1997, Zerangue et al., 1999, Heusser et al., 2006); see discussion. 
  
 Figure 3.6 WT but not the E282K mutant, K
were co-transfected with the indicated channel subunits plus the GFP
Temperature shift treatments (37°/39.5°/10°C) as well as co
Sar1H79G caused accumulation of GFP
ERES. WT-KATP channels (A) but not the E282K mutant channels (B) co
GFP-VSVGts045 at the ERES. Representative confocal images from three independent 
experiments are shown; 
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Further, since proteins that enter ERES are expected to exit the ER and enter ERGIC 
(ER-Golgi intermediate compartment) (Appenzeller-Herzog and Hauri, 2006), an 
experiment was designed to look at the post-ER itinerary of the individual KATP 
subunits. Each of the subunits expressed alone were stained along with the protein 
ERGIC-53, a marker for the ERGIC (Appenzeller-Herzog and Hauri, 2006); see Figure 
3.8). Both Kir6.2 and SUR1 co-localised with ERGIC-53, indicating that the individual 
subunits were able to escape out of the ER and therefore assembly of Kir6.2 and 
SUR1 is not critical for ER exit of the channel subunits. These data also suggest the 
possibility of existence of an ER exit motif on SUR1, which seems quite likely 
considering the fact that SUR1 is a relative of the CFTR, a protein reported to exit ER 
in COPII mediated vesicles using the diacidic ER exit motif (Wang et al., 2004b). 
 
3.3.5 Kir6.2 interaction with the COPII machinery 
These data suggested that Kir6.2 and SUR1 subunits, when expressed independently, 
can exit the ER. However, in a natural scenario, both Kir6.2 and SUR1 would be co-
expressed (Shyng and Nichols, 1997) and therefore it could be argued that in an 
assembled octamer of Kir6.2 and SUR1 subunits, the diacidic ER exit motif on Kir6.2-
CT may not even be stearically accessible for interaction with the COPII machinery (Bi 
et al., 2002, Mossessova et al., 2003) see discussion. If this was true, the DLE motif on 
Kir6.2-CT might not even be able to bind to the COPII complex and the effect of the 
mutation E282K might be indirect.  
 
To test if the DLE motif on the Kir6.2-CT was specifically responsible for interaction 
with COPII complex, a CD4-Kir6.2-CT fusion protein was used. CD4 is a type I 
membrane protein expressed on cell surface with no known ER exit/ retention signals 
and is exported from the ER in a COPII independent manner (Figure 3.9.A). CD4 
showed no distinct co-localisation with GFP-VSVGts045 puncta in presence of Sar1H79G 
and appeared on the cell surface (Figure 3.9.B).  
  
 Figure 3.7 Kir6.2 and SUR1 subunits can enter ERES independently, while the 
mutant E282K cannot.
Kir6.2WT and myc-SUR1 subunits but not HA
in pseudo-grey were stained with DAPI. Representative confocal images from three 
independent experiments are shown; 
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-Kir6.2E282K with GFP
Scale bars: 10 µm. 
 
 
 of both HA-
-VSVGts045. Nuclei (N) 
 Figure 3.8 Kir6.2 and SUR1 subunits can enter ERGIC independently
Kir6.2WT and myc-SUR1 subunits expressed independently were found to enter ERGIC 
as seen by co-localisation
ERGIC-53 antibody. Nuclei in pseudo
confocal images from three independent experiments are shown; 
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. Both HA-
Scale bars: 10µm. 
 Figure 3.9 CD4 protein expression on cell surface does not depend on Sar1
were transfected with CD4 and GFP
immunostained (red) with an antibody against its extracellular domain without (surface 
CD4) and with permeabilisation (total cellular CD4). CD4 expresses on cell surface (A). 
Surface expression of 
images from three independent experiments are shown; 
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The C-terminus of CD4 was replaced with the C-terminus of Kir6.2WT devoid of the ER 
retention signal (Figure 3.10A) because the Kir6.2 subunit with deletion of the last 26 
amino acids (Kir6.2∆26) has been shown to express on cell surface in the absence of 
the SUR1 subunit in HEK cells (Tucker et al., 1998). This is because the RKR motif on 
the Kir6.2-CT terminus lies distal to the DLE sequence and is reported to act as the ER 
retention signal. Interaction with the SUR1 subunit is considered to mask this signal 
and allow ER exit of the channel subunits (Zerangue et al., 1999). If the ER retention 
signal is deleted from the Kir6.2-CT, the subunit would not require co-expression with 
the SUR1 subunit in order to express on the cell surface. This approach allowed the 
interaction between the COPII complex and the C-terminus of Kir6.2 to be studied 
independent of the SUR1 subunit.  
 
The rationale behind the use of the fusion protein was that if the diacidic ER exit motif 
on the Kir6.2-CT was responsible for interaction with the COPII complex then it would 
cause CD4 to exit the ER in a COPII dependent manner. The fusion protein (CD4-
Kir6.2-CT) was expressed on the cell surface and co-localized with GFP-VSVGts045 in 
the cell and on cell surface (Figure 3.10B). However, when Sar1H79G was also 
expressed in the cells, the CD4-Kir6.2-CT protein was not expressed on the cell 
surface and was seen to co-localise with the punctate structures of GFP-VSVGts045 at 
the ERES (Figure 3.10C). When the DLE motif on the Kir6.2-CT was mutated to DLK, 
the mutant fusion protein CD4-Kir6.2-CTE282K was found to be expressed within the cell 
but was absent from the cell membrane (Figure 3.11A).  
 
When the CD4-Kir6.2-CTE282K fusion protein was co-expressed with GFP-VSVGts045 
and Sar1H79G, there was no co-localisation seen with punctate VSVG vesicles marking 
the ERES (Figure 3.11B), indicating the inability of the fusion protein to enter ERES. 
The CD4-Kir6.2-CTE282K mutant thus behaved like the E282K mutant KATP channel. 
Taken together, data from experiments with the fusion proteins indicated that the DLE 
motif on the Kir6.2 is responsible for interaction with the COPII complex resulting in the 
concentration of the channel subunits in the ERES and the SUR1 subunit is not 
required for recognition of the KATP channels by COPII coat proteins. 
 Figure 3.10 DXE motif on Kir6.2 is responsible for entry of K
ERES. (A) Structural model of Kir6.2, schematic of CD4 and CD4
protein containing the C
gray lines represent hypothetical membrane borders. (B) Cells were stained for 
extracellular epitope on CD4 on surface and total. The C
ability to enter the ERES on CD4. (C) Sar1
Kir6.2-CT and the fusion protein co
images). Representative confocal images are shown from three independent 
experiments; Scale bars
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 Figure 3.11 Mutation of the DXE motif in the CD4
expression and concentration of the protein into ERES
transfected to express the CD4
Staining for expression on cell surface (red) and internal (green) shows that the mutant 
fusion protein is not expressed on cell surface. (B) Co
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3.3.6 Studying interaction between Kir6.2-CT and proteins of COPII 
coat using membrane permeable TAT-conjugated peptides 
The Sec24 subunit of COPII coat complex is known to recognise and bind its cargo 
through the diacidic motif present on the cargo (Miller et al., 2003). Involvement of the 
DXE motif on the Kir6.2-CT was evident from the experiments presented in the 
previous sections. Presence of a competing cargo should disrupt this interaction and 
affect the ER exit of the KATP channel. In principle, the TAT-DXE peptide would be 
expected to compete with the Sec24 binding site and its effect on surface expression of 
KATP should resemble that of the mutant Sar1
H79G. To test this theory, synthetic peptide 
(TAT-DXE) containing a stretch of the Kir6.2 channel subunit with the DLE motif 
(HHQDLEIIV) fused to the HIV TAT peptide sequence was synthesized commercially. 
The presence of the TAT sequence renders the peptide permeable to the cell 
membrane (Schwarze et al., 2000). The TAT peptide alone and TAT peptide 
conjugated to Kir6.2 stretch with mutated DLE motif (HHQDLKIIV) referred to as TAT-
DXK were used as controls (See Figure 3.12). HEK-MSRII cells transfected with the 
KATP channel subunits were treated with the synthetic TAT peptides (see methods for 
details). The TAT-DXE peptide treated cells but not the TAT-DXK or TAT peptide 
treated cells showed lack of surface expression of the KATP channel as seen by imaging 
(Figure 3.13.A) and chemiluminescence assay (Figure 3.13.B).  
 
Further, if the TAT-DXE peptide was competitively inhibiting Sec24 binding, then the 
KATP channels would not be recruited to the COPII vesicle and would be absent from 
the ERES. To check if this was true, cells co-expressing the KATP channel and/or GFP-
VSVGts045 were treated with the TAT-conjugated peptides. The cells were fixed, 
permeabilised and stained for total channel within the cell. Interestingly, GFP-VSVGts045 
was completely absent from cell membrane in cells treated with the TAT-DXE peptide 
(Figure 3.14.A). Moreover, the protein assembled into punctate structures marking 
ERES as seen in case of co-expression with Sar1H79G. These data suggested that 
GFP-VSVGts045 bearing COPII vesicles were formed but did not bud off (see 
discussion). Further, when cells expressing KATP and GFP-VSVG
ts045 were treated with 
TAT-DXE peptide, the channels co-localised with the punctate GFP-VSVGts045 
structures marking ERES (Figure 3.14.B). The cells treated with TAT or the TAT-DXK 
peptide did not cause accumulation of GFP-VSVGts045 in punctate structures. When the 
cells expressing GFP-VSVGts045 or the KATP channels were treated with the TAT-DXE 
peptide and stained (total) for HA-Kir6.2 along with the ERGIC-53, a marker for the 
ERGIC compartments, no co-localisation could be seen between ERGIC-53 and GFP-
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VSVGts045 or KATP (Figure 3.14.C). Taken together the data indicated that the TAT-DXE 
peptide prevented the escape of GFP-VSVGts045 and KATP channels from the ER. 
 
The punctate GFP-VSVG and HA-Kir6.2 both did not show any co-localisation with 
ERGIC-53 which strengthens the observation that the TAT-DXE peptide locks the DXE 
motif containing COPII cargo in the ERES. These data further strengthen the 
importance of the DXE motif in ER exit. Also, the effect of the TAT-conjugated peptides 
is encouraging for the use of these peptides as tools for COPII mediated ER exit 
studies. 
 
As in all the above experiments using the peptides, the cells were transiently 
transfected to express the channel; it was interesting to look at the effect of the peptide 
on surface expression of the channel in cells stably expressing it. Figure 3.15 shows 
results from experiments using a KATP stable cell line that co-expressing HA-Kir6.2 and 
SUR1. The cells were treated with the TAT-DXE and TAT-DXK peptides for different 
times and the channels on cell surface were stained. The cells treated with the TAT-
DXE peptide showed a decrease in the surface expression of the channel and most of 
the cells showed nearly complete loss of KATP from cell surface after 96 hours of 
treatment with the peptide. The TAT-DXK peptide however had no effect.  
  
 Figure 3.12 Schematic of TAT
Figure 3.13 TAT-conjugated
exit signal of Kir6.2 prevents surface expression of K
cells were transfected with HA
(0.5 mM, made up in Optimem
(red) HA-Kir6.2. Representative confocal images of three independen
shown. Scale bars: 10
the surface expression of K
normalised to control (untreated); *P > 0.001.
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-conjugated peptides.  
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ATP channels.
-Kir6.2 and SUR1 and treated with the indicated peptides 
®) and stained for cell surface (red) and intracellular 
 µm. (B) Quantitative analysis of the effect 
ATP channels using chemiluminescence. All values are 
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t images are 
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 Figure 3.14 TAT-DXE peptide treatment causes accumulation of the cargoes 
containing the diacidic
VSVGts045. (B) HEK-MSRII cells were transfected to express GFP
HA-Kir6.2WT and SUR1. Following treatment with TAT, TAT
as in Figure 3.13, the cells were fixed, permeabilised and stained for total HA
(red). (C) Cells expressing GFP
treatment with the TAT
Nuclei in pseudo-grey were stained with DAPI. Representative confocal images from 
three independent experiments are shown; 
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 Figure 3.15 TAT-DXE peptide treatments cause 
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3.3.7 Rescue of Kir6.2E282K subunit to the cell surface by the Kir6.2WT 
The above studies showed that KATP channels contain a functional diacidic ER exit 
signal (DLE) which promotes concentration of the channel into COPII enriched ERES 
prior to secretion and that in the absence of such a concentrative step, delivery of the 
channel to the cell surface is almost completely prevented. In light of this information it 
was interesting to understand the effect of the mutation in the DLE motif on Kir6.2 at a 
functional level. The pancreas of the Swedish patient in whom the E282K mutation in 
the Kir6.2 subunit was first reported (Christesen et al., 2007); see Figure 3.1) had two 
kinds of cells. The tumorous cells expressed the E282K mutant Kir6.2 subunits and 
SUR1. Experiments to look at the surface expression of the KATP channels made up of 
Kir6.2E282K and SUR1 subunits showed lack of surface expression of the channels 
(Figure 3.3). The non-tumorous pancreatic cells had a heterozygous mutation in the 
KCNJ11 gene and they expressed both wild type and E282K mutant Kir6.2 subunits 
along with SUR1. Therefore, effect of surface expression of the KATP channels in cells 
simultaneously expressing both Kir6.2WT and Kir6.2E282K subunits along with SUR1 was 
investigated. HEK-MSRII cells were transfected to co-express SUR1, HA-Kir6.2E282K 
and FLAG-Kir6.2WT (Kir6.2WT subunit with a FLAG tag but no HA-tag). The cells were 
stained with the anti-HA antibody to label the channels expressed on cell surface (red) 
and for channels expressed within the cells (green). Interestingly, in cells expressing 
both FLAG-Kir6.2WT and HA-Kir6.2E282K, the HA-Kir6.2E282K channels were labelled on 
cell surface which showed that the wild type Kir6.2 subunits were capable of rescuing 
the E282K mutants to the cell surface. However, when the trafficking deficient mutant 
of HA-Kir6.2W91R was co-expressed with the FLAG-Kir6.2WT, the HA-tagged mutant 
subunits were not expressed on the cell surface. The Kir6.2W91R subunits are known to 
be retained in the ER due to misfolding (Crane and Aguilar-Bryan, 2004) and therefore 
are not rescued to the cell surface when co-expressed with the Kir6.2WT subunits and 
SUR1. As an experimental control, when HA-Kir6.2WT subunits were co-expressed with 
the FLAG-Kir6.2WT subunits, the HA-Kir6.2WT subunits were found to express on the 
cell surface (Figure 3.16). It was evident from these data that the E282K mutation 
unlike the W91R mutation only affects the ability of Kir6.2 subunits to be recruited to 
the COPII vesicles and does not cause subunit misfolding.  
  
 Figure 3.16 Kir6.2E282K
HEK-MSRII cells were co
control) or HA-Kir6.2
(red) and internal (green) using the anti
HA-tagged constructs
transfected with the HA
subunits on cell surface due to co
Representative confocal images of three independent experiments are shown. 
bars: 10 µm 
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3.4 Discussion 
 
The aim of this study was to investigate the cell biological mechanism by which the 
genetic mutation E282K in the Kir6.2 subunit of the KATP channel causes the focal form 
of CHI (Christesen et al., 2007). The E282K mutant channels were found to be absent 
from cell surface. Experiments to find out why the mutant channels do not express on 
cell membrane revealed a previously unrecognised diacidic ER exit motif (DLE) on the 
C-terminus of the Kir6.2 subunit which is crucial for trafficking of the KATP channels to 
the cell surface and that abrogation of this motif leads to the disease (CHI) as reported 
in the patient.  
 
The lack of surface expression of the E282K mutant KATP channels observed in 
confocal imaging (Figure 3.3, top panel) was supported by electrophysiological 
experiments (Taneja et al., 2009), J. Mankouri’s thesis) which showed that the mutant 
failed to form functional channels in Xenopus oocytes. Taken together, these data 
classified the E282K into the league mutations that affect forward trafficking instead of 
those that alter function of the channel (see introduction for details on mutations that 
alter KATP channel function but not expression).  
 
Mutations that cause protein misfolding and therefore defective forward trafficking are 
not uncommon in Kir6.2 or SUR1, as well as in several other membrane proteins such 
as CFTR (Brown et al., 1996) and hERG (Anderson et al., 2006). Mutations such as 
delta F1388 in SUR1 lead to lack of surface expression through ER retention of the 
KATP channels (Cartier et al., 2001), while others cause retention of the protein in the 
Golgi (Partridge et al., 2001). CHI caused by lack of functional KATP channels on β-cell 
surface due to folding defects in the SUR1 subunit of the channels is a common cause 
of the disease. Patients suffering this form of CHI can be treated using diazoxide 
(Partridge et al., 2001). Mutations in the Kir6.2 subunit either introduce a premature 
stop codon that results in truncated non-functional Kir6.2 protein, or introduce mis-
sense mutations that cause rapid degradation of the protein (Aguilar-Bryan and Bryan, 
1999, Marthinet et al., 2005). Mutation W91R in Kir6.2 causes misfolding of the subunit 
that prevents expression of the KATP channels on cell surface. The misfolded subunit is 
unable to bind SUR1 subunit stably and is rapidly degraded. The W91R mutation of the 
Kir6.2 subunit is reported to cause severe hyperinsulinism in patients (Crane and 
Aguilar-Bryan, 2004). Similarly mutations such as delta F508 in CFTR (Brown et al., 
1996) and N470D in hERG (Zhou et al., 1999) cause protein misfolding and forward 
trafficking defects. The patient with the E282K mutant KATP channels however had 
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consistently high insulin levels leading to severe hypoglycemia and did not respond to 
treatment with diazoxide, a potassium channel activator. Moreover, co-
immunoprecipitation studies using myc-SUR1 as bait suggested that HA-Kir6.2E282K 
was capable of binding SUR-1 (Taneja et al., 2009). Also, co-expression with the wild 
type channel rescued the E282K mutant subunits to the cell surface (Figure 3.16) and 
formed functional channels (Taneja et al., 2009), J. Mankouri thesis). These data 
indicated that the mutation E282K did not affect folding of the Kir6.2 subunit, nor did it 
affect its association with other Kir6.2WT and SUR1 subunits. Therefore the ER 
retention of the E282K mutant KATP channels appears to be mechanistically different 
from the previously reported mutations where misfolding was the cause of deficient 
trafficking. 
 
E282 was part of the stretch D280L281E282 on the Kir6.2 C-terminus. This sequence in 
which two acidic amino acids separated by a non-acidic amino acid has been identified 
to act as the diacidic ER exit motif [(D/E) X (D/E)] in several membrane proteins 
including VSV-G (Nishimura et al., 1999), CFTR (Wang et al., 2004b) and some 
potassium channels such as TASK-3 (Zuzarte et al., 2007, Barlowe, 2003, Nishimura 
and Balch, 1997); see Figure 3.2). The DXE motif is required for the transport of 
proteins from the ER in COPII vesicles. Recruitment of cargo into COPII vesicles is 
initiated by the activation of Sar1 GTPase, which involves exchange of bound GDP for 
GTP in a reaction catalyzed by the GDP-GTP exchange factor Sec12. This is followed 
by the attachment of activated Sar1 to the ER membrane, which in turn recruits the 
Sec23-Sec24 hetero-dimer by binding to the Sec23 protein. Sec24 captures cargo by 
interacting with the ER export signals. Sec13–Sec31 coat proteins are then added, 
leading to the formation of the pre-budding complex, which when fully formed is 
released into the cytoplasm as a COPII-coated vesicle for transport to the Golgi 
apparatus.  
 
The Sec24 protein can recognize COPII cargo with high specificity through interaction 
with the ER exit motifs present of COPII cargoes which allows recruitment of the cargo 
protein into COPII vesicles for exit from ER (Miller et al., 2002). Disruption of the acidic 
amino acids of this motif causes ER retention (Nishimura et al., 1999). Mutation of the 
residues D and E of D280L281E282 but not L to their neutral amide forms resulted in lack 
of surface expression like the E282K mutant (Figure 3.3). These data suggested that 
DLE stretch on Kir6.2 could be acting as the diacidic ER exit motif known to be critical 
for export of cargo proteins in COPII vesicle. 
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The assembly of the COPII vesicles at the ERES located on the ER membrane is a 
part of a concentrative step that ensures efficient delivery of proteins to the cell surface 
(Barlowe, 2003, Miller et al., 2003, Mossessova et al., 2003, Fromme et al., 2008, 
Gurkan et al., 2006, Wang et al., 2004b). Formation of the COPII coat is considered to 
initiate with the recruitment of Sar1-GTP to the ERES and budding of the COPII vesicle 
containing its cargo requires hydrolysis of Sar1-GTP to Sar1-GDP (Bi et al., 2002, 
Barlowe, 2002). The Sar1 mutant Sar1T39N is a weak dominant negative and is ‘GDP 
on’; therefore over-expression of this mutant prevents COPII vesicle formation. The 
mutant Sar1H79G is ‘GTP on’ and therefore favours COPII vesicle formation but not 
vesicle budding resulting in the accumulation of cargo in COPII vesicles at ERES 
(Nishimura et al., 1999, Wang et al., 2004b). Co-expression of KATP channels with the 
Sar1 mutants prevented surface expression of the channel (Figure 3.4), indicating that 
forward trafficking of KATP channels is Sar1 dependent. Sar1
H79G also prevents surface 
expression of the GFP-VSV-Gts045 protein and arrests it in the COPII vesicles in ERES. 
Effect of Sar1H79G on GFP-VSV-Gts045 was similar to that of the temperature shift 
treatment (37°C-39.5°C-10°C) that arrests the protein in ERES (Mezzacasa and 
Helenius, 2002). GFP-VSV-Gts045 appears as punctate structures in the perinuclear 
region (Figure 3.5). The wild type KATP channels (HA-Kir6.2
WT+ SUR1) entered the 
ERES marked by GFP-VSV-Gts045 in the temperature shift experiment as well as in 
presence of Sar1H79G (Figure3.6A). However, the mutant KATP channels made of the 
HA-Kir6.2E282K and SUR1 subunits did not enter ERES (Figure 3.6B). Thus an intact 
DLE motif on Kir6.2 is critical for entry of the channels into ERES for export out of the 
ER. 
 
Each of the KATP channel subunits Kir6.2
WT and SUR1 expressed independently of 
each other were capable of entering into ERES (Figure 3.7). These data presented 
some interesting evidence towards the existence of a signal on SUR1 for sorting into 
COPII vesicles at ERES. In native cells, both the subunits of the KATP channels are co-
expressed and it has been reported that both Kir6.2 and SUR1 contains an ER 
retention signal ‘RKR’ which retains un-assembled subunits in the ER (Zerangue et al., 
1999). The study suggested that Kir6.2 subunits assemble into tetramers and the ER 
retention RKR motifs are exposed. Assembly with SUR1 subunits completes the 
formation of the octameric channels. This assembly masks the exposed RKR motifs 
and allows trafficking of fully assembled channels to the cell surface. The evidence 
towards this theory was that the KATP channel subunits expressed independently of 
each other did not express on the cell surface (Zerangue et al., 1999, Crane and 
Aguilar-Bryan, 2004). Studies on the RKR motif suggested that 14-3-3 proteins have a 
role in probing the assembly of the KATP channels in the post ER compartment 
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(Heusser et al., 2006). If there are any partially assembled channels with exposed RKR 
signals, they would be bound by 14-3-3 proteins that is recognised by the COPI 
machinery. The COPI vesicle transports the unassembled channels back to the ER 
(Heusser et al., 2006, Mrowiec and Schwappach, 2006).  
 
If it was considered that the channel subunits assemble prior to ER exit, then since the 
E282K mutant Kir6.2 subunit could associate with SUR1 (Taneja et al., 2009), it should 
be rescued to the cell membrane with the help of the ER exit signal on SUR1 (Sharma 
et al., 1999). However, the mutant channel co-expressed with SUR1 did not express on 
cell surface (Figure 3.3 top panel). Therefore, ER exit motif on Kir6.2 was critical for 
COPII mediated ER exit of the channels. Also, co-expression with the wild type Kir6.2 
subunits rescued the E282K mutant to the cell surface. Therefore, the Kir6.2 subunits 
must assemble prior to ER exit and it was most likely that they formed tetramers. Both 
Kir6.2 and SUR1 subunits were capable of independently reaching the post-ER 
destination of ERGIC compartments (Figure 3.7) and the RKR motif did not cause ER 
retention of the subunits. Taken together these data suggest that the Kir6.2 subunits 
must dimerise or multimerise in the ER prior to ER exit and the complete assembly of 
the channel by binding of the SUR1 subunits may be occurring in the ERGIC 
compartment.  
 
Any unassembled channels or channel subunits must be returned back to the ER in the 
COPI vesicle due to recognition of the un-masked RXR motifs. Therefore the RKR 
motif on the KATP channel subunits is more likely to act as an ER-retrieval signal rather 
than the ER-retention signal. This model of KATP channel assembly is further supported 
by the consideration that in the fully assembled state (Mikhailov et al., 2005), the ER 
exit signals on Kir6.2 subunits are quite likely to be masked by the SUR1 subunits 
preventing their recognition by the COPII machinery. Also, the fully assembled complex 
is 900 KDa and has a diameter of 18 nm (Mikhailov et al., 2005); while the COPII 
vesicles appear to be about 60-70 nm in diameter (Gurkan et al., 2006, Fromme and 
Schekman, 2005). Packaging of such a huge channel complex might pose mechanistic 
problems for the COPII coat machinery while individual subunits and partial complexes 
of the channel, on the other hand, could be more easily accommodated into COPII 
vesicles. 
 
The molecular basis of interaction between the COPII complex and the DLE motif on 
the Kir6.2-CT was intriguing since it was this small stretch of three amino acids which 
was critical for expression of the channels on the cell surface. An analysis of the 
available structural information about the Kir6.2 subunits and the COPII proteins 
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showed that the binding site for the DLE motif on the Sec23.24-Sar1 complex of COPII 
is at an estimated distance of 20 Å from the membrane interface. The DLE motif on 
Kir6.2-CT is estimated to be located at a distance of 25 Å from the membrane interface 
(Figure 3.17). Therefore, the concave shaped Sec23/24-Sar1 complex should be 
favourably placed to bind the DXE motif and also bend the membrane to form the 
COPII vesicle (Barlowe, 2002, Fromme and Schekman, 2005, Taneja et al., 2009). 
However, if it is considered that the channel subunits assemble, it presents the 
question if the DLE motif is really accessible for binding to the COPII machinery and 
thereby mediate ER exit. These questions are answered by the data which show ability 
of the Kir6.2-CT to transfer the ability of Sar1-dependent ER exit in COPII vesicles to 
CD4 protein (Figure 3.10). The surface expression of CD4 is not Sar1-dependent 
(Figure 3.9). When the C-terminus of CD4 was replaced by the Kir6.2-CT containing 
the DLE motif, but no RKR signal, the fusion protein is expressed on cell surface in a 
Sar1-dependent manner and enters COPII vesicles at ERES (Figure 3.10). 
 
Moreover, mutation E to K in the DXE motif of the fusion protein prevents surface 
expression of the fusion protein like the E282K mutant channel (Figure 3.11). Thus, the 
DXE motif on the Kir6.2-CT is required for interaction with the COPII complex for Sar-
dependent ER exit. Disruption of the interaction between the DXE motif on Kir6.2 and 
COPII complex was possible using a membrane permeable TAT fusion peptide that 
had a stretch of the Kir6.2-CT containing the DLE sequence (Figure 3.12). The HIV 
TAT peptide stretch has been used to deliver small peptides into the cell (Schwarze et 
al., 2000). The stretch of DLE motif containing Kir6.2-CT fused to it, acted as a 
competitive cargo for the Sec24 binding. The TAT-DXE peptide could efficiently 
saturate the Sec24 binding sites for the diacidic ER exit motif (DXE) as cells treated 
with the TAT-DXE peptide but not the TAT or TAT-DXK peptide showed lack of surface 
expression of KATP (Figure 3.13, 3.15). The KATP channels in TAT-DXE treated cells 
were stuck in ER and did not enter ERGIC (Figure 3.16), which confirmed that 
interaction with Sec23/24-Sar1 complex was necessary for export out of ER. In cells 
transfected to express the KATP channel, treatment with the TAT-DXE peptide could 
significantly reduce the surface expression of the channels within 24 hours of treatment 
(Figure 3.13) but a similar effect of the TAT-DXE peptide could be seen in the cells 
stably expressing the KATP channels after 96 hours of treatment of the cells (Figure 
3.15). This is because the peptide treatment affects the channels only during their 
synthesis and so in cells consistently expressing the channels, treatment of the peptide 
would not become apparent till all the channels that are already expressed in the cells 
and are on the cell surface or a part of endosomal recycling pathways reach the end of 
their lifecycle. The TAT-DXE peptide also prevented surface expression of the GFP-
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VSV-Gts045 (Figure 3.14), indicating that the saturation of the DXE binding motif on 
Sec24 (Miller et al., 2002) affects ER export of all proteins that follow Sar1-dependent 
ER export. The peptide could therefore be used as a tool for studying COPII mediate 
ER export of proteins. Also, if details of the trafficking mechanisms are known, then 
with proper delivery systems in place, the TAT-conjugated peptides may be considered 
for altering surface expression of the channel protein for therapeutic applications.  
 
This study initiated with the report (Christesen et al., 2007) of a Swedish patient who 
was suffering from a focal from of CHI and had inherited the E282K mutation in the 
Kir6.2 subunit of the KATP channel. KATP channel activity in the pancreatic β-cells 
regulates insulin secretion in response to the metabolic state of the cell (Ashcroft, 
2005, Dunne et al., 2004). Channel closure or absence from the cell surface leads to 
pancreatic β-cell membrane depolarization which opens the depolarization dependent 
Ca2+ channels. Influx of Ca2+ into the cell causes insulin secretion (Ashcroft, 2005, 
Nichols, 2006), see Chapter1 and Figure 1.4). Lack of KATP channel expression on cell 
surface would result in continued insulin secretion as observed in the patient. The 
absence of the E282K mutant KATP channel from the cell surface therefore accounted 
for the disease phenotype and the molecular basis of this lack of surface expression of 
the mutant channel presented itself as an interesting point of study.  
 
The patient’s pancreas had two populations of cells, one which expressed just the 
E282K mutant channels which also lacked the tumour suppressor protein. These cells 
were therefore tumorous and foci of these tumorous cells were secreting insulin in an 
unregulated manner. Since they expressed mutant E282K channels that are stuck in 
the ER due to the abrogated DXE motif, absence of the KATP channels in these cells led 
to unregulated insulin secretion by the cells. Following resection of the focal 
hyperinsulinaemic area to remove the tumorous focal region of the pancreas, the 
patients was clinically cured. This could be explained as follows: the population of cells 
in the islets of the patient left behind after the pancreactomy expressed both wild type 
and the E282K mutant channel subunits. The wild type subunits when co-expressed, 
rescue the mutant channel subunits to the cell surface (Figure 3.16). Moreover, there 
would be a mixed population of KATP channels having different combinations of the WT 
and E282K mutant subunits in the KATP channels in these cells. Currents recorded from 
Xenopus oocytes (Taneja et al., 2009)and thesis of J. Mankouri) show that the 
heteromers are functional as well. Thus, having removed the cells secreting excessive 
insulin, the patient is left with islets that have functional KATP channels and therefore are 
capable of normal glucose stimulated insulin secretion (Arnoux et al., 2010). Thus, the 
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molecular basis of the cure of focal form of CHI is explained in support of the clinical 
cure of the disease.  
 Figure 3.17 KATP channel and the Sec23
Kir6.2 (Antcliff et al., 2005)
Sar1 complex (Bi et al., 2002)
diagonally opposite subunits are shown. The DLE residues of Kir6.2 are highlighted in 
CPK and are situated approximately 25Å away from the putative membrane border 
(shown as grey lines). De
containing 17 transmembrane (TM) segments organized into three domains, TMD0 
(TM segments 1-5), TMD1 (TM segments 6
the two cytosolic nucleotide binding domains (
TMD2. The bottom image shows the structure of the (QLKDLESQI), shown in CPK, 
bound to the binding pocket; the peptide is located approximately 20Å away from the 
putative vesicle membrane border (grey line). The Sec23/24
(Mossessova et al., 2
spherical shape of a vesicle. The complex is an elongated thin particle, measuring 
~150Å in the long direction (parallel to the membrane) and about 40Å in the direction 
away from the membrane.
white, carbon in black. Nitrogen in blue and oxygen atoms are depicted in red
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3.5 Summary 
 
The study of molecular basis of CHI causing mutation E282K in the Kir6.2 subunits of 
the KATP channels has led to the discovery of the presence of a diacidic ER exit motif 
(DXE) on the Kir6.2 C-terminus formed by the D280L281E282 stretch of amino acids. 
Disruption of this motif due to the mutation E282K in the Kir6.2 prevented the surface 
expression of the channel. The DXE motif is shown to allow the concentration of the 
channels in COPII enriched ERES. Entry of the channels into COPII vesicles in a Sar1-
GTPase dependent manner is required for entry of the channels into the ERES for 
transport out of the ER. Co-expression with the wild type Kir6.2 subunits rescues the 
E282K mutant Kir6.2 subunits to express on cell surface which shows that the mutation 
has no affect on the channel properties or folding and also explains the clinical cure of 
the patient following pancreactomy. Further, this study has not only provided 
explanation to the molecular nature of the disease but has also given insights into the 
mechanisms of channel assembly. The study suggests that the Kir6.2 subunits 
assemble in the ER prior to ER exit but rest of the channel assembly with SUR1 
subunits is more likely to occur in a post ER compartment. Also, from the experiments 
that show rescue of surface expression of the E282K mutant subunits by WT-Kir6.2 
subunits, it seems that all the four DLE motifs from the four Kir6.2 subunits of the 
channel are not necessary for entry into the COPII vesicles and ER export. The present 
data suggest that the RKR motif on the Kir6.2 subunits appears to function as the ER 
retrieval signal since the channel subunits are on their own able to exit ER and reach 
ERGIC. The RKR signal is therefore more likely to retrieve partially assembled KATP 
channels from the ERGIC to the ER. This model of the KATP channel assembly and ER 
export that emerged from the studies presented in this chapter is illustrated in Figure 
3.18.  
 
The ER exit signal has physiological importance as its abrogation causes severe CHI. 
Disease causing mutations have been reported in genes encoding the components of 
the COPII machinery, including Sar1 (Jones et al., 2003) and Sec23 (Boyadjiev et al., 
2006); however, this study provides the first example of a mutation in a cargo protein 
causing disease in humans. Since the motif works through interaction with the proteins 
of the COPII machinery it was possible to design and employ a membrane permeable 
TAT fusion peptide (TAT-DXE) which acts as a competing cargo for binding the COPII 
complex and prevents surface expression of the KATP channel. This peptide could be 
used as a tool in trafficking studies or for altering surface expression of the channel 
protein for therapeutic applications.  
 Figure 3.18 Schematic of assembly trafficking of the K
Kir6.2 and SUR1 subunits are expressed in the ER. The Kir6.2 subunits dimerise or 
multimerise, followed by entry into the COPII vesicles which requires the 
exit motif (DLE) present on the Kir6.2
intact DLE sequence. The Kir6.2 and SUR1 subunits are exported out of the ER and 
enter ERGIC compartments where they must be assembled into the octameric K
channels with four subunits each of the Kir6.2 and SUR1. Un
which have un-masked RKR motifs are transported back to the ER by action of the 14
3-3 proteins. The octameric K
on the cell surface. 
149 
ATP channel subunits
-CT. All the four subunits do not need to have
ATP channels are processed in the Golgi and expre
 
. The 
diacidic ER 
 and 
ATP 
-assembled channels 
-
ssed 
150 
 
 
 
 
 
 
 
 
 
CHAPTER 4 
Sar1-GTPase dependent ER exit of cardiac hERG potassium channels 
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4.1 Introduction  
 
The hERG (human ether-a-go-go related gene) potassium channel (Kv11.1), encoded 
by the KCNH2 gene, underlies the rapidly activating delayed rectifier K+ current (IKr), 
which is the most important component of the repolarisation phase of the cardiac action 
potential (Sanguinetti et al., 1995, Sanguinetti and Tristani-Firouzi, 2006). Its 
importance in cardiac function is underscored by the identification of >200 inherited 
loss-of-function mutations that lead to long QT syndrome 2 (LQTS2) (OMIM: 152427) 
in which the QT interval of the electrocardiogram is lengthened leading to potentially 
fatal arrhythmias (Sanguinetti and Tristani-Firouzi, 2006, Anderson et al., 2006, 
Rajamani et al., 2002, Furutani et al., 1999, Sanguinetti et al., 1995). More alarmingly, 
a wide range of pharmaceutical agents have been shown to cause LQTS2 through 
interactions with hERG, leading to the withdrawal of several useful clinical agents (e.g., 
terfenadine, cisapride and grepafloxacin) (Brown, 2004). Testing of novel therapeutic 
agents for potential deleterious effects on hERG function has therefore become 
mandatory and it remains one of the principal causes of failure in pre-clinical testing. A 
relatively rare but related disorder, short QT syndrome 1 (SQT1) (OMIM: 609620) 
results from gain-of-function mutation in hERG where the biophysical properties of the 
channel are altered (Brugada et al., 2005, Hong et al., 2005). 
 
Hereditary LQTS2 mutations and drugs affect the channel in two ways: some inhibit 
channel function or alter its biophysical properties, whereas others reduce the channel 
density at the cell surface (Robertson and January, 2006, Sanguinetti and Tristani-
Firouzi, 2006, Rajamani et al., 2006, Eckhardt et al., 2005, Ficker et al., 2005). Recent 
studies suggest that defective trafficking may be the most dominant mechanism for the 
loss of hERG function (Anderson et al., 2006). Interestingly, defective trafficking 
caused by many mutations could be rescued pharmacologically in several cases 
(Robertson and January, 2006, Delisle et al., 2003, Rajamani et al., 2002, Zhou et al., 
1999, Ficker et al., 2005, Gong et al., 2006). Several groups have investigated the 
mechanisms underlying the defective trafficking of the hERG mutant channels and the 
pharmacological rescue. It seems that most mutations cause misfolding of the channel 
protein, resulting in retention by the quality control machinery of the ER. Molecular 
chaperones, including Hsc70 (70 KDa heat shock cognate protein), Hsp90 (90 KDa 
heat shock protein) (Ficker et al., 2003) and calnexin (Gong et al., 2006) are involved in 
the ER retention. Studies showed that they bind the misfolded channels more strongly 
than the wild type channel (Ficker et al., 2003, Gong et al., 2006). Drugs which rescue 
defective trafficking appear to work by weakening such interactions with chaperones 
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(Gong et al., 2006, Ficker et al., 2003). Misfolded mutant proteins have been shown to 
undergo degradation by the cytosolic proteasomes in a process that involves poly-
ubiquitinylation and deglycosylation (Gong et al., 2005,(Kagan et al., 2000).  
 
Despite the patho-physiological importance, the mechanisms by which hERG channels 
traffic to the cell surface and how trafficking is regulated are not fully understood. Many 
membrane proteins contain signals in their primary sequence that control their ER exit 
(Ellgaard and Helenius, 2003). Some proteins contain ER retention/retrieval signals 
that play a crucial role in the ER quality control by allowing only properly folded and 
fully assembled proteins to exit the ER (Ellgaard and Helenius, 2003). Some contain 
export signals that promote efficient ER export (Barlowe, 2003, Mossessova et al., 
2003, Gurkan et al., 2006, Fromme et al., 2008, Ellgaard and Helenius, 2003, Miller et 
al., 2003). Native IKr channels are made up of two subunits, hERG1a and hERG1b that 
are products of the alternate transcripts of KCNH2; they differ only in the N-terminus. 
hERG1b has an ER retention signal of the RXR type that prevents its surface 
expression unless hetero-oligomerisation with hERG1a masks the retention signal 
(Phartiyal et al., 2007). However, it is not known if hERG has an ER export motif. In a 
recent study, Delisle et. al. reported that the surface expression of hERG is prevented 
by a dominant negative construct of Sar1-GTPase (Delisle et al., 2009). Based on this 
observation, the authors proposed that hERG may exit the ER via COPII vesicles. 
However, entry of the channel into COPII vesicles was not demonstrated.  
 
Studies showed that membrane proteins destined to exit the ER via COPII vesicles 
contain discrete ER export signals. These include the diacidic motifs [(D/E)X(D/E)], di-
hydrophobic motifs (FF, YY, LL or FY), YXXXNPF and LXXLE motifs (Barlowe, 2003, 
Mossessova et al., 2003, Fromme et al., 2008, Gurkan et al., 2006, Nishimura et al., 
1999, Wang et al., 2004b). The COPII machinery recognizes the ER exit signals on 
proteins destined to exit the ER and package the proteins into COPII vesicles in a 
process that requires Sar1-GTPase (Gurkan et al., 2006, Fromme et al., 2008). The 
cargo-loaded vesicles exit the ER from specialized sites, known as the ER exit sites 
(ERES) and deliver the cargo protein to the ER-Golgi intermediate compartment, from 
where the proteins traffic to the plasma membrane via the Golgi (Barlowe, 2003, 
Fromme et al., 2008, Miller et al., 2003, Mossessova et al., 2003). hERG has several 
potential ER exit motifs in its C-terminus, including three diacidic motifs (Nishimura et 
al., 1999), which is consistent with the proposition that hERG might exit the ER via 
COPII vesicles.  
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In this chapter, the mechanism of ER exit of hERG was investigated using a 
temperature sensitive mutant of GFP-tagged VSV-G protein (GFP-VSV-Gts045), as a 
reporter protein. Dominant negative mutants of Sar1-GTPase required for COPII 
mediated ER exit and Sec24 blocking peptides (described in Chapter 3) to examine the 
process of ER exit. Our results demonstrate that hERG exits the ER via COPII vesicles 
in the same way as GFP-VSV-Gts045. Further, the location of the DXE motif on the distal 
C-terminus of hERG was investigated. The results show that, unlike VSVG, hERG 
does not appear to use diacidic ER exit motifs to access the COPII coat machinery.  
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4.2 Materials and Methods  
4.2.1 Plasmid constructs 
HA-tagged hERG in pcDNA3 was transfected into HEK-MSRII cells for transient 
expression of the HA-hERG channels. HA-hERG truncation mutants were prepared by 
inserting a stop codon using QuikChange® PCR by other members of the Rao lab. For 
details of the Sar1 constructs and GFP-VSVGts045 see Materials and methods section in 
Chapter 3.  
4.2.2 Antibodies 
Antibodies against the HA-tag on the hERG channels were diluted and used as in 
Chapter 3.  
4.2.3 TAT-conjugated peptides 
Tat (YGRKKRRQRRR), Tat-DXE (YGRKKRRQRRRHHQDLEIIV) and Tat-DXK 
(YGRKKRRQRRRHHQDLKIIV) peptides were used as in Chapter 3. 
4.2.4 Immunofluorescence staining 
Cells were stained for HA-hERG channels (wt or mutants) using antibodies against the 
HA- epitope for immunofluorescence imaging using the protocols described in 
Chapter2, section 2.5. 
4.2.5 Determination of surface density of channels 
(chemiluminescence assay) 
For quantification of cell surface density of the HA-hERG channels, the 
chemiluminescence assay was used as described in Chapter 3. 
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4.3 Results  
4.3.1 Characterisation of the HA-hERG construct 
The aim of this study was to investigate the ER exit mechanisms for the hERG 
potassium channels. ER exit is a key step in the forward trafficking of the channels and 
a major determinant of surface density. For this study, a hERG construct (referred to as 
HA-hERG) with an HA-epitope inserted between the extracellular loop between the S1 
and S2 transmembrane domain of the channel (Ficker et al., 2003) was used (Figure 
4.2.1A, see Chapter 2, section 2.2.10 for details). HEK-MSRII cells were transfected to 
express the HA-hERG protein. The channels were immunostained to detect expression 
on cell surface (red) and within the cell (green), (see Chapter 2, section 2.5 for detailed 
protocol). A substantial proportion of HA-hERG channels expressed by the transfected 
HEK-MSRII cells are found at the plasma membrane (Figure 4.1). The channels 
conducted hERG currents in electrophysiological recordings done by other members of 
the lab as reported before (Ficker et al., 2003). Taken together, the HA-hERG channels 
are functional and express on cell surface and therefore suitable for further 
experiments to study the ER exit mechanisms of the channels.  
 
4.3.2 Sar1-dependency of ER exit of the hERG potassium channels 
Proteins can exit the ER via a non-specific, less efficient route, known as ‘bulk flow’, or 
via a more efficient, specific route where cargo proteins are concentrated into COPII 
vesicles in a process that involves Sar1 (Sato and Nakano, 2007c). Formation of the 
cargo containing COPII vesicles at ER exit sites (ERES) is Sar1-dependent (Barlowe, 
2003, Fromme et al., 2008, Matsuoka et al., 1998). In order to examine the mode of 
hERG ER exit, HA-hERG channels were co-expressed with GFP-tagged, dominant 
negative constructs of Sar1; GFP-Sar1T39N or GFP-Sar1H79G to intercept the function of 
endogenous Sar1 protein. Sar1T39N (‘GDP-on’) binds GTP poorly and prevents 
recruitment of cargo into COPII vesicles whereas Sar1H79G (‘GTP-on’) is incapable of 
hydrolysing bound GTP and prevents release of COPII vesicles (Nishimura et al., 1999, 
Wang et al., 2004b, Kuge et al., 1994). The channels were immunostained to detect 
channels on cell surface (red). Both the dominant negative constructs, but not the wild 
type Sar1, co-expression prevented surface expression of the HA-hERG channels 
(Figure 4.2). 
  
  
Figure 4.1 HA-hERG construct is 
(A) Schematic of the membrane topology of hERG 
position of the engineered HA epitope. (B) Expression of HA
plasma membrane (red) and within (green) in transientl
detected by immunostaining with rat anti
anti-rat secondary antibodies (see methods for details). Representative confocal 
images from three independent experiments are shown; 
 
 
 
Figure 4.2 Surface expression of the hERG potassium channels is 
dependent. HEK-MSRII cells co
GFP-Sar1 constructs (green) were stained to label the channel expressed on surface 
expression (red). Representative confocal images from three independent experiments 
are shown; Scale bars
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4.3.3 Entry of hERG channels into ERES and ERGIC 
The above experimental results showed that surface expression of hERG channels is 
Sar1 dependent, consistent with the previous report (Mezzacasa and Helenius) that 
dominant negative mutants of Sar1 block surface expression of proteins that are 
transported by the COPII complex. However, these results did not indicate if HA-hERG 
is recruited into COPII vesicles. To address this question, the temperature sensitive 
mutant version of GFP-tagged vesicular stomatitis virus glycoprotein (GFP-VSVGts045) 
was used as a reporter (Mezzacasa and Helenius, 2002).  
 
This protein, has been previously used to label the COPII enriched ERES and to follow 
forward trafficking of membrane proteins and to study ER exit of the pancreatic KATP 
channel described in the previous chapter. At the non-permissive temperature 
(39.5°C), GFP-VSVGts045 is misfolded and retained in the ER, but does not enter COPII 
vesicles. Upon shift to the permissive temperature (32°C or lower), it assumes correct 
folding and exits the ER via COPII vesicles, but this exit step can be arrested by 
switching from 39.5°C to 10°C, allowing visualization of COPII enriched ERES by 
confocal microscopy (Mezzacasa and Helenius, 2002). A similar effect could be 
reproduced by co-expression of the ‘GTP-on’ Sar1H79G protein that prevents COPII 
vesicle budding (Kuge et al., 1994). The dominant negative Sar1 construct causes 
GFP-VSVGts045 to accumulate in ERES, which appear as distinct green puncta that 
mark COPII vesicles at ERES (Figure 4.3.A). GFP-VSVGts045 co-expressed with 
Sar1H79G could also therefore be used as a reporter for Sar1H79G activity through the 
appearance of punctate structures.  
 
Control experiments, suggested that co-expression with GFP-VSVGts045 had no effect 
on the surface expression of the channels (Figure 4.3.B). These data also suggested 
that GFP-VSVGts045 and HA-hERG channels co-localise extensively, suggesting that 
the two proteins may follow a similar traffic route. Co-expression of Sar1H79G prevented 
surface expression of both proteins and led to their co-localisation in punctate 
structures, representing ERES (Figure 4.3.C). 
 
Further, when the HA-hERG channels expressed in the cells were seen to co-localise 
with ERGIC-53 (Figure 4.4), a marker for ERGIC (Appenzeller-Herzog and Hauri, 
2006). This proved that the channels enter the ERGIC compartments following exit 
from the ER.  
  
  
Figure 4.3 hERG enters ERES in
Labelling ERES with GFP
accumulation of GFP
incubations at 37°C (24 hrs), 39.5°C (18 hrs) and 10°C (5 hrs) before fixing and 
imaging. Co-expression of Sar1
ERES. (B) Co-expression of GFP
HA-hERG; nuclei are stained blue. (C) Co
expression of HA-hERG and leads to the accumulation of the channel (red) in ERES 
labelled with GFP-VSVG
the two proteins. Nuclei stained blue with DAPI. Representative confocal images from 
three independent experiments are shown; 
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However, when the Sar1H79G was co- expressed in the HEK-MSRII cells, no co-
localisation of HA-hERG with ERGIC-53 was observed which implied that the mutant 
Sar1 prevented ER exit of the channel. Taken together these data demonstrated that 
hERG enters COPII enriched ERES before exiting the ER on its way to the ERGIC 
compartment.  
 
4.3.4 Probing interaction of hERG channels with cargo binding sites 
on Sec24 
The COPII coat machinery binds cargo with its Sec24 subunits (see discussion in 
Chapter 3). Sec24 has discrete binding sites for ER exit signals located in the 
cytoplasmic region of cargo proteins (Barlowe, 2003, Mossessova et al., 2003, Wang et 
al., 2004b, Nishimura et al., 1999). One of the best characterised ER export signal is 
the diacidic motif, DXE (where D is aspartate, X is any amino acid and E is glutamate) 
(Wang et al., 2004b, Nishimura et al., 1999, Barlowe, 2003). The diacidic motif was 
found in a number of cargo proteins including VSV-G (Nishimura et al., 1999) and 
some potassium channels including the Kir6.2 subunit of the pancreatic KATP channel in 
the study presented in the previous chapter (Zuzarte et al., 2007, Taneja et al., 2009). 
The binding site for the DXE motif on Sec24 has been characterized using structural 
and biochemical approaches (Mossessova et al., 2003, Bi et al., 2002). Since, the ER 
export of hERG was Sar1 dependent, the hERG sequence was analysed to screen for 
a potential ER exit motif on hERG C-terminus which could be responsible for 
recognition by the COPII machinery. The hERG sequence had three potential DXE 
motifs (Figure 4.5). In addition, ER export of hERG appeared to be similar to that of 
VSV-G protein which has a functional DXE motif (Mezzacasa and Helenius, 2002); and 
Figure 4.3). Confirmation of the role of a DXE motif on the hERG C-terminus was 
therefore required.  
 
The study investigating ER exit of KATP channels (Chapter 3) had led to the 
development of the membrane permeable TAT-DXE fusion peptide containing the 
diacidic ER exit signal (DLE) derived from the KATP channel (Mezzacasa and Helenius) 
fused to the HIV-TAT peptide sequence (Schwarze et al., 2000). The rationale 
underlying this approach was that the TAT peptide derived from a HIV-TAT protein 
sequence would facilitate penetration of the fusion peptide into the cell and that the 
peptide would bind the intracellular Sec24 protein of the COPII machinery with its DXE 
sequence. This interaction would saturate the DXE binding sites on Sec24 (Miller et al., 
2002) and prevent the ER exit of any cargo bearing the diacidic ER export motifs.  
 Figure 4.5 Potential ER exit motifs in hERG C
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As control, the TAT peptide and a mutant peptide, TAT-DXK was used. The mutant 
peptide is identical to TAT-DXE except that the conserved glutamate (E) residue is 
substituted with a lysine (K) which would inactivate the ER exit signal (Taneja et al., 
2009) and Figure 4.6.A). 
 
Treatment of cells with the TAT-DXE peptide but not the TAT or TAT-DXK peptides 
(controls) showed block of surface expression of the KATP channels (Chapter 3) and the 
VSV-G protein. GFP-VSV-Gts045 was used as a control in the experiment to look at the 
effect of the TAT peptides on surface expression the HA-hERG channels. (Figure 
4.6.B) shows that the Tat-DXE peptide prevented surface expression of the GFP-VSV-
Gts045 protein while neither of the two control peptides affected its surface expression. 
When cells expressing the HA-hERG channels were treated with the peptides, the Tat-
DXE test peptide, but not the control TAT and TAT-DXK peptides, significantly 
suppressed the surface expression of HA-hERG (Figure 4.6.C). These data suggested 
that the hERG channels must contain an ER exit signal to promote its assembly into 
COPII vesicles and that a binding site for the signal exists on Sec24. Since the DXE 
peptide prevented the ER exit of the hERG channels, the data suggested that the ER 
exit signal on hERG channels was likely to be a diacidic motif (DXE). The data also 
strengthened the finding that ER exit of HA-hERG channels occurs via COPII vesicles 
in a Sar1-dependent manner. 
 
4.3.5 Locating ER export signals in the distal end of the hERG C-
terminus 
The above data indicated that hERG channels may have a functional ER exit motif 
enabling recognition and binding to the Sec24 protein of the COPII complex and that it 
was more likely to be DXE and it would be interesting to identify this motif. hERG 
sequence analysis showed that there are three potential diacidic motifs (899DTE, 
976DCE and 1036DVE) in the cytoplasmic portion of the channel, all located in the distal 
C-terminal domain. Other potential signals in the C-terminus include a LXXLE motif 
(1049LXXLE1053) and a number of di-hydrophobic signals (Figure 4.5). Since there were 
several potential ER exit signals in the C-terminus, in order to identify the key motif, 
mutants with a series of truncations, 1073X, 1029X, 970X and 870X, (where X is a stop 
signal) in the distal C-terminus of the hERG channel were used. These truncations 
sequentially removed all the three potential DXE motifs, the LXXLE motif and three LL 
motifs. 
  
 Figure 4.6 Peptides that compete for the cargo binding sites on Sec24 prevent 
surface expression of hERG
TAT-DXK peptides. (B
hERG (C) were treated with the indicated T
see methods). The cells were fixed and the channels expressed on cell surface were 
stained using anti HA
confocal images from three independent experiments are shown; 
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Truncation mutants extending into the proximal C-terminus of hERG were not used as 
this region contains the cyclic nucleotide binding domain (CNBD-742-842), which is 
important for the function of hERG channels (Akhavan et al., 2005). The hypothesis 
was that if the key motif was absent in the deletion mutant, then the Sar1 dependent 
expression of the channels on cell surface would be lost. None of the four truncations 
prevented surface expression of the channel (Figure 4.7.A). These data suggest that 
none of the three DXE motifs and other motifs found in the distal C-terminus direct the 
channels to the COPII coat machinery. Furthermore, the truncations failed to prevent 
dependency of hERG on Sar1 for ER exit: Co-expression of Sar1H79G prevented 
surface expression of all truncation mutants and led to their accumulation in ERES 
marked by GFP-VSV-Gts045 (Figure 4.7B). This result was somewhat unexpected given 
the fact ER exit of hERG channels could be blocked with a DXE peptide. The channels 
were able to enter the COPII vesicles at ERES in a Sar1 dependent manner through 
interaction by some unidentified signal that allowed recognition and interaction with the 
COPII machinery. 
  
 Figure 4.7 ER export signals are absent in the C
cyclic nucleotide binding domain
hERG fails to prevent surface expression (red) of the channel (A) and Sar1 
dependency for ER exit (B). In (B), Sar1
(red) in ERES labelled
confocal images shown from three independent experiments are shown; 
µm. 
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4.4 Discussion 
 
The C-terminus of hERG channels has been implicated in its forward trafficking. 
However, not much is known about the mechanism underlying the ER exit of the 
channels. The study aimed at investigating the forward trafficking of the channels and 
found that the ER exit of hERG channels is mediated by COPII vesicles in a Sar1 
dependent manner. The channels enter the COPII vesicles and are exported out of the 
ER from ERES. 
 
The hERG C-terminus is large (462 amino acids) and is reported to be important for 
proper IKr function (Kupershmidt et al., 1998). Patients suffering from congenital 
LQTS2 have mutations within the hERG C-terminus. The disease is attributed the lack 
of channel function. Impaired trafficking of the channel is one of the major causes of 
the disease. Channel trafficking may be affected due to protein misfolding or due to 
anomalies in forward trafficking or recycling of the channel (Anderson et al., 2006, 
January et al., 2000). Therefore, knowledge of how the anterograde trafficking of the 
hERG channels occurs may be critical for understanding the channel patho-physiology.  
 
Export of the newly synthesised proteins from ER is a key step in the forward trafficking 
of a protein since it also may regulate entry of only correctly folded proteins into the 
forward trafficking route. Some proteins can exit the ER either via a nonspecific 
process known as ‘bulk flow’ (Barlowe, 2003, Gurkan et al., 2006, Fromme et al., 
2008). But an increasing number of proteins appear to exit the ER via a more efficient 
process, involving selective recruitment of the cargo into COPII vesicles. Concentration 
of cargo greatly exceeds the bulk flow marker proteins in these vesicles. This selective 
recruitment is driven by ER export signals located in the cytoplasmic domains of the 
cargo protein that are recognised and bound by the Sec24 proteins of the COPII 
complex (Mossessova et al., 2003, Barlowe, 2003, Zuzarte et al., 2007). The 
mechanism by which cargo is captured into COPII vesicles has been extensively 
studied using biochemical, cell biological and structural approaches (Mossessova et 
al., 2003, Bi et al., 2002, Fromme et al., 2008, Gurkan et al., 2006). COPII vesicle 
formation requires the Sar1-GTPase and involves a cascade of steps (see Figure 1.9 
and discussion in Chapter 3). 
 
It has been reported that hERG C-terminus has a putative ER retention motif (R-X-R) 
(Nufer and Hauri, 2003) at amino acids 1005 to 1007 which is exposed in misfolded 
hERG proteins with mutations resulting in a reduced number of hERG proteins at the 
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cell membrane (Kupershmidt et al., 2002, Delisle et al., 2003, Rajamani et al., 2006). 
Deletion of the RKR motif from the hERG C-terminus has been shown to increase 
hERG currents. Therefore, this signal is thought to regulate export of correctly folded 
and assembled hERG protein from the ER. Existence of beta subunits of hERG is not 
well established. Proteins such as MinK are known to associate with hERG channel; 
however, their requirement is not considered to be critical for hERG expression and 
function on cell surface (Sanguinetti and Tristani-Firouzi, 2006). Therefore, these 
subunits of hERG are unlikely to contribute towards ER export of the channel. 
Considering the importance of channel subunit assembly as well as correct channel 
subunit folding, it was less likely that the channel is exported from the ER by bulk flow.  
 
In order to study trafficking of the channel, an HA-epitope tagged construct of hERG 
was used. The epitope on the extracellular loop of the channel allowed detection of the 
channel on cell surface and within the cell (Figure 4.1). Experiments showed that 
trafficking of the HA-hERG channels to the cell surface is significantly reduced by Sar1 
mutants (Figure 4.2). Electrophysiological studies (done by other members of the lab) 
using patch-clamp analysis also showed significant decrease in hERG currents in cells 
co-expressing Sar1T39N as compared to the Sar1WT. Sar1-GTPase is recruited to the 
COPII vesicle assembly site by conversion from Sar1-GDP to Sar1-GTP, a step that is 
considered to initiate the COPII vesicle formation. The cargo is packaged into the 
vesicle which then buds off from the ER following hydrolysis of Sar1-GTP to Sar1-GDP. 
Disruption of Sar1 function by over-expression of the Sar1 mutants Sar1H79G and 
Sar1T39N that are ‘GTP on’ and ‘GDP on’ respectively would prevent COPII vesicle 
budding or formation and thereby affect Sar1-dependent COPII mediated ER export of 
proteins. This effect of Sar1 mutants was observed with the KATP channel surface 
expression which was found to be exported out of the ER in COPII vesicles (Chapter 
3). Thus, lack of surface expression of the HA-hERG when Sar1 mutants were over-
expressed indicated that the ER export of the protein was Sar1 dependent.  
 
The entry the hERG channels into COPII vesicles at ERES was then confirmed through 
co-localisation with GFP-VSV-Gts045. The protein was used as an ERES marker 
following a temperature shift treatment as described in the results section 4.2.3. Co-
expression with Sar1H79G also accumulated the protein in COPII vesicles at ERES and 
when imaged, the protein appeared as punctate green spots close to the nucleus 
(Figure 4.3A). Since the co-expression of GFP-VSV-Gts045 had no effect on surface 
expression of the HA-hERG channels (Figure 4.3B), the protein was used as a marker 
for ERES. The HA-hERG channels were found to co-localise with GFP-VSV-Gts045 at 
the ERES (Figure 4.3C). These data showed that HA-hERG enters the COPII vesicles 
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at ERES. Moreover, the Sar1 mutant also prevented entry of the channel into the post-
ER, ERGIC compartments (Figure 4.4). These data further strengthen the evidence 
towards requirement of Sar1 for COPII mediated ER export of the hERG channels.  
 
If hERG channels entered the COPII vesicles like the KATP channels and GFP-VSV-
Gts045 (Chapter 3), then there should be motifs on the channel C-terminus that allow 
recognition and binding to the Sec24 protein of the COPII machinery. Studies have 
shown that VSV-G uses the diacidic DXE motif to exit the ER (Nishimura et al., 1999). 
Crystallographic studies have shown that Sec24 has three cargo binding sites, A, B 
and C; the A-site binds YXXXNPF, the ‘B’ site recognises the DXE motif and LXX (L/M) 
E site and C-site binds an unidentified motif (Miller et al., 2003, Mossessova et al., 
2003, Bi et al., 2002). Although no direct evidence has yet been presented, it is 
conceivable that recruitment of VSVG into COPII vesicles would involve binding to the 
‘B’ site on Sec24. The KATP channel was also found to have the DXE motif on its Kir6.2 
subunit. Saturation of the DXE binding site on Sec24 using the TAT-DXE peptide which 
had a small stretch of the Kir6.2 subunit containing the DXE motif affected surface 
expression of the KATP channel (Chapter 3). The TAT-DXE peptide was designed to 
have a stretch of the HIV-TAT protein to allow cell penetration. TAT alone and TAT-
DXK (peptide with mutated DXE sequence) were used as controls (Figure 4.6.A). The 
TAT-DXE peptide was able to prevent surface expression of VSV-G (Figure 4.6.B). 
This result was consistent with such an expectation, because the peptide would occupy 
the ‘B’ binding site on endogenous Sec24, preventing recruitment of GFP-VSV-Gts045 
into COPII vesicles. Application of the TAT-DXE peptide (but not the TAT and TAT-
DXK peptides) onto cells expressing HA-hERG showed it was able to block the ER 
export of hERG (Figure 4.6.C). These data suggested that hERG was recruited into 
COPII vesicles by binding to the B site on Sec24. It was therefore interesting to identify 
if there was a Sec24 binding motif in the hERG C-terminus. 
 
Sequence analysis showed that native sequence of hERG has three DXE sequences 
in its C- terminus, 899DTE891, 976DCE978 and 1036DVE1038 and three di-leucine motifs on 
the hERG C-terminus, the first being 1022LL (Figure 4.5). Any of these sequences could 
be the functional Sec24 binding motifs (Barlowe, 2003) on hERG that mediate ER 
export of the channel. Experiments showed that hERG proteins with truncations in the 
C-terminus up to position 870 express on cell surface like the wild type channel (Figure 
4.7A) and are retained at the ERES in presence of Sar1H79G (Figure 4.7B). Thus, 
removal of all the three potential DXE motifs and the only LXX(L/M)E motif from hERG 
failed to prevent ER export of the channel. It is possible that motifs other than the DXE 
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signals in hERG bind the COPII machinery, and our understanding of ER exit motifs is 
incomplete (Sato and Nakano, 2007a).  
 
While the ER exit motif on hERG channels was being investigated, Delisle et al (2009) 
published their findings on hERG trafficking which were in agreement with the data 
presented above. Further work on the project was therefore discontinued with the 
conclusion that further studies to identify how the hERG channels are recognised and 
packaged into the COPII machinery were required to further the understanding of the 
forward trafficking of the channels. It would be important to find out, how the channels 
are recognised by the COPII machinery and if present, what the ER exit signal on the 
channel is. Use of the TAT-DXE peptides for altering surface density of the channels 
was an interesting option, considering that defective ER exit of hERG channels is the 
major cause of the LQTS2 in humans. 
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4.5 Summary 
 
The hERG potassium channels contribute to the rapidly activating delayed rectifier K+ 
current (IKr), responsible for rapid repolarisation of the cardiac action potential. Genetic 
mutations affecting the function or plasma membrane expression of the channels 
cause life threatening Long QT syndrome 2 (LQTS2) and therefore understanding of all 
the biological processes such as forward trafficking of the channels that can play a role 
in altering surface density of the channels is important. In this chapter, techniques in 
cell biology, molecular biology were employed to look at the mechanism of Sar1-
GTPase dependent ER exit of hERG channels in COPII vesicles. When the function of 
Sar1 was intercepted, surface expression of hERG is abolished as the channel 
accumulates in the COPII-enriched ER exit sites and was unable to reach the ERGIC. 
Blocking the cargo binding sites on the Sec24 component of the COPII coat machinery 
with membrane-permeable peptides led to inhibition of ER exit of hERG channels. 
Progressive deletion of the potential diacidic ER exit motifs failed to prevent surface 
expression of the channels, indicating lack of involvement of canonical diacidic motifs 
in the ER exit of the hERG channels.  
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CHAPTER 5 
Pathways of hERG internalisation
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5.1 Introduction  
 
The cardiac potassium channel hERG (Kv11.1) is responsible for the rapid delayed 
rectifier current IKr, which plays a central role in terminal repolarisation of human 
ventricular myocytes (Sanguinetti et al., 1995, Sanguinetti and Tristani-Firouzi, 2006). 
Loss of hERG/IKr function either by inherited mutations or unintentional drug blockade 
produces LQTS and is characterised by a prolongation of the QT interval on the ECG 
which put the patients at an increased risk of suffering from torsades de pointes 
arrhythmias, or sudden cardiac arrest (Sanguinetti and Tristani-Firouzi, 2006). This 
property of hERG has generated immense interest in hERG biosynthetic trafficking. 
Therefore, while much is known about hERG biosynthetic delivery (Delisle et al., 2009, 
Ficker et al., 2005, Ficker et al., 2003), relatively little is known about the fate of 
channels after they are expressed on the plasma membrane or how the wild type (WT) 
hERG channel density is regulated under either physiological or patho-physiological 
conditions. The LQT / SQT disease models demonstrate the necessity of maintaining 
an appropriate level of hERG channels at the cell surface (Brugada et al., 2005, 
Thomas et al., 2003a). 
 
Ion channel current is the sum of its biophysical (gating, permeation), biochemical 
(phosphorylation, etc), and biogenic (biosynthesis, processing, trafficking) processing. 
The following equation is used for ion channel current: 
 
 = . . o 
 
Where I = current, n= number of channels, i= channel conductance and Po is the 
channel open probability (Delisle et al., 2004, Hille, 2001). Biogenic processes regulate 
the surface density of a protein through a dynamic balance between the biosynthetic 
secretion, endosomal trafficking (internalisation, recycling and degradation) of a 
membrane protein (Kennedy and Ehlers, 2006, Drake et al., 2006). A tilt in the balance 
could have important patho-physiological consequences as has been demonstrated for 
ion channels in other physiological conditions by having a direct effect on ion channel 
currents (Okiyoneda and Lukacs, 2007, Mankouri et al., 2006, Jarvis and Zamponi, 
2007).  
 
Research indicates that hERG channels can be removed from the plasma membrane 
by internalisation. Following stimulation with ceramide the channels were shown to 
undergo ubiquitinylation and lysosomal degradation (Chapman et al., 2005). It has also 
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been shown that lowering of extracellular potassium ion concentration accelerates 
internalisation and degradation of the hERG channels (Guo et al., 2009). This study 
provides a potential mechanism for hypokalemia-induced LQTS. However, under 
physiological conditions, the underlying mechanisms of hERG internalisation and the 
subsequent fate of internalised channels is unclear.  
 
The mechanisms that regulate internalisation of a membrane protein would be largely 
affected by location of the protein in the cell membrane. The cell membrane is a 
heterogeneous mixture of proteins, cholesterol, glycero‑, phospho‑ and sphingolipids 
(Harder and Simons, 1997). The cell membrane has micro-domains that are rich in 
cholesterol and sphingolipids which are considered to laterally associate with one 
another and form lipid-rafts that are resistant to detergent solubilisation (Lai, 2003, 
Lingwood and Simons, 2010). Cholesterol and sphingolipid enriched membranes are 
believed to coordinate multiple cellular processes, which include second messenger 
regulation, membrane recycling of proteins, ion channel function and membrane 
protein internalisation (Mayor and Pagano, 2007, Harder and Simons, 1997).  
 
Membrane proteins are internalised by a variety of mechanisms (Doherty and 
McMahon, 2009, Mayor and Pagano, 2007) which can be broadly classified as GTPase 
dynamin-dependent and independent mechanisms (see Introduction for detailed 
account and Figure 5.1, (Mayor and Pagano, 2007). Dynamin is required for the final 
scission of several types of vesicles that bud off from membranes containing the 
endocytic cargo. Dynamin-dependent internalisation can be clathrin, caveolin or RhoA 
mediated (Mayor and Pagano, 2007). The clathrin mediated pathway of internalisation 
(CME) is the most common and well studied route of internalisation. It relies on the 
recruitment of the adaptor protein 2 (AP2) complexes by cargo proteins with a 
subsequent association of clathrin leading to membrane invaginations that form clathrin 
coated vesicles (CCV) (Doherty and McMahon, 2009, Kirchhausen, 1999). Caveolin 
coat proteins form flask shaped invaginations termed as caveolae (Mayor and Pagano, 
2007) in the cell membrane that contain endocytic cargo. Caveolae require the action 
of dynamin for pinching off from the cell membrane and are classified under the clathrin 
independent endocytic mechanisms (CIE) that require dynamin (Mayor and Pagano, 
2007). Another class of CIE mechanism is regulated by the small GTPase RhoA and 
requires dynamin to complete membrane scission (Ellis and Mellor, 2000). CIE 
internalisation is found to occur in lipid-rafts that are dynamic structures with 
cholesterol as a linker (Harder and Simons, 1997, Mayor and Pagano, 2007). 
  
 Figure 5.1 Classification of endocytic mechanisms 
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Although CME is thought to be the most commonly used mechanism (Doherty and 
McMahon, 2009), recent studies indicate that an increasing number of membrane 
proteins undergo internalisation via CIE (Eyster et al., 2009, Mayor and Pagano, 2007) 
that involve lipid-rafts. Unlike CME, however, CIE is not a single mechanism, but 
comprises several different mechanisms (Mayor and Pagano, 2007, Donaldson et al., 
2009). A better understanding of the processes that govern cell surface density of 
hERG may reveal mechanisms that differentiate hERG from other membrane proteins 
and potentially reveal targets for future therapeutic interventions. It is therefore 
important to elucidate the endocytic mechanisms of the hERG potassium channel.  
 
Having understood how the hERG channels undergo internalisation, it would be 
interesting to understand how the process is regulated. This information would 
enhance the understanding of mechanisms underlying several cardiac anomalies 
caused due to altered hERG channel function under physiological and patho-
physiological conditions. Protein phosphorylation is one of the most common molecular 
mechanisms known to modulate the activity of ion channels (Levitan, 1994). Protein 
kinases have been found to regulate ion channels (Cohen et al., 1996) by altering their 
biophysical properties. Most common of these are protein kinase C (PKC) and protein 
kinase A (PKA), (see introduction) which are implicated to regulate a variety of cellular 
processes including membrane trafficking and internalisation (Alvi et al., 2007, Manna 
et al., 2010, Herring et al., 2005, Dada et al., 2003). It would be interesting to study 
how signalling molecules such as protein kinases regulate internalisation of hERG 
leading to altered surface density of the channels. 
 
In this chapter, the mechanism of hERG internalisation was investigated using a 
combination of cell biological, pharmacological, functional and biochemical 
approaches. The study indicated that majority of hERG channels are internalised via a 
clathrin- and dynamin-independent, lipid-raft and ARF6-mediated pathway. 
Interestingly, when ARF6 function was suppressed, the channel was found to undergo 
internalisation via a dynamin-dependent mechanism that was independent of caveolar 
rafts. Further, the effect of signalling molecules including protein kinase C (PKC) and 
protein kinase A (PKA) was examined. Activation of PKC was found to inhibit 
internalisation and increase the surface density of hERG channels. 
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5.2 Materials and Methods  
5.2.1 Cell lines 
As described in Chapter 2, section 2.2.1. For experiments involving drug treatments, 
poly-L-lysine coated cover-slips were used for growing cells (as described in Chapter 2, 
section 2.5.1). The cells were transiently transfected with the required DNA constructs 
to express the required proteins using Fugene®6 transfection reagent (as described in 
Chapter 2, section 2.4.2).  
 
5.2.2 Plasmid constructs 
HA-tagged hERG in pcDNA3 was transfected into HEK-MSRII cells for transient 
expression of the HA-hERG channels as described in Chapter 4. GFP-tagged 
dynamin constructs dynamin1 (WT), dynamin1 (K44A), dynamin2 (WT) and dynamin2 
(K44A) were gifts from H McMahon, Laboratory of Molecular Biology, Cambridge. 
Other cDNA clones were generous gifts from various researchers (indicated in 
parenthesis): GFP-tagged Caveolin1 (P132L) (Dr PG Mermelestein, University of 
Minnesota), HA- or GFP-tagged ARF6 (WT) and ARF6 (T27N) (Prof. Martin, University 
of Wisconsin), GFP-CDC42 (T17N) (Dr G Bokoch, Scripps Research Institute, La 
Jolla), GFP-GPI-AP (Dr M. Edidin, Johns Hopkins), and myc-RhoA(T19N), HA-ARF6 
(WT) and HA-ARF6 (T27N) (Dr S Poonambalam, University of Leeds), MHCI (Dr E 
Hewitt, University of Leeds). HA-tagged Kir.2 and SUR1 (subunits of the KATP channel) 
are as described in Chapter 3. All the constructs were sequenced to confirm their 
sequence and large scale DNA preparations were made (as described in Chapter 2) 
and used for transient transfections in HEK-MSRII and HeLa cells. 
 
5.2.3 Antibodies 
Primary antibodies 
Antibodies against the HA-tag on the HA-hERG channels and HA-ARF6 (WT) and HA-
ARF6 (T27N), rat anti-HA (Roche), were diluted 1:500 in antibody dilution buffer for 
immunofluorescence imaging and for western blotting the anti-HA antibodies were 
diluted 1:10000 in SM-PBST (2% skim milk powder, 0.5% Tween-20, PBS). Mouse 
anti-MHCI (BB7.2, Abcam) were diluted 1:100 and mouse anti-myc (Cell Signalling) 
antibodies were used at a dilution 1:250 for immunofluorescence staining. For western 
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blotting, mouse anti-flotilin1 (Abcam) antibodies were diluted 1:1000 in SM-PBST; 
mouse anti-clathrin (heavy chain; Dr. S. Poonambalam University of Leeds) antibodies 
were diluted 1:1000 in SM-PBST with 0.2% skim milk. Rabbit anti-Kv11.1 against S1-
S2 loop (Sigma) were used at a dilution of 1:50 for immunofluorescence imaging and at 
1:5000 in SM-PBST. 
 
Secondary antibodies 
Anti-rat, anti-rabbit and anti-mouse Cy3- and Cy5-conjugated secondary antibodies 
(Jackson ImmunoResearch.), anti rat and anti-mouse Alexa488- conjugated secondary 
antibodies (Invitrogen) were all used at 1:500 dilution. HRP-conjugated goat anti-rat, 
anti-mouse and anti-rabbit secondary antibodies were obtained from Sigma or Thermo 
and used at 1:20000 dilution for western blotting. HRP-conjugated anti-rat antibodies 
for chemiluminescence assays were used at 1:100 dilution.  
 
5.2.4 Cardiac myocytes isolation 
Isolation of neonatal rat ventricular myocytes  
NRVCM were isolated from ventricles dissected from hearts of 3-7 day old Wistar rats 
as described previously (Patten et al., 2004). Briefly, cells were dissociated by 
incubating the minced ventricles with collagenase (0.4 mg/ml, type II, Worthington) and 
protease (0.6 mg/ml, type XV, Sigma) in a dissociation buffer that contained (in mM): 
NaCl 116; KCl 5.4; NaH2PO4 0.8; Glucose 5.6; HEPES 20; MgSO4 0.8, pH 7.35; 
incubation was at 37°C with agitation for a suitable length of time. Cells were filtered 
through a 70µm nylon filter and cultured on glass cover-slips in DMEM/F12 medium 
supplemented with 10% horse serum, 5% fetal bovine serum, 50 U/ml penicillin and 50 
µg/ml streptomycin for 2-3 days at 37°C and 5% CO2.  
 
Isolation of Guinea Pig Ventricular Myocytes 
All experimental protocols requiring the use of animals conformed to the Animals 
Scientific Procedures Act, 1986. Single ventricular myocytes were isolated according to 
methods previously described by (Rodrigo et al., 2002). In brief, adult male Dunken 
Hartley guinea pigs, weighing between 300 and 500g were humanely sacrificed by 
cervical dislocation. The heart was then rapidly excised and suspended from a 
Langendorff apparatus and perfused at 37 °C with Tyrode at a rate of 10 ml/min with a 
nominally calcium-free solution and then a solution containing 1.66 mg/ml BSA (from 
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factor V albumin, Sigma Aldrich), 1 mg/ml collagenase (type I, Sigma Aldrich) and 0.66 
mg/ml protease (type XIV, Sigma Aldrich). Following enzymatic digestion the heart was 
perfused with Tyrode solution containing 2 mM calcium (calcium Tyrode). The heart 
was then cut down and the ventricles were agitated gently in calcium Tyrode. Isolated 
myocytes were filtered through 300 µm gauze and washed 2-3 times in calcium 
Tyrode. Cells were stored at room temperature and used within 36 hours of isolation. 
 
5.2.5 Drug treatments 
Dynasore, methyl-β-cyclodextrin (MβCD), α-cyclodextrin (α-CD), DAG and forskolin 
were all purchased from Sigma. PMA, CHE, GÖ6976, H89, were purchased from 
Calbiochem. Water soluble cholesterol containing a mixture of MβCD and cholesterol 
was purchased from Sigma (catalogue no. Sigma C4951). Tissue culture grade DMSO 
was from Sigma. Transferrin-Alexa488 (Tfn-488), Transferrin-Alexa633 (Tfn-633) were 
from Invitrogen and cholera toxin-Alexa647 (CT-B) was purchased from Molecular 
Probes. Tfn-488 and Tfn-633 stocks of 5 mg/ml were used at a working concentration 
of 50 µg/ml (added to cells for 15 min) and CT-B stock at 1 mg/ml was used at a 
concentration of 1 µg/ml (added to cells for 5 min).  
 
Stock solutions of the pharmacological compounds used in this study were prepared 
and stored at -20°C as small aliquots. All working concentrations of drugs were 
prepared in antibody dilution buffer (1% Ovalbumin in DMEM) prior to treatment of 
cells. Pre-treatment with drugs was for 30 to 60 min at 37oC. Primary antibody 
treatment for internalisation assay carried out in presence of drugs. Details of drug 
preparations are as follows: 
 
 
Compound Solvent Stock solution Working solution 
dynasore DMSO 40 mM 80 µm 
genestein DMSO 200 mM 200 µm 
methyl-β-cyclodextrin water 30 mM 3 mM 
α-cyclodextrin DMSO 10 mM 100 µM 
aluminium fluoride (AlF) 
 
ethanol, water 
water 
100 mM AlCl3 
600 µM NaF 
100 µM AlCl3 
60 µM NaF 
diacylglycerol (DAG) DMSO 1 mM 10 µm 
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Compound Solvent Stock solution Working solution 
phorbol 12-myristate 13-
acetate (PMA) 
DMSO 100 µm 100 nM 
chelerythrine chloride 
(CHE) 
DMSO 10 mM 10 µm 
GÖ6976 DMSO 1 mM 1 µm 
forskolin DMSO 30 mM 30 µM 
cholesterol- MβCD water 5 mmole/L 
cholesterol plus 
5 mmole/L 
MβCD 
0.5 mmole/L 
cholesterol plus 
0.5 mmole/L 
MβCD 
nystatin DMSO, water 50 mg/ml 50 µg/ml 
chlorpromazine ethanol 25 mg/ml 25 µg/ml 
 
5.2.6 Immunofluorescence staining 
Internalisation assay 
Cells grown on cover-slips were transfected with HA-hERG or HA-KATP (HA-Kir6.2 and 
SUR1) and subjected to internalisation assay as described previously (Lingwood and 
Simons, 2010). Cells were incubated in presence of primary antibodies and allowed to 
internalise with the channels, washed, fixed, permeabilised and labelled with a 
fluorophore (Cy3 or Alexa488) labelled secondary antibodies. Where required, cells 
were treated with drugs or co-transfected with cDNA clones encoding the wild type or 
dominant negative isoforms of proteins involved in endocytic trafficking. To assay 
internalisation in NRVCM, cells were incubated with rabbit anti-Kv11.1 targeted to the 
S1-S2 loop of hERG, un-internalised antibodies removed by washing with acidic strip 
buffer (0.5 M NaCl/0.5% acetic acid, pH 2.0) before fixing, permeabilising and staining 
with fluorescent secondary antibodies, (see Chapter 2 for methods of fixing and 
permeabilisation of cells). Where MHCI antibodies were used, methanol at -20°C was 
used for fixing of cells instead of 2% PFA. Stained cells were imaged on a Zeiss 510 
META laser scanning confocal microscope (as described in Chapter 2, section 2.5.3).  
Co-localisation was scored using Image J macros designed by Dr Gareth Howell, 
University of Leeds. The macros scored total red pixels and the red pixels in the image 
that co-localised with the green pixels in the image. Ratio of these values gave percent 
co-localisation of the red over green. The data from several sets of images obtained 
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from three independent experiments were analysed and presented in bar graphs as 
mean ± s.e.m. ANOVA and Student’s t test were used for statistical analysis.  
 
5.2.7 Quantitation of surface expression  
Chemiluminescence assay 
Surface density of hERG was assayed as described previously using a 
chemiluminescence based assay (Mankouri et al., 2006). Transfected cells on cover-
slips were given the indicated drug treatment or were co-transfected with HA-hERG 
and GFP plasmid (control) or with the indicated plasmids. To determine the effect of 
these factors on channel internalisation, percent internalisation of the channels was 
determined following 15 minutes of incubation at 37°C. HA-hERG channels were 
labelled on cell surface for 30 min at 4°C, the cells were washed with chilled PBS and 
incubated at 37°C to allow internalisation for 15 min. A set of cover-slips with HA-hERG 
transfected cells were surface labelled for HA-hERG and retained at 4°C where no 
internalisation of the channel occurs and therefore surface channel density is taken as 
100%. The cells were washed, fixed and channels remaining on cell surface after 
internalisation were labelled with HRP-conjugated secondary antibody. Following 
several washes in PBS, the cells were solubilised in RIPA buffer supplemented with 
Benzonase (5 units). Chemiluminescence assay was performed as described in 
Chapter 2, section 2.5.4, to get the value for density of channels remaining on the cell 
surface. Percentage of channels internalised from the cell surface was determined 
using the following equation: 
 
% Internalisation of the channels = 
 channel density after internalisation (37°C)
 channel density before internalisation (4°C)  
 X 100 
 
Data were obtained from three separate transfection experiments, each measured in 
duplicate and presented in bar graphs as mean ± s.e.m. ANOVA and Student’s t test 
were used for statistical analysis. Significant differences as compared to vehicle control 
are denoted by * (P<0.05) and ** (P<0.01) in the figures.  
 
5.2.8 Raft isolation and Western blotting 
Rafts were isolated using OptiprepTM density gradient centrifugation (Schuck, 2006b). 
HEK-MSRII cells (~5x108) transfected to express HA-hERG and other raft and non-raft 
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reporter proteins using the calcium phosphate transfection method (as described in 
Chapter 2, section 2.4.2). The cells were collected and washed twice in PBS. The cell 
pellet was lysed in chilled TNE buffer (150 mM NaCl, 2 mM EDTA, 50 mM Tris-HCl; 
pH7.4) containing 1% Triton X-100 at 4°C for 30 min. The lysate was centrifuged at 
10,000xg for 5 min to remove the nuclear fraction. 0.5 ml of the lysate was mixed with 
1.5 ml of OptiprepTM and overlaid with 3 ml of 30% OptiprepTM and 0.5 ml of TNE 
before centrifugation at 155,000xg for 16 hrs at 4°C. Fractions were subjected to 
western blotting for the desired proteins (as described in Chapter 2, section 2.5.5.  
 
For isolation of rafts from neonatal rat heart tissue, hearts from 3-7 seven day old rat 
pups were excised, washed thrice in chilled TNE buffer and dissected to obtain 
ventricular tissue. The tissue was chopped finely in chilled tissue homogenisation 
buffer (TMB, 1XTNE, protease inhibitor, 0.25M sucrose). 1 ml buffer per heart was 
used. The finely chopped tissue was then dounced in a glass douncer (in chilled 
conditions) and 10% Triton X-100 was added to a final concentration of 1% w/v. The 
crude tissue lysate was centrifuged at 10000xg for 5 minutes to obtain a post-nuclear 
fraction. 0.5 ml of the post-nuclear fraction was mixed with an equal volume of 90% 
(w/v) sucrose in TNE. On ice, 1 ml of the heavy fraction was overlaid first with 2 ml 
30% (w/v) sucrose in TNE then by 2 ml 5% (w/v) sucrose in TNE in an ultracentrifuge 
tube. Following centrifugation 0.5 ml fractions were collected from the top including the 
pellet in the bottom fraction that was suspended in 0.5 ml TNE. The proteins in the 
density gradient fractions were treated with 100 mM DTT and resolved by SDS-PAGE. 
Proteins of interest were visualised by western blotting.  
 
Rafts from guinea pig myocytes were prepared following lysis of washed cell pellet of 
myocytes isolated from a guinea pig heart (as described in section 5.2.4) in chilled TNE 
buffer containing 1% Triton X-100 at 4°C for 30 min. The lysate was centrifuged at 
10,000xg for 5 min to remove the nuclear fraction. 0.5 ml of the post-nuclear fraction 
was mixed with an equal volume of 90% (w/v) sucrose in TNE and rafts were isolated 
as described above for the rat heart tissue.  
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5.3 Results  
5.3.1 Internalisation of native and recombinant hERG channels 
The aim of this study was to investigate the mechanism underlying internalisation of the 
cardiac hERG potassium channels. To achieve this aim an assay to study 
internalisation of the channel from the cell surface was standardized (see methods for 
details). The assay involved the use of anti-hERG antibodies against extracellular 
epitope on the hERG channel. These monoclonal antibodies were raised against the 
S1-S2 peptide (AFLLKETEEGPPATEC) which is conserved in human, rabbit, guinea 
pig and rat ERG channels. The native neonatal rat ventricular cardiac myocytes 
(NRVCM) (see methods for myocytes isolation procedure) were stained with the anti-
Kv11.1 antibodies treated with and without the S1-S2 peptide. Following staining with 
fluorophore-conjugated secondary antibodies, it could be seen from the confocal 
images that when the Kv11.1 antibodies were pre-incubated with the S1-S2 peptide 
against which they were raised, no staining is visible in NRVCM. However, staining can 
be seen in NRVCM stained using anti-Kv11.1 antibodies without incubation with the 
peptide (Figure 5.2.A). HEK-MSRII cells that do not express native hERG channels did 
not show any staining with the anti-Kv11.1 antibodies (Figure 5.2.B). These data 
established the specificity of the anti-hERG antibody. 
 
In order to look at internalisation of native ERG channels, live NRVCM were incubated 
in the presence of anti-Kv11.1 primary antibodies at 4°C or 37°C for 60 min. This would 
allow antibodies that bound the ERG channels on cell surface to be internalised along 
with the channel. At 4°C, when biochemical processes of a cell are stalled, 
internalisation of proteins does not occur. The cells were then washed at 4°C, fixed, 
permeabilised and stained with a fluorescent secondary antibody (red). At 4°C, staining 
was seen at the cell surface, whereas at 37°C staining was seen on the cell surface as 
well as within the cell as punctate structures (Figure 5.3.A, top panel). To eliminate the 
possibility that the punctate structures appeared due to clustering of channels at the 
cell surface (rather than internalised channels), another set of cells was washed with 
an acidic buffer (pH 2.5) after the primary antibody incubation step in order to strip any 
surface bound antibody. Antibodies internalised within the cell along with the channel 
would be protected from the acid strip and get stained with the secondary antibody.  
  
  
Figure 5.2 Testing the specificity of the anti
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The results (Figure 5.3.A, bottom panel) showed absence of staining in cells incubated 
at 4°C, but robust staining of ERG in punctate structures was observed in cells 
incubated at 37°C, indicating that at 4°C all the channels remained on the cell surface 
but at 37°C channels internalised. Thus in NRVCM, the ERG channels are 
endocytosed into intracellular structures in a temperature dependent manner. 
Maintenance and genetic manipulation of native cells is difficult, therefore, HEK-MSRII 
and HeLa cells were chosen to investigate the mechanisms of hERG internalisation. 
These cells are easy to transfect and are therefore widely used for trafficking studies. 
Internalisation of transiently transfected HA-hERG (hERG with extracellular HA-epitope 
engineered into the S1-S2 loop (Ficker et al., 2003), Chapter 3) in HEK-MSRII and 
HeLa cells was looked at. The channels were stained by incubation of the cells in the 
presence of anti-HA antibodies at 4°C or 37°C. The cells were then fixed, 
permeabilised and stained with the Cy3-conjugated secondary antibodies. 
Immunofluorescence imaging showed that in both the cell types, the HA-hERG 
channels remained on cell surface following incubation at 4°C but they were 
internalised to punctate structures within the cells at 37°C (Figure 5.3.B).  
 
Next, the time course of internalisation of the HA-hERG channels was investigated. 
The pool of channels expressed on the cell surface were labelled on the surface with 
anti-HA antibodies at 4°C and then allowed to internalise at 37°C for different time 
points. The cells were washed, fixed, permeabilised and stained with Cy3- conjugated 
secondary antibodies for immunofluorescence imaging. The confocal images indicated 
that internalisation of HA-hERG channels labelled on the cell surface occurs within 5 
min at 37°C, (see Figure 5.3.C). The amount of channels left on the cell surface 
following internalisation for different time points was quantitatively determined using the 
chemiluminescence assay described in detail in Methods. The percentage of the 
channel internalisation was then calculated from the remaining surface density after 
internalisation for each time point divided by the total channel density prior to 
internalisation (time 0). The assay showed that in both HEK-MSRII and HeLa cells, the 
transiently expressed HA-hERG channels are internalised rapidly with ~50 % of the 
channels expressed on the cell surface being endocytosed within 20 min (see Figure 
5.3.D). 
 
Having established that both native and transfected ERG channels undergo rapid 
constitutive internalisation, the study was then directed towards elucidating the 
mediators of hERG internalisation. 
 
186 
 
5.3.2 Dynamin-independent, raft-dependent internalisation of hERG 
channels 
The approach taken to find out the endocytic mechanism of the hERG channels was to 
use the relevant dominant negative (DN) isoforms or pharmacological compounds 
known to disrupt function of key proteins of different endocytic pathways and find out 
which of these affected internalisation of hERG. The internalisation assay followed by 
immunofluorescence staining (see Methods) was used to look if DN proteins or 
pharmacological compounds prevented internalisation of the HA-hERG channels. For 
native ERG channels in NRVCM, the acid strip method was used to confirm 
internalisation as described in the previous section (Figure 5.2.A). The amount of 
internalisation of the channel was quantitatively determined using the 
chemiluminescence assay (see Methods). Both these techniques allowed continuous 
labelling of channels internalised from the cell surface. Block of internalisation would 
cause accumulation of the channels at the cell surface and absence of punctate 
structures within the cells in imaging or a decrease in the internalised channel density 
in the chemiluminescence assay.  
 
The Figure 5.1 shows the general classification of endocytic pathways with the two 
major classes of internalisation being dynamin-dependent and dynamin-independent. 
Dynamin-dependent internalisation can be classified as CME that requires clathrin and 
CIE that is mediated by caveolar rafts or RhoA-GTPase (Doherty and McMahon, 2009, 
Mayor and Pagano, 2007). Internalisation of proteins that undergo dynamin-dependent 
internalisation is prevented by expression of DN-dynamin 1 & 2 (K44E-Dynamin1 & 2) 
(Bobanovic et al., 2002, Bonifacino and Lippincott-Schwartz, 2003, Mankouri et al., 
2006). Co-expression of the GFP-tagged DN-Dynamin1 or 2 did not inhibit 
internalisation of the HA-hERG channels in HEK-MSRII or HeLa cells (Figure 5.4). 
These data suggested that internalisation of the hERG channels was independent of 
dynamin. 
 
As a further confirmation that hERG internalisation was not affected by any of the 
dynamin-mediated pathways (that are dependent upon proteins: clathrin, caveolin or 
RhoA); DN-µ2 (D176A/W412A), DN-caveolin1 (P132L) and DN-RhoA (T19N) were 
each co-expressed with HA-hERG and the channels were stained following the 
internalisation assay. The images from confocal microscopy showed that internalisation 
of the HA-hERG channels was largely unaffected by disruption of activity of any of 
these proteins (Figure 5.5). 
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Some of the internalised HA-hERG channels however appeared to co-localise with the 
DN-caveolin1-GFP protein (Figure 5.5), which suggested that a small pool of the hERG 
channels could be internalised via dynamin mediated pathway. A recent report 
(Massaeli et al., 2010) suggested that a caveolin-dependent endocytic route is involved 
in low potassium (0 mM) induced degradation of mature hERG channels. Thus, the 
major pathway of hERG internalisation in normal physiological conditions appears to be 
clathrin- and dynamin- independent but some of the channels may also be internalised 
by alternate dynamin-dependent pathways which might become predominant in altered 
physiological conditions.  
 
The use of DN constructs (Figure 5.4 and 5.5) indicated that hERG internalisation was 
not affected by all known dynamin-dependent pathways and left open the possibility 
that internalisation of the hERG channels could be mediated by lipid-rafts. To check if 
lipid-rafts but not dynamins were involved in hERG internalisation, pharmacological 
drugs were used. Treatment of the HA-hERG expressing cells with dynasore, a 
chemical inhibitor of dynamin function (Macia et al., 2006), failed to inhibit 
internalisation of hERG while uptake of fluorescently labelled transferrinAlexa488 (Tfn-
488) was blocked in these cells. Tfn is specifically recognised by the transferrin 
receptor (TfnR). TfnR is the archetypical cargo for internalisation through dynamin and 
AP-2 dependent CME (Nesterov et al., 1999, Motley et al., 2003). As a parallel control, 
cells expressing HA-KATP (HA-Kir6.2 +SUR1) the pancreatic KATP channels which are a 
cargo of CME (Mankouri et al., 2006) showed blocked internalisation of the channels 
when treated with dynasore (Figure 5.6.A, top panel).  
 
Disruption of lipid-rafts with methyl-β-cyclodextrin (MβCD), a cholesterol sequestering 
agent (Klein et al., 1995), blocked internalisation of the HA-hERG but not the KATP 
channels and Tfn-488 (Figure 5.6A middle panel). As a negative control, α-cyclodextrin 
(αCD), an inactive analogue of MβCD, was used and it had no effect on internalisation 
of HA-hERG, Tfn-488 and HA-KATP (Figure 5.6A, bottom panel). When internalised 
channel density for HA-hERG channels was quantitatively determined using the 
chemiluminescence assay (see Methods), cells treated with dynasore showed ~70% 
internalisation which was similar to the vehicle (no drug) control. However, cells treated 
with MβCD showed near complete block of internalisation compared to the αCD treated 
cells (Figure 5.6.B). Preloading of MβCD with cholesterol prior to treatment of cells 
expressing HA-hERG abolished the ability of the compound to prevent internalisation of 
the channels in contrast to treatment of cells with cholesterol (Figure 5.6.C). These 
data confirmed that effect of MβCD was due to cholesterol depletion.  
 Figure 5.6 Internalisation
dependent. (A) HeLa cells transfected with HA
pre-treated with the indicated drugs (see 
incubation with anti-HA antibodies 
during the last 15 min of anti
permeabilised and stained with Cy3
hERG channels (red). (B) HEK
with the indicated drugs (vehicle, DMSO) as in 
HA-antibodies was allowed to occur for 15 min prior to assaying the remaining surface 
density. Following the chemiluminescence assay, percent
channels was calculated (
internalisation and the total surface density of the channels prior to internalisation
mean ± s.e.m (n = 3) data are shown; ** indicates p value <0.01 
cells were treated with cholesterol saturated M
stained after the internalisation assay as in (A). Cells were treated with no drug, M
and cholesterol as experimental controls. Nuclei stained blue with DAP
Representative confocal images are shown; 
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The results from the above experiments confirmed that HA-hERG internalisation was 
dynamin-independent and required the integrity of the cholesterol rich lipid-rafts. 
Whether this was true for native ERG channels was tested using the pharmacological 
tools on NRVCM. Treatment of NRVCM with dynasore or αCD did not prevent 
internalisation of ERG channels, as seen by the presence of stained ERG channels 
after acid-strip (described in section 5.2.1 and Figure 5.2.A). Treatment with MβCD, on 
the other hand, inhibited ERG internalisation in NRVCM (Figure 5.7). Taken together 
these data indicated that hERG internalisation is predominantly dynamin-independent. 
Moreover, the data also confirmed the validity of the use of recombinant system and 
the HA-tagged hERG for further investigations into the mechanism of internalisation of 
the hERG channels. 
 
5.3.3 Localisation of hERG channels to lipid-rafts 
Depletion of membrane cholesterol that would disrupt membrane lipid-rafts using 
MβCD blocked HA-hERG internalisation (Figure 5.6 & 5.7). These data indicated that 
raft localisation of the channels was important for their internalisation. To strengthen 
these conclusions it was required to confirm raft localisation of the channel. Towards 
this, neonatal rat heart lysates were fractionated in the presence of 0.1% Triton X-100 
on a sucrose density gradient using high speed centrifugation as described in Methods, 
(Schuck, 2006a). Western blot analysis of the fractions showed that majority of hERG 
was localised to the detergent resistant raft membranes (DRM) containing fractions 
marked by flotillin (Bickel et al., 1997). A small fraction of the channels was also found 
to be localised to the detergent soluble bottom fraction marked by clathrin (Schuck, 
2006a), and Figure 5.8A). Disruption of the detergent resistant raft membranes by 
treatment of the lysates with MβCD shifted the hERG channels to non-raft, clathrin 
containing fractions. Similarly the channels were found to be localised to the top raft 
fractions in Guinea pig cardiac myocytes (Figure 5.8.B). Since the study used HA-
hERG transfected in model cells, the localisation of HA-hERG expressed in HEK-
MSRII cells was examined.  
 
  
 Figure 5.7 Native hERG is 
independent of dynamin
(see methods) prior to and during 60 min 
cells at 37oC (internalisation assay). 
Figure 5.3.A) to confi
permeabilised and stained with Cy3
hERG channel (red). Nuclei stained blue with DAPI. Representative confocal images 
from three independent experime
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internalised by lipid raft dependent pathway 
. NRVCM were treated with the indicated drugs for 30 min 
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A set of cells was subjected to acid strip (used in 
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 Figure 5.8 ERG channels are localised to 
was homogenised, treated with or without M
100 and subjected to sucrose density gradient 
to western blotting for ERG, flotillin (raft marker), and clathrin (non
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gradient centrifugation as in (A). Fractions wer
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Known raft marker GFP (extracellular)- tagged glycoslyphosphatidylinositol-anchored 
protein (GFP-GPI-AP) was also co-transfected in these cells which were subjected to 
detergent extraction followed by raft isolation using the OptiprepTM gradient and high 
speed centrifugation (see methods for details). As in the heart tissue, majority of HA-
hERG in the HEK-MSRII cells was also found to be localised to the raft fractions 
marked by GFP-GPI-AP and flotillin, but a small proportion was also present in non-raft 
fractions along with clathrin (Figure 5.8.C). These data established that hERG was 
localised to lipid-rafts.  
 
Furthermore to investigate if internalisation of hERG occurred in lipid-rafts, internalised 
HA-hERG in HEK-MSRII cells was labelled along with raft markers (Mayor and 
Pagano, 2007, Naslavsky et al., 2004, Torgersen et al., 2001), GFP-GPI-AP (Figure 
5.9.A) or Alexa633 conjugated cholera toxin B (CT-B) (Figure 5.9.B). HA-hERG 
channels were found to co-localise with both these raft cargos on cell surface and in 
vesicular compartments within the cells after internalisation. Taken together, the data 
demonstrated that hERG channels are localised to lipid-rafts in the cell membrane and 
are internalised by a raft mediated pathway. 
 
5.3.4 CDC42-independent, ARF6-mediated internalisation of hERG 
channels 
The above experimental results left open the possibility that hERG internalisation was 
mediated by one of the raft dependent pathways which included mediators CDC42 and 
ARF6 (Chadda et al., 2007, Donaldson et al., 2009, Mayor and Pagano, 2007). Co-
expression of GFP-tagged DN isoform of CDC42 (T17N) did not affect the 
internalisation of HA-hERG (Figure 5.10). Further, immunofluorescence imaging of 
cells expressing HA-hERG and DN-ARF6 (T27N) did not appear to completely block 
internalisation of the channel compared to the WT-ARF6 (Figure 5.11.A). However, 
chemiluminescence assay to determine percent internalisation (as in Figure 5.6.B) 
showed that there was an increase in the surface density of the channels when DN-
ARF6 was co-expressed due to reduced internalisation (Figure 5.11.B). These results 
were consistent with the electrophysiological assays which showed that co-expression 
of DN-ARF6 but not CDC42 resulted in a significant increase in the current density of 
hERG channels in HEK293 cells (Figure 5.10.B&C, experiments done by Andrew 
Smith, n=4 or more cells for patching). 
  
 
 
Figure 5.9 Internalised hERG channels co
HEK-MSRII cells made to express HA
on cell surface with anti
incubated at 37°C for 0 and 15 min to allow 
permeabilised and stained for immunofluorescence imaging. (B) HA
were labelled following internalisation of anti
described in Fig.5.3.B). Alexa633
the assay (pseudo green). Representative confocal images from three independent 
experiments are shown; panels with zoomed sections highlight co
of the lipid-raft markers (pseudo green) with HA
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 Figure 5.10 CDC42-
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 Figure 5.11 hERG internalisation
and HEK-MSRII cells co
for HA-hERG (red) following internalisation assay (A) or for remaining surface channels 
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Taken together, these data suggested that internalisation of the hERG channels occurs 
via the ARF6-dependent pathway but could not explain why DN-ARF6 did not cause 
complete inhibition of internalisation of the channels. One possible explanation was 
that co-expression of DN-ARF6 and HA-hERG was allowed for about 40 hrs prior to the 
internalisation assay and staining of the channels for imaging and this long term block 
of the ARF6 function could be causing diversion of internalisation of the hERG 
channels by an alternate pathway, independent of ARF6. 
 
To test this hypothesis, cells expressing HA-hERG channels and a known ARF6 cargo, 
Major Histocompatibility Complex class I protein (MHCI), were treated with aluminium 
fluoride (AlF: AlF3 + AlF4
-), which, unlike DN-ARF6, can disrupt ARF6 function acutely, 
following 30 min of pre-treatment at 37°C (Radhakrishna et al., 1996, Donaldson et al., 
2009). Cells were labelled with anti-HA and anti-MHCI antibodies on cell surface at 4°C 
and allowed to internalise at 37°C for 0 min and 15 min in presence of AlF. Cells were 
then fixed, permeabilised and stained for HA-hERG and MHCI. Immunofluorescence 
staining showed that control (untreated) cells showed robust internalisation of both the 
cargos (Figure 5.12.A) while treatment with AlF blocked internalisation of both the 
cargos (Figure 5.12.B). Chemiluminescence assay carried out to determine percent 
internalisation of the channels showed complete block of HA-hERG internalisation in 
support of the results from imaging (Figure 5.12.C). Further, treatment of NRVCM with 
AlF also showed total block of native ERG channel internalisation (Figure 5.13).  
 
The effect of AlF was not non-specific, since treatment of cells expressing the 
pancreatic KATP channel known to undergo CME did not block its internalisation (Figure 
5.14A). Mediators of CIE, DN-CDC42 and DN-ARF6 did not appear to alter the 
internalisation of this channel (Figure 5.14B). Moreover, following the prolonged block 
of ARF6 using the DN isoform,  internalisation of MHCI was completely blocked, which 
is an ARF6 cargo (Donaldson and Williams, 2009), Figure 5.15). Taken together, it 
could be concluded from the results that internalisation of hERG channels is ARF6-
dependent and that the channels are also capable of internalisation by other alternate 
pathways. 
  
 Figure 5.12 Acute block of ARF6 activity prevents hERG 
cells co-transfected with HA
treated (B) with AlF and incubated with a mixture of rat anti
antibodies at 37°C f
permeabilised and stained with appropriate fluorescent secondary antibodies for 
imaging. (C) Effect of AlF on the surface density of HA
determined as in Figure 5.6.B, using the chemilu
3) data are shown; ** indicates p
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blue with DAPI. 
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Figure 5.13 Native ERG channel 
on internalisation of native ERG in NRVCM using acid strip method described in Figure 
5.7. Representative confocal images of three independent experiments are shown; 
Scale bars: 10 µm, nu
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 Effect of AlF 
 Figure 5.14 Internalisation of clathrin cargo HA
of ARF6 activity by AlF
(HA-Kir6.2 + SUR1) were untreated or treated with AlF (see methods) followed by 
incubation with anti-HA antibody at 37°C for 1hr. Cells were then fixed, perm
and stained with Cy3
Cells were co-transfected with the indicated DN isoforms and HA
channels were stained (red) following the internalisation assay.
confocal images are shown; 
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 Figure 5.15 Internalisation of MHCI is 
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5.3.5 Dynamin and clathrin mediated alternate pathway of hERG 
internalisation  
Chronic suppression of ARF6 was found to trigger internalisation of hERG via an 
alternate pathway (Section 5.2.4). To investigate this alternate pathway of hERG 
internalisation, HEK-MSRII cells co-transfected to express HA-hERG and DN-ARF6 
were treated with drugs to block CME and CIE pathways: dynasore, MβCD and AlF 
(Figure 5.16). Since functional ARF6 was absent, AlF did not block internalisation. 
However, dynasore that blocks dynamin-dependent internalisation showed a complete 
inhibition of internalisation. Also, raft disruption with MβCD failed to inhibit HA-hERG 
internalisation after chronic suppression of the channel density with ARF6. These 
effects were exactly opposite to those seen in cells expressing only the hERG channels 
(Figure 5.6.A & 5.12.A). This dynamin-dependent alternate pathway of internalisation of 
the hERG channels was also apparent in HeLa cells (Figure 5.16.B). Thus, the 
alternate pathway of hERG internalisation was dynamin-dependent and raft-
independent.  
 
Dynamin-dependent pathways include CME or caveolin and RhoA mediated endocytic 
pathways (Doherty and McMahon, 2009, Mayor and Pagano, 2007). The latter two are 
also mediated by lipid-rafts. Treatment of cells expressing HA-hERG and DN-ARF6 
with drugs genestein and nystatin, which are known to block caveolin mediated 
internalisation failed to inhibit internalisation of the channels (Figure 5.17). Moreover, 
co-transfection with DN-Cav1 (P132L) and DN-RhoA (T19N) also did not block 
internalisation of HA-hERG in cells expressing HA-hERG (Figure 5.18). These data 
further confirmed that the alternate pathway was not clathrin independent (raft 
mediated, dynamin-dependent). The only known pathway of internalisation which 
requires dynamin and is not mediated by lipid-rafts is CME (Doherty and McMahon, 
2009, Mayor and Pagano, 2007). Therefore, effect of ARF6 suppression on co-
localisation of endocytosed HA-hERG channels with clathrin cargo transferrin (Tfn) was 
examined. The results (Figure 5.18) showed that in cells where ARF6 function was 
chronically suppressed, there was a substantial increase (~ 4-fold; p <0.05) in the co-
localisation of the hERG channels with internalised Tfn. Thus, the investigation 
suggested that though internalisation hERG channel is ARF6-mediated, chronic 
suppression of ARF6 function causes the channels to internalise via a dynamin-
dependent, clathrin-mediated pathway. 
  
 Figure 5.16 Chronic suppression of ARF6 function enables dynamin
internalisation of the hERG channels
transfected with HA-
and internalisation of anti
assay as in Figure 5.6
confocal images from four independent experiments are shown; scale
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 Figure 5.17 Pharmacological blockers of caveolin mediated 
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5.3.6 Effect of signalling molecules Protein Kinase A (PKA) and 
Protein Kinase C (PKC) on internalisation of hERG channels 
Autonomic regulation of hERG channels is an area of active investigation with 
possibility of involvement of kinases, second messengers, and protein–protein 
interactions. PKA has been shown to affect the rate of hERG channel synthesis (Chen 
et al., 2009). It has been shown that PKC activators, ceramide, diacylglycerol (DAG) 
and its precursor phosphatidylinositol 4,5-bisphosphate (PIP2) modulate hERG 
function. DAG has been reported to reduce surface hERG density and thereby alter 
channel function by causing channel internalisation (Ramstrom et al., 2010). Another 
group has reported that direct activation by PKC increases the hERG channel protein 
and K+ current density in a time- and dose-dependent manner (Chen et al., 2010b). 
The reports however were thus conflicting and a clear effect of the protein kinases on 
channel internalisation had not been adequately investigated. Having investigated the 
endocytic pathway of hERG, it was interesting to look further into the regulation of 
hERG internalisation by PKC and PKA. To fulfil this aim, cells expressing HA-hERG 
channels were treated with activator and inhibitor drugs for PKC (Figure 5.20) and PKA 
(Figure 5.21). Following the internalisation assay as in Figure 5.16, cells were fixed, 
permeabilised and stained to label the channel (red). The imaging data were confirmed 
using the quantitative chemiluminescence assay as in Figure 5.6.B. Activation of PKC 
using diacylglycerol (DAG) or PMA was found to inhibit internalisation of the channel 
and increase surface channel density, while PKA activation or inhibition did not have 
significant effect on channel internalisation. The physiological significance of these data 
would be interesting to understand.  
 Figure 5.20 Internalisation
(A) HEK-MSRII cells transfected to express HA
activators (DAG and PMA) or PKC inhibitors (GÖ6976 and CHE); see methods for 
details. HA-hERG channels were stained (red) following the internalisation assay. 
Representative confocal images of three independent experiments are shown; 
bars: 10 µm. (B) Cells expressing the HA
indicated drugs for 30 min prior
antibodies (15 min, 37°C). The remaining surface density of the channels was 
determined using the chemil
data are shown, * indicates p value <0.01
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 Figure 5.21 hERG internalisation
MSRII cells transfected to express HA
(forskolin) or PKA inhibitor (H89); see methods for details. HA
after the internalisation assay. Representative confocal images of three independent 
experiments are shown; 
treated with the indicated drugs. Internalisation of pre
allowed to occur for 15 min prior to assaying the remaining surface density. Mean ± 
s.e.m (n = 2) data are shown; ns,
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5.4 Discussion 
 
Plasma membrane density of the cardiac hERG channels requires to be critically 
regulated since altered number of the channels is proven to be associated with life 
threatening cardiac arrhythmias (Anderson et al., 2006, Sanguinetti and Tristani-
Firouzi, 2006). Besides the cardiac tissue, other tissues showing evidence of hERG 
expression include the pancreatic β-cells (Rosati et al., 2000) and neuronal cells 
(Selyanko et al., 1999). Also, hERG has been found to express in cancerous tissue that 
do not normally express the channels in non-cancerous conditions (Cherubini et al., 
2000, Wang et al., 2002). Thus the path-physiological importance of hERG is immense 
and it is important to understand how the channel is regulated in terms of both channel 
function and expression on the cell surface.  
 
It is known that the plasma membrane density of most proteins is controlled by a 
balance between biosynthetic delivery and endosomal trafficking processes (Doherty 
and McMahon, 2009, Drake et al., 2006, Kennedy and Ehlers, 2006). The unique 
properties of the hERG channels make them susceptible to a huge variety of drugs that 
directly block the channel (Thomsen et al., 2006) or alter its biosynthetic trafficking 
(Eckhardt et al., 2005, Rajamani et al., 2006, Anderson et al., 2006), causing drug 
induced LQTS. Therefore, the channel has become a major target of drug safety 
screens, which have added to the drug development costs and reduced the number of 
drugs that get past these screens for use in therapy. However, studies show that 
approximately 40% of acute hERG blockers also affect trafficking of the channels 
(Wible et al., 2005). Moreover, another major cause of LQTS is loss of function of 
mutations in hERG which may lead to any of the following: altered current kinetics, 
altered ion selectivity, or defective intracellular protein trafficking. Trafficking of the 
hERG channels attracted more attention, with reports that some of the mutant subunits 
display wild type current properties when normal trafficking was restored and channels 
were inserted in the cell membrane in vitro (Thomas et al., 2003b). These studies 
focused mainly on folding and biosynthetic delivery of the hERG channels and is still an 
area of interest to researchers (van der Heyden et al., 2008). As a result, while there 
have been many studies on the biosynthetic delivery of the channels to the membrane 
(Chen et al., 2010b, Ficker et al., 2003, Kagan et al., 2000), little is known about how 
the channel density is regulated post biosynthesis under physiological or patho-
physiological conditions.  
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Two studies have reported that hERG channels undergo internalisation (Chapman et 
al., 2005, Guo et al., 2009); however, the mechanism by which the channels are 
endocytosed was not clear from either of these studies. Chapman et al., 2005, reported 
that ceramide treatment causes a time-dependent decrease in hERG current which 
was attributed to rapid internalisation of the channels from the cell surface. The authors 
reported that after ceramide stimulation the channel undergo ubiquitinylation and 
subsequent lysosomal degradation. These results suggested that surface density of the 
hERG channels expressed on the cell surface must be strictly regulated by endosomal 
trafficking. Another study by Guo et al., (2009) demonstrated that under hypokalaemic 
(low serum potassium) conditions, internalised hERG channels undergo increased 
degradation. The authors used both the heterologously expressed hERG channels in 
HEK cells and its native counterpart in rabbit hearts for their experiments. HEK cells 
expressing the channels were grown in medium containing 0 mM extracellular K+ 
concentration. The hERG channels expressed in these cells had accelerated 
internalisation and degradation of hERG channels. The authors suggest that reduction 
of K+ ion concentration induces a conformational change in the channel that somehow 
triggers ubiquitinylation and internalisation (Guo et al., 2009). Moreover, intracellular 
potassium ions are known to stabilise hERG folding and promote forward trafficking of 
the channels (Wang et al., 2009). These reports could explain how electrolyte 
imbalances, such as reduced serum K+ levels (hypokalemia), trigger potentially fatal 
arrhythmias (Robertson, 2009), but the mechanism of hERG internalisation in 
physiological conditions was not understood from these studies. Investigation of 
endocytic pathways of hERG channels was therefore critical towards better 
understanding of how the surface channel densities might be regulated.  
 
Membrane proteins are internalised by a variety of mechanisms, of which CDE is best 
characterised (Figure 5.1 and (Doherty and McMahon, 2009, Mayor and Pagano, 
2007). Whilst many membrane proteins appear to use CDE to internalise proteins and 
ligands, there is growing evidence for the existence of a number of other pathways, 
collectively known as CIE (Doherty and McMahon, 2009, Donaldson et al., 2009, 
Mayor and Pagano, 2007, Eyster et al., 2009). In order to study internalisation of hERG 
it was important to be able to track the channels expressed on the cell surface 
independent of the biosynthetic pathway. Therefore, for this study, the internalisation 
assay was used to track the internalised channels. In the assay, live cells were 
incubated with antibodies against extracellular epitope on the hERG channel which 
allowed only channels expressed on the cell surface and internalised there from to be 
labelled and immunostained. While anti-HA antibodies were used to label HA-hERG 
channels, native ERG channels in NRVCM were labelled using the anti-Kv11.1 
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antibody after confirming their specificity (Figure 5.2). The acid strip ensured that only 
the internalised channels were being imaged in the NRVCM (Figure 5.2). HEK-MSRII 
and HeLa cells were used for transient expression of HA-hERG channels. Using this 
assay it was clearly demonstrated for the first time using immunofluorescence imaging 
that ERG channels, native (Figure 5.3.A) and recombinant (Figure 5.3.B) undergo 
internalisation from the cell surface at body temperature but remain on cell surface at 
4°C. The time course of hERG internalisation showed that the channel was capable of 
undergoing internalisation very rapidly with about 50% of the channel internalised 
within 15 minutes (Figure 5.3.C-D). These data also indicated that the endocytic 
mechanism was capable of rapidly altering the surface channel density.  
 
Endocytic pathways are broadly classified as dynamin-dependent and independent. 
Co-expression of dominant negative dynamins did not affect internalisation of HA-
hERG (Figure 5.4). These constructs have been shown to inhibit the internalisation of 
clathrin and dynamin-dependent endocytic cargo KATP (Mankouri et al., 2006). DN-µ2 
(Doherty and McMahon, 2009, Nesterov et al., 1999) also did not affect internalisation 
of HA-hERG channels as confirmed by the dominant negative approach (Figure 5.5). 
Thus, hERG internalisation is clathrin-independent (CI). Dynamin-dependent CI 
endocytic pathways chiefly include caveolae and the less characterised clathrin- and 
caveolin independent carriers (CLICs), (Mayor and Pagano, 2007). Caveolae are flask 
shaped invaginations on the cell membrane that are made of caveolin. The caveolae 
require dynamin for fission from the cell surface to carry the endocytic cargo into the 
cell (Mayor and Pagano, 2007, Hansen and Nichols, 2010). Several ion channels such 
as the Kv1.5 and Kv1.3 are known to be targeted to caveolar lipid-rafts for 
internalisation (Martinez-Marmol et al., 2008). Others, such as Kv2.1, are associated 
with lipid-rafts that do not contain caveolin (Martens et al., 2001). Co-expression of DN 
dynamins and DN caveolin1, which are both required for caveolin-mediated 
internalisation, did not block internalisation of the HA-hERG channels (Figure 5.4 & 
5.5). These data suggest that caveolae and CLICs do not have a role in internalisation 
of channels. A recent report (Massaeli et al., 2010) suggests that under low K+ 
conditions, mature hERG channels and caveolin1 (Cav1) co-immunoprecipitate and 
knockdown of cavolin1 or dynamin2 using siRNA transfection significantly reduces the 
extensive hERG internalisation under low K+. Another study reported that there is a 
significant increase in hERG current amplitude in HEK293 cells expressing the hERG 
channels when membrane lipid-rafts were disrupted or caveolin1 was knocked down by 
RNA interference. The authors (Lin et al., 2008) claim that hERG channels interact with 
caveolin1 and are negatively regulated by this interaction. Association with caveolins 
does not necessarily indicate that the proteins undergo caveolin dependent 
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internalisation because caveolins have also been implicated in membrane signalling 
without having a role in internalisation (Nichols, 2002). Another group has provided 
evidence that ERG channels in physiological conditions do not associate with caveolin 
through co-immunoprecipitation experiments (Balijepalli et al., 2007). The authors show 
that the ERG channels localise to cholesterol and sphingolipid enriched membranes 
and are modulated by membrane cholesterol.  
 
Another group (Massaeli et al., 2010) show that in 0 mM K+, hERG channels co-
immunoprecipitate with caveolin1 and are endocytosed in a caveolin dependent 
manner to the lysosomes for degradation. The data from the present study, using the 
internalisation assay, clearly indicates that dynamin-dependent pathways, clathrin, 
caveolin and RhoA do not block internalisation of hERG (Figure 5.4 & 5.5) which is in 
contradiction to the report by(Massaeli et al., 2010). This may be because in the 
presented study internalisation of hERG channels in normal conditions was 
investigated and severe conditions of K+ depletion were not used. Moreover, the 
channels were found to be capable of internalisation by dynamin-dependent alternate 
pathway and therefore it is possible that the channels are diverted to different endocytic 
pathways depending on the physiological state of the cell. 
 
All of the known CI pathways are generally mediated by cholesterol rich membrane 
lipid-rafts (Nichols and Lippincott-Schwartz, 2001). The pharmacological approach 
using dynasore to inhibit dynamin function (Macia et al., 2006) suggested that 
internalisation of hERG channels is dynamin-independent (Figure 5.6.A & B). 
Disruption of lipid-rafts with MβCD (Klein et al., 1995) inhibited channel internalisation 
(Figure 5.6). Internalisation of ERG channels in NRVCM was also dynamin-
independent but lipid-raft dependent (Figure 5.7). Consistent with these 
pharmacological data, and previously published biochemical experiments which 
showed that in canine cardiac cells, the majority of hERG channels are present in lipid-
rafts (Balijepalli et al., 2007), HA-hERG in HEK-MSRII cells and ERG in NRVCM and 
guinea pig myocytes were localised to lipid-rafts (Figure 5.8). The raft localisation of 
hERG was also apparent with the extensive co-localisation of HA-hERG with GFP-GPI-
AP and cholera toxin (Figure 5.9). Both these proteins are used as lipid raft markers 
(Nichols et al., 2001). GFP-GPI-AP .is internalised to the Golgi by clathrin and Rab5- 
independent pathway and fractionates to lipid-rafts (Nichols et al., 2001, Singh et al., 
2003). The endocytic pathway of GPI-APs is thought to be CDC42-regulated, and the 
proteins internalised via this route enter the GPI-AP-enriched early endosomal 
compartments (GEECs), (Chadda et al., 2007).  
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Cholera toxin (CT), produced by Vibrio cholera, binds to the GM1 protein present in 
lipid raft domains on cell membranes and undergoes internalisation to be delivered to 
the Golgi and finally to the ER (Massol et al., 2004). CT is an interesting endocytic 
cargo since it has been shown to be able to undergo internalisation by several alternate 
routes including CDC42, caveolae, flotillin and even clathrin. Blocking of one or several 
endocytic pathways simultaneously does not prevent cholera infection (Massol et al., 
2004). Co-localisation of internalised HA-hERG with GFP-GPI-AP and CT could aid in 
studying the post-endocytic destinations of the channel.  
 
The presence of hERG in lipid-rafts is interesting because there is growing evidence 
from both functional and structural studies that lipids influence both functional 
properties and trafficking (surface density) of ion channels (O'Connell et al., 2004, 
Martens et al., 2004). Thus association of ion channels with lipid-rafts can have 
significant impact on cell signalling and physiology, (for example, depletion of 
cholesterol with MβCD causes a dramatic hyperpolarising shift in the steady-state 
inactivation properties of the Kv1.2 channels,(Martens et al., 2000). Balijepalli et al 
(2007) reported that depletion of cholesterol with MβCD results in a positive shift of 
voltage dependence of activation and an acceleration of deactivation kinetics of the 
hERG channel. The consequence of these changes to cardiac rhythm is not known, but 
it is conceivable that removal of cholesterol could prolong the repolarisation phase of 
the cardiac action potential, increasing the risk of cardiac arrhythmias.  
 
Having established that the hERG channels are internalised via cholesterol rich lipid-
rafts, further investigation into the mediators of the endocytic pathway eliminated the 
role of CDC42. Although HA-hERG channels co-localise with CDC42 cargo, GFP-GPI-
AP, disruption of CDC42 activity using the DN isoform approach did not inhibit 
internalisation of the channels (Figure 5.10). Moreover, DN-CDC42 did not alter 
functional hERG current density, while the hERG current density was significantly 
increased in HEK cells co-expressing DN-ARF6 (Figure 5.10.B&C, experiments by 
Andrew Smith, a member of Rao lab). Immunofluorescence studies did not appear to 
completely block internalisation of the channels (Figure 5.11A), though internalisation 
of ARF6 cargo, MHCI (Donaldson, 2003) was completely blocked by co-expression of 
the DN-ARF6 construct (Figure 5.15). Quantitative measurements of internalisation by 
the chemiluminescence assay showed that DN-ARF6 was causing a reduction in the 
internalisation of the channels (Figure 5.11.B).  
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ARF6 belongs to the family GTP-binding proteins that are expressed in all eukaryotes 
(see Introduction). ARF6 activity requires it to cycle between GDP-bound, inactive and 
GTP-bound, active states (Donaldson, 2003). ARF6 influences membrane trafficking 
(internalisation and recycling) and the actin cytoskeleton at the plasma membrane (PM) 
(Donaldson, 2003, Balasubramanian et al., 2007, Radhakrishna and Donaldson, 1997). 
The dominant negative ARF6 (T27N) is ‘GDP on’ and is mainly localised to intracellular 
tubulovesicular structures which can block cell surface molecules from recycling back 
to the cell surface. Majority of the endogenous ARF6 is present at cell surface and in 
recycling endosomes. Activation by hydrolysis of ARF6-GTP to ARF6-GDP is 
considered to signal its internalisation along with membrane rafts to recycling 
compartments (Sabe, 2003). Therefore, since DN-ARF6 was increasing the surface 
density of the hERG channels (Figure 5.11.B), ARF6 appeared to have a role in 
channel internalisation. 
 
Aluminium fluoride prevents the GDP-GTP exchange of ARF6 (Radhakrishna et al., 
1996) and thereby distrupts the function of the GTPase in a short duration (30 min 
pretreatment). Treatment with AlF completely blocked internalisation of hERG channels 
as well as MHCI (Figure 5.12). Internalisation of clathrin cargo, the pancreatic KATP 
channels was not affected by either DN-CDC42, DN-ARF6 or AlF treatment indicating 
that these methods of disruption of ARF6 function were specific (Figure 5.14). 
Moreover, disruption of ARF6 function in NRVCM with AlF also blocked ERG 
internalisation indicating the physiological relevance of the findings. Thus, unlike other 
cardiac ion channels, which are known to use dynamin-dependent clathrin- or caveolin-
mediated mechanisms (Steele et al., 2007b, Steele et al., 2007a), hERG channels 
appear to undergo internalisation largely via a dynamin-independent route which is 
regulated by ARF6. Proteins known to depend on ARF6 for endocytic recycling are 
generally viral proteins such as the herpes simplex virus protein (VP22) (Nishi and 
Saigo, 2007), coxsackievirus type B3 (CVB3) (Marchant et al., 2009) and cellular prion 
protein (PrPc) (Kang et al., 2009). It is interesting why the hERG channel chooses an 
endocytic pathway that viral elements hijack. One explanation could be that viruses 
prefer to use robust pathways for entry into the cell that are difficult to disrupt and since 
regulation of the surface density of the hERG channels is critical, these channels also 
use this endocytic mechanism. 
 
The only ion channel known to associate with ARF6 is the neuronal TWIK1 channel 
which is involved in cell volume regulation and excitability (Decressac et al., 2004). 
However, the role of ARF6 in the TWIK1 channel internalisation and recycling is not 
established. ARF6 has been shown to influence recycling of the inwardly rectifying 
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potassium channels, Kir3.4 (Gong et al., 2007a), but it appears to have no role in their 
internalisation. Thus hERG could represent the first report of an ion channel to use 
ARF6 for internalisation. Further research might reveal the role of ARF6 in trafficking of 
other ion channels in the future. 
 
Chronic suppression of ARF6 activity using dominant negative isoform of ARF6, ARF6 
(T27N) did not completely block internalisation of HA-hERG (Figure 5.11) unlike that of 
MHCI (Figure 5.15), while AlF completely prevented internalisation of the channels. 
Given that effect of AlF was not observed on non-ARF6 cargo, the HA-KATP channels 
(Figure 5.14.A), why DN-ARF6 was not able to completely block internalisation of the 
HA-hERG channels like AlF presented an interesting point of investigation. These 
differences in block of internalisation of HA-hERG by DN-ARF6 and AlF treatment 
could be due to the difference in the way these treatments work: whilst application of 
AlF produces an acute effect, transfection of DN-ARF6 gradually knocks down the 
ARF6 function. A simple explanation could be that DN-ARF6 was not fully blocking 
endogenous ARF6 function, However treatment of cells co-expressing HA-hERG and 
DN-ARF6 with AlF did not block internalisation of the channels (Figure 5.16.A) although 
AlF treatment should inactivate any remaining functional ARF6 in the cells. These data 
suggested that HA-hERG channels seen to internalise in cells expressing DN-ARF6 
were taking an alternate pathway of internalisation that is ARF6-independent. 
Interestingly, dynamin inhibitor dynasore, completely blocked hERG internalisation 
while MβCD did not do so. This effect of the drugs was completely opposite to that 
seen on cells expressing HA-hERG alone (Figure 5.6, 5.12). These data raised the 
possibility that prolonged suppression of ARF6 function could promote deployment of 
alternative mechanisms of hERG internalisation and that the alternative mechanism 
was dynamin-dependent. Moreover since MβCD, DN-Caveolin1 and caveolae blocker 
drugs genestein and nystatin did not block the alternate pathway (Figure 5.17 & 5.18); 
it was considered to be non-caveolar. Increase in co-localisation with clathrin cargo Tfn 
(Figure 5.19) indicated that the channels are more likely to undergo dynamin and 
clathrin mediated endocytosis. Although the dynamin-dependent alternate pathway of 
internalisation of the HA-hERG channels was revealed only when ARF6 function was 
suppressed, it is possible that under normal conditions a small proportion of the 
channels undergo internalisation via the alternate pathway. Under patho-physiological 
conditions the channels may be diverted to internalisation via alternate endocytic 
pathway/s which are dependent on dynamin and caveolin (Massaeli et al., 2010).  
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Ability of proteins to undergo internalisation via more than one mechanism has been 
reported in a few other cases. Cholera toxin can enter cells via multiple endocytic 
pathways (Massol et al., 2004, Torgersen et al., 2001). A number of signalling 
receptors which use multiple mechanisms to promote internalisation and to regulate 
signal output include the epidermal growth factor receptor, EGFR (Sigismund et al., 
2008) and TGFbR (Di Guglielmo et al., 2003). CME is the major pathway of 
internalisation of these receptors which commits the receptors to recycling and thereby 
sustains signalling. On the other hand, CIE couples the receptors with degradation 
leading to attenuation of signalling. In the case of Wnt3a activated pathway of low-
density-lipoprotein receptor-related protein 6 (LRP6), major endocytic pathway is 
caveolar. However inhibition of Wnt3a shunts the LRP6 to a CME pathway. The mode 
of internalisation of the LRP6 determines if β-catenin signalling is activated or inhibited 
(Yamamoto et al., 2008), showing that the partitioning of the receptors to different 
endocytic routes has physiological importance. Although the significance of the two 
pathways for hERG internalisation is unclear at present, whether partitioning of hERG 
between the ARF6 and clathrin dependent pathways is similarly regulated, and if so, 
what signalling molecules determine the traffic route, and what effect such changes 
might have on cardiac rhythm remains to be investigated.  
 
The fact that a variety of signals, including protein kinases (Chen et al., 2010a), lipids 
(Bian et al., 2004, Chapman et al., 2005) and ions (Guo et al., 2009) influence cardiac 
action potential, and that these signals also regulate the surface density of hERG, 
could suggest that differential trafficking might have a physiological role. The effect of 
protein kinases on hERG function has been demonstrated and autonomic regulation of 
hERG channels is an area of active investigation.  
 
Protein kinase C (PKC) is known to control the function of proteins through 
phosphorylation of hydroxyl groups of serine and threonine amino acid residues. 
Diacylglycerol (DAG) is one of the key lipid second messengers which bind to the C1 
domains of all PKC isozymes resulting in their activation (see introduction). Phorbol 
esters such as PMA bind to C1 domains of PKC isozymes and thus mimic DAG and 
activate PKC (Yang and Kazanietz, 2003).  
 
Regulation of hERG potassium channels by activation of PKC was reported to be 
independent of direct phosphorylation of the channel protein by use of hERG mutants 
lacking the possible PKC phosphorylation sites in the hERG C-terminus (Thomas et al., 
2003b). Experiments with activators and inhibitors of protein kinase C (PKC) showed 
that PKC activation by treatment with PMA and DAG blocks internalisation leading to 
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increase in surface channel density (Figure 5.20). A more recent publication 
(Ramstrom et al., 2010) claimed that DAG potently reduces hERG current due to a 
PKC-evoked internalisation of the channels from the cell surface and the endocytic 
mechanism requires the dynein–dynamin complex. However, the data presented to 
support this hypothesis measured total hERG channels instead of channels 
internalised from the cell surface. On the other hand, direct activation of PKC with PMA 
has been shown to increase abundance of the hERG protein and K+ current density in 
a time- and dose-dependent manner by protecting the channel from degradation and 
also enhancing channel synthesis (Chen et al., 2010b). The data presented in this 
chapter show that treatment with PMA and DAG blocks internalisation of the HA-hERG 
channels leading to an increase in surface channel density (Figure 5.20). If 
internalisation was blocked by PMA or DAG then the channels would not be diverted to 
degradation, which would explain the increase in the hERG channel protein reported by 
Chen et al (2010).  
 
There are reports of regulation of hERG by the α1A-adrenergic receptor (α1A-AR). 
Stimulation of α1A-AR increases abundance of hERG protein and K+ current density 
through the activation of PKC in a time and dose dependent manner (Chen et al., 
2009). The block of hERG internalisation by activation of PKC (Figure 5.20) could 
explain the mechanism behind the up-regulation of hERG by PKC, a process that may 
have relevance in cardiac diseases and treatment. Activation or inactivation of PKA did 
not affect surface density of the channel (Figure 5.21). It has been shown that PKA 
activity is required for functional expression of the channel (Chen et al., 2009). This 
would imply that short term modulation of the kinase would not alter the surface density 
of the channel by processes such as internalisation.  
 
In a patho-physiological context, hERG channels have been found to be over-
expressed in cancer cells and blocking of the channels is being tested for use in cancer 
therapy (Felipe et al., 2006). Infection with hepatitis B virus transactivator (HBx) is a 
known cause of cancer and HBx infection has been shown to cause an increase in 
DAG and activation of PKC (Luber et al., 1993). Since PKC activation leads to an 
increase in surface hERG density, it may be one of reasons why elevated levels of 
hERG channels are found in cancer cells. The patho-physiological role of the channels 
in cancerous tissue is however not well understood. Another interesting question is 
how PKC activation regulates hERG internalisation. One explanation could be that 
PKC activates ARNO, an upstream regulator of ARF6 (Frank et al., 1998) that 
catalyses exchange of ARF6-GTP to ARF6-GDP (Santy and Casanova, 2001). This 
would result in blocking of ARF6 function and thereby block internalisation of the 
channels.   
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5.5 Summary 
 
The aim of the present study was to investigate the mechanism underlying the 
internalisation of the cardiac hERG potassium channel. This knowledge was necessary 
to gain an insight into how the channel density and thereby function might be regulated. 
The results demonstrated that internalisation of hERG occurs via a lipid-raft and ARF6-
dependent mechanism. Such a mode of internalisation is previously unreported for ion 
channels. Though this was a major pathway of internalisation of the channel, a 
prolonged block of ARF6 function revealed a dynamin-dependent alternate endocytic 
pathway of the channel. The alternate pathway appeared to be mediated by clathrin 
and independent of lipid-rafts. These findings suggested the possibility that the channel 
internalisation may be differentially regulated in different physiological and patho-
physiological conditions. Experiments to look at the effect of PKC on internalisation of 
hERG channels showed that activation of the kinase inhibits channel internalisation. 
These data explain the mechanism behind the increase in hERG currents by PKC 
activators and the α1A-adrenergic receptor stimulation. The hERG channels are known 
to be different from other members of the Kv potassium channel family since they 
exhibit unusual biophysical properties and pharmacology, in particular with regard to 
their susceptibility to promiscuous blockade by several commonly used drugs. It is 
therefore seems not surprising that the hERG channels differ from other members of 
the family in terms of how they are internalised from the plasma membrane.  
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CHAPTER 6 
hERG Channels Recycle and Blocking Rab11a Function Increases Channel 
Degradation 
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6.1 Introduction 
 
Cells express several membrane proteins on their surface and in most cases these 
proteins are removed from the cell surface by internalisation. Cell membranes are 
known to internalise the equivalent of their cell surface one to five times per hour 
(Steinman et al., 1983). The endocytic machinery plays an important role in delivering 
membrane components which include membrane proteins, lipids, solute molecules and 
receptor associated ligands to various intracellular destinations. Following 
internalisation from the cell membrane the proteins are generally delivered to early 
endosomal compartments. Depending upon the nature of the regulatory signals, the 
cargoes undergo sorting which allows some membrane proteins to recycle back to the 
plasma membrane, while others traffic to lysosomes for degradation or are returned to 
the trans-Golgi network (TGN) (Kennedy and Ehlers, 2006, Drake et al., 2006, 
Bonifacino and Traub, 2003, Grant and Donaldson, 2009). Different membrane 
proteins can take different routes and differ in the recycling kinetics. Generally, it is the 
dynamic balance between the recruitment (biosynthetic secretion and endocytic 
recycling) and removal (internalisation) mechanisms that governs the composition of 
the plasma membrane and thereby contributes to cellular processes that membrane 
proteins mediate. A tilt in this balance could have important (patho-) physiological 
consequences (Maxfield and McGraw, 2004, Grant and Donaldson, 2009).  
 
The mechanism by which membrane proteins undergo internalisation is a major 
determinant of their post- endocytic destination. Endocytic mechanisms can be broadly 
classified as those that are clathrin-dependent (CDE) and those that are clathrin 
independent (CI) (Doherty and McMahon, 2009, Mayor and Pagano, 2007). Cargoes of 
CDE (see introduction), such as receptors for transferrin (TfR), are packaged into 
clathrin-coated vesicles that pinch off from the cell membrane with the help of 
dynamins and transported into the cell (Doherty and McMahon, 2009, Mayor and 
Pagano, 2007). Endocytic recycling of CDE cargo has been extensively studied. 
Cargoes of CI internalisation such as the Major Histocompatibility Complex Class I 
(MHCI) (Donaldson and Williams, 2009) depend on membrane lipid-rafts (see 
introduction). Since these pathways of internalisation are not well studied, a lot remains 
to be understood about endocytic recycling of CI endocytic cargo (Grant and 
Donaldson, 2009). 
 
Endosomal trafficking is mediated by Rab GTPases. The functionality of this family of 
proteins underlies their ability to act as molecular switches that cycle between GTP- 
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and GDP-bound states. Several Rab proteins are known to play specific roles in 
endosomal trafficking (see Chapter1). Rab4, Rab11 proteins have been implicated in 
the regulation of endosomal recycling. Rab4 is localised to the early endosomes (EE) 
and sorting endosomes (SE) and is considered to be involved in direct recycling of 
internalised proteins back to the plasma membrane. Rab11 is localised to the late 
endosomes (LE) and the recycling endosomes (RE) and plays a role in recycling of 
internalised proteins back to the plasma membrane. The family of Rab11 GTPases 
include Rab11a, Rab11b and Rab25 (Grant and Donaldson, 2009). Both Rab11a and 
Rab11b are ubiquitously expressed and Rab11b is enriched in the brain, heart and 
testis (Lai et al., 1994); while Rab25 expression is limited to certain tissue types 
(Lapierre et al., 2003). Recent studies have shown that in polarised epithelial cells 
where Rab11a and Rab11b are thought to regulate the apical transport of different 
endocytic cargo, Rab11b may have specific functions as it only partially co-localises 
with Rab11a in polarised, filter-grown, Madin-Darby canine kidney (MDCK) cells 
(Lapierre et al., 2003). Rab11a has been shown to regulate the apical recycling of 
several membrane proteins including the immunoglobulin receptor, human transferrin 
receptor, and bile salt export pump (ABCB11) and CFTR (Silvis et al., 2009). 
Trafficking by Rab11b is less understood but it has been implicated in the recycling of 
human transferrin receptor (Schlierf et al., 2000), and exocytosis of the human growth 
hormone (Khvotchev et al., 2003).  
 
Cargos of CI internalisation such as MHCI and interleukin-2 receptor α-subunit (Tac) 
have been shown to enter early endosomal compartments which are distinct from the 
ones that carry cargoes of CME immediately after internalisation. However, on a later 
time point in the endocytic itinerary, proteins of CME and CI internalisation have been 
found to converge and enter late endosomes from where can be diverted to lysosomes 
for degradation in a Rab7-dependent manner or be recycled back to the cell surface 
(Grant and Donaldson, 2009, Naslavsky et al., 2003). 
 
In this chapter, the role of post endocytic trafficking in regulating surface density of the 
cardiac hERG channel was investigated. Any change in the steady-state levels of this 
channel at the cell surface would have a significant impact on the net K+ conductance 
and, therefore, on repolarisation of the cardiac action potential and the cardiac rhythm 
(Anderson et al., 2006). Hence, it is important to understand if hERG undergoes 
endocytic recycling and how this process affects the surface channel density. Such a 
study would have a major impact in understanding the patho-physiology hERG related 
cardiac arrhythmias. Results presented in Chapter 4 showed that forward trafficking of 
hERG is mediated by COPII vesicles in a Sar1 dependent pathway. Synthesis of hERG 
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has been shown to be stringently regulated with the help of chaperones and proteins of 
the COPII machinery (Ficker et al., 2003). It has been reported that Rab11b is required 
for the expression of mature hERG (Delisle et al., 2009). This was the first report of the 
Rab11 protein being implicated in forward trafficking rather than endocytic recycling. 
Studies presented in Chapter 5 showed that hERG was rapidly internalised from the 
cell membrane mostly in a lipid raft and ARF6 regulated manner. Also, it has been 
shown that the hERG channels can bind ubiquitin and get degraded subsequent to the 
ubiquitinylation (Chapman et al., 2005). However, there were no reports on endosomal 
recycling of the channel. 
 
In this chapter, the endocytic recycling of the hERG channel was investigated with an 
attempt to understand the time course of turnover of the endocytosed channels. The 
study revealed that internalised hERG channels recycle back to the cell surface but are 
eventually rapidly degraded. Co-expression of a dominant negative isoform of Rab11a 
showed that there was a significant increase in the channel degradation. Degradation 
of the channels could be prevented if internalisation of the channel was blocked using 
aluminium fluoride (AlF), a compound that disrupts ARF6 function (described in chapter 
5). Thus, inhibition of hERG recycling results in a substantial reduction in the cell 
surface density of hERG and block of internalisation can protect the channels from 
degradation. These data suggested that endosomal recycling of the channel may be a 
major mechanism for regulation of surface hERG density. 
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6.2 Materials and Methods  
6.2.1 Cell lines 
As described in Chapter 2, section 2.2.1. For experiments involving drug treatments, 
poly-L-lysine coated cover-slips were used for growing cells (as described in Chapter 2, 
section 2.5.1). The cells were transiently transfected with the required DNA constructs 
using the Fugene®6 transfection reagent (as described in Chapter 2, section 2.4.2).  
6.2.2 Plasmid constructs 
HA-tagged hERG in pcDNA3 was transfected into HEK-MSRII cells for transient 
expression of the HA-hERG channels as described in Chapter 4. Other cDNA 
clones were generous gifts from various researchers (indicated in parenthesis): GFP-
tagged EEA1 (Dr H Stenmark, Norwegian Radium Hospital, Oslo), GFP-Rab5 (S34N), 
(Dr Vas Poonambalam, University of Leeds, UK), GFP-Rme1(G429R) (Dr B Grant, 
Rutgers University, NY), GFP-Lamp1 (Dr P Boquet, Institut National de laSante et de la 
Recherché Medicale, Nice), GFP-Rab11b(WT), GFP-Rab11b (N124I) and GFP-
Rab11b(S25N), (Dr. Beate Schlierf, Institut für Biochemie, Universität Erlangen-
Nürnberg, Erlangen, Germany).  
6.2.3 Antibodies 
Rat anti-HA antibodies (Roche) were as described in Chapter 5. Anti-CD63 
antibodies were purchased from Abcam and used at 1:250 dilution. Anti-rat, Cy3- 
and Cy5-conjugated secondary antibodies (Jackson ImmunoResearch) are described 
in Chapter 5.  
6.2.4 Drug treatments 
Stock solutions of pharmacological compounds and treatment of cells was done as in 
Chapter 5. Leupeptin (Sigma) was used at a concentration of 10 µM and monensin 
(Sigma) at 200 µM and cell-permeable C6-ceramide at 10 µM. Aluminium fluoride was 
prepared as described in Chapter 5.  
6.2.5 Immunofluorescence staining 
Immunostaining of HA-hERG channels was performed as described in Chapter 2.  
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6.3 Results 
6.3.1 Recycling of internalised hERG channels to the cell surface 
The internalisation assay used in Chapter 5 showed that the hERG channels undergo 
internalisation. Therefore in this chapter, the question asked was if these internalised 
channels undergo recycling back to the cell surface. In order to address this question, a 
recycling assay, previously described for KATP channels (Manna et al., 2010), was 
adopted. In this assay cells expressing HA-hERG channels were incubated at 37°C for 
60 min in presence of the anti-HA antibodies directed against the extracellular HA-
epitope cloned into the channel. When the channels were internalised, the antibodies 
bound to the channel were internalised along with it. This step of the assay allowed 
labelling of the channels expressed on the cell surface as well as the channels 
undergoing internalisation. The cells were then moved to 4°C to stop all endosomal 
trafficking of the channels and the channels present on the cell surface labelled with 
the primary antibody were labelled with a no-tag secondary antibody. The cells were 
then incubated in the presence of Cy3-conjugated secondary antibodies at 37°C or 4°C 
for 15 min which allowed labelling of the primary antibody bound internalised channels 
that recycled back to the cell surface. Immunofluorescence imaging indicated that prior 
to labelling with no-tag antibody; there are a number of HA-hERG channels present on 
the cell surface which cannot be detected in the cells labelled with no-tag secondary 
antibody at 4°C (Figure 6.1, first panel). This indicates that the no-tag antibody is able 
to bind all the channels present at the cell surface after the internalisation assay and 
that no channels recycle at 4°C (Figure 6.1, second panel). However, in cells incubated 
at 37°C, the internalised HA-hERG channels recycle back to the cell surface and bind 
the Cy3-tagged secondary antibody and are stained red (Figure 6.1, third panel). 
These data indicated that after internalisation the HA-hERG channels are able to 
recycle back to the cell surface and re-internalised. This protocol allows specific 
labelling of the recycling pool of channels and has been designated as the recycling 
assay. 
  
 Figure 6.1 HA-hERG channels are recycled
expressing HA-hERG were 
chilled to 4°C. While one set of cells was stained on cell surface, other sets were 
incubated with no tag
immunofluorescence imaging. Cells were then incubated at 4°C (control where no 
recycling would occur) or 
15 min to allow the channels recycled back the cell surface to be 
cells were then washed, fixed and mounted for imaging. Nuclei were stained (blue) with 
DAPI. Representative co
Scale bars: 10 µm. A schematic representation of the images is included below the 
image panels to illustrate how the channels are being stained (see methods for more 
details). 
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6.3.2 hERG channels recycle rapidly and undergo degradation 
Having established that hERG is capable of recycling back to the cell surface after 
internalisation, it was important to find out how fast the recycling process could occur. 
Towards this, the recycling assay was modified to examine the rate of recycling. As in 
the standard recycling assay, channels labelled on the cell surface with primary 
antibodies (anti-HA) were allowed to undergo internalisation. The channels remaining 
on the cell surface were allowed to bind no-tag antibodies at 4°C, following which the 
internalised channels were allowed to recycle back to the cell surface at 37°C in 
presence of Cy3-conjugated secondary antibodies for different time durations. 
Recycling of the channels was stopped by moving the cells to 4°C. The cells were 
washed and fixed with 2% PFA. This protocol allowed the recycled channels for 
different time points to be stained (red). The non-recycled channels that remained 
within the cells were stained with Alexa488-conjugated secondary antibody (green) 
following permeabilisation of the cells (see schematic Figure 6.2.A). Data presented in 
Figure 6.2.B shows that at time 0, there are no red stained channels since none were 
recycled. The internalised channels rapidly recycle back to cell surface within 5 minutes 
of incubation and by 30 minutes, most of the internalised HA-hERG channels have 
recycled as indicated by the absence of green stained channels in the panel for non-
recycled channels. The channels also appear to re-internalise and interestingly by 120 
minutes, the recycled channels appeared to have reduced in number which could be 
because of channel degradation. The following conclusions could be made from these 
experiments:  
(i) Internalised HA-hERG channels are rapidly recycled back to the cell 
surface. 
(ii) Recycled hERG channels disappear within 2-3 hours, raising the possibility 
of rapid degradation.  
After internalisation, membrane proteins are commonly known to have two fates; they 
recycle back to the cell surface or are diverted to the lysosomes for degradation (Grant 
and Donaldson, 2009, Maxfield and McGraw, 2004). Recycling of the hERG channels 
appeared to be rapid (Figure 6.2B) and could therefore represent a very fast mode of 
altering surface channel density. Towards this theory, it would be interesting to look at 
how the process of recycling of hERG might be regulated. The data (Figure 6.2B) also 
suggested that the channels are rapidly degraded. This raised the question if there was 
a link between channel recycling and degradation.  
 
 Figure 6.2 Time-course study of recycling of hERG channels
showing the recycling assay designed to exclusively label the recycled and non
recycled pool of internalised channels (see 
study, a set of HeLa cells expressing HA
time points (0-150 min) in presence of Cy3
follow the recycling of the channel over a per
permeabilised and then stained with Alexa
the non-recycled channels green. Nuclei were stained blue with DAPI and the cells 
were mounted for imaging. (B) Representative image
assay are shown. The top panel shows the non
shows the recycled channels over the different time points and the bottom panel shows 
the merged images for the top and bottom panes along with 
10 µm.  
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6.3.3 Internalised hERG channels undergo degradation 
The experiments for time course of recycling of hERG channels showed that the 
recycled channel pool decreased over a period of time (Figure 6.2.B). These data 
suggested that the internalised hERG channels might be undergoing both recycling 
and degradation. To confirm this hypothesis, HA-hERG channels expressed on the cell 
surface at a given point of time were followed over a period of 90 minutes. Another set 
of cells were treated with aluminium fluoride (AlF), a drug that disrupts ARF6 function 
leading to inhibition of internalisation of the hERG channels (shown in Chapter 5). The 
idea was that if internalised channels were being degraded, then block of 
internalisation would protect them from degradation. Images of the cells with the 
internalised channels stained red showed that at time 0 all the channels were on the 
cell surface. They rapidly internalised within first 5 minutes of incubation and by 60 to 
90 minutes, most of them disappeared (Figure 6.3, top panel). In the set of cells treated 
with AlF, the channels remained on the cell surface and did not disappear even after 90 
minutes of incubation (Figure 6.3, bottom panel). These data suggested that following 
internalisation hERG channels undergo rapid degradation.  
 
It has been reported that following treatment with ceramide, there is a decrease in 
surface density of the hERG channels. The authors suggested that this decrease was 
due to an increase in channel degradation. This hypothesis of channel degradation was 
supported by the authors by comparing the degree of co-localisation of the hERG 
channels with lysosomal marker protein, Lamp1, in cells treated with and without 
ceramide (Chapman et al., 2005). The authors used immunostaining of total hERG 
channels in their study. In order to see if these observations were reproducible with 
regards to channels internalised from the cell surface, HeLa cells expressing HA-hERG 
channels were treated without and with C6-ceramide (10 µM, 60 minutes) prior to and 
during the internalisation assay. No apparent increase in co-localisation of the stained 
channels with the GFP-tagged Lamp1 protein co-expressed in these cells could be 
seen on treatment with ceramide (Figure 6.4.A). Similar results were obtained when the 
experiment was repeated with staining for another marker for lysosomes, the CD63 
protein (Figure 6.4.B).  
  
 Figure 6.3 Internalised HA
rationale behind the design of the experiment to examine degradation of internalised 
channels. (B) Schematic of the internalisation assay. Cells expressing HA
incubated with anti-HA antibodies at 4°C to label the channels present on the cell 
surface which were then allowed to internalise for different time points at 37°C. The 
cells were then fixed, pe
to detect the channels internalised from the cell surface. (C) A set of cells each was 
treated with no drug (control) or AlF (see methods) for 30 min before and during the 
internalisation assay described in (B). Representative confocal images from 
independent experiments are shown for the indicated drug treatments and times; 
bars: 10 µm.  
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 Figure 6.4 Effect of ceramide on hERG degradation
channels were treated with or without ceramide (10 µM) for 60 minutes before and 
during incubation with anti
along with the channel from 
permeabilisation of the cells. As markers for lysosomes, protein Lamp1
was co-expressed in the cells
CD63 antibodies (B),
Representative confocal images from three independent experiments are shown; 
bars: 10 µm.  
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Taken together, these data suggest that internalised hERG channels enter lysosomal 
compartments resulting in rapid degradation; however, treatment with ceramide did not 
indicate any significant increase in lysosomal co-localisation of the channels in contrast 
to the reports by Chapman et al., 2005).  
 
6.3.4 Internalised hERG channels enter recycling endosomes  
In order to understand how the surface density of hERG might be regulated by 
endosomal trafficking, it was important to understand how the internalised channels are 
recycled back to the cell surface. Towards this aim, localisation of the channels after 
internalisation was determined by examining the co-localisation of the channel with 
different endosomal markers. Some hERG channels were seen to co-localise with 
endosomal marker EEA1 but co-localisation of the channels with GFP-Rab5 (DN) 
which is also localised to EE was not apparent. These data (Figure 6.5, top two panels) 
were therefore not conclusive in determining if the internalised hERG channels entered 
EE. Further, hERG channels co-localised with the GFP-Rme1 (DN) and dominant 
negative isoform GFP-Rab11a (S25N) which are localised to the perinuclear endocytic 
recycling endosomal compartments (ERC). These data (Figure 6.5, bottom two panels) 
suggested that internalised hERG channels enter the recycling endosomes.  
  
 Figure 6.5 Co-localisation of internalised HA
endosomal markers
GFP-tagged, DN isoforms (green) of early and recycling endosomal markers were 
stained (red) for HA-hERG following internalisation
indicated with arrows 
Representative confocal images of three independent experiments have been shown; 
Scale bars: 10 µm. 
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6.3.5 Role of Rab11a and Rab11b in maintaining surface density of 
hERG channels 
Both Rab11a and Rab11b have been implicated in recycling of membrane proteins 
from recycling endosomes to the cell surface (Gardner et al., 2010, Grant and 
Donaldson, 2009, Lapierre et al., 2003). Rab11b has also been implicated in forward 
trafficking of the hERG channel (Delisle et al., 2009). Internalised HA-hERG channels 
were found to co-localise with the weak dominant negative isoform, GFP-Rab11a 
(S25N), (see Figure 6.5). These data suggested that the channels enter recycling 
endosomes and can undergo recycling in presence of (weak DN) GFP-Rab11a (S25N). 
However, when the strong DN isoform, GFP-Rab11a (N124I) was co-expressed with 
HA-hERG channels, there was a substantial decrease in the number of channels 
expressed on cell surface as compared to the cells expressing no Rab or the GFP-
Rab11a (WT), (Figure 6.6, Top and middle panel). Moreover, co-expression with GFP-
Rab11b (S25N) also showed a near complete block of surface expression of the 
channels as opposed to the cells expressing HA-hERG alone or with GFP-Rab11b 
(WT) (Figure 6.6, Top and bottom panel). Also, it appeared from the confocal image 
that, more the expression of the GFP-Rab11a (N124I) protein in the cells, lesser was 
the expression of HA-hERG on cell surface. Taken together these data (Figure 6.6) 
indicated that both DN-Rab11a (N124I) and DN-Rab11b (S25N) reduce surface density 
of the hERG channels.  
 
Since the experiments were carried out using transient expression of the channels and 
the relevant Rab11 constructs, lack of channels on cell surface could also be due to 
failure of the channels to express in the cells. To eliminate this possibility, a parallel set 
of cells expressing HA-hERG and GFP-Rab11a (N124I) or GFP-Rab11b (S25N) were 
fixed, permeabilised and stained for total hERG channels (see methods). HA-hERG 
channels were stained in both sets of cells (Figure 6.7) which eliminated the possibility 
of lack of HA-hERG transfection. Further, in cells co-expressing GFP-Rab11a (N124I), 
the channels appeared to be present in punctate vesicular structures within the cells 
which showed some co-localisation with GFP-Rab11a (N124I), (Figure 6.7.A, top-
panel). Since Rab11a is known to be localised to recycling endosomal compartments 
(van de Graaf et al., 2006) the data suggested that in cells where Rab11a function was 
disrupted, some hERG channels were localised to ERC. Immunofluorescence staining 
for total HA-hERG showed diffuse distribution and extensive co-localisation (Figure 
6.7.A, bottom panel) of the channels with GFP-Rab11b (S25N). It has been previously 
reported that majority of Rab11b is localised to distinct spatial structures that are 
thought to be reminiscent of the TGN and a small amount of the protein is scattered 
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throughout the cell (Schlierf et al., 2000). Therefore, co-localisation of the hERG with 
Rab11b (as seen in Figure 6.7.A bottom panel) suggested that the channels are 
retained in the TGN in agreement with the report (Delisle et al., 2009). The authors 
found that mature hERG channels were not formed when co-expressed with DN-
Rab11b but not with DN-Rab11a. They also showed that hERG currents were absent 
in cells co-expressing DN-Rab11b, but not with DN-Rab11a The authors suggest 
involvement of Rab11b in forward trafficking of the hERG channels and show extensive 
co-localisation of hERG with Rab11b by imaging. Effect of DN and WT Rab11a 
constructs on HA-hERG channel function was studied by Andrew Smith, a member of 
the lab. He used patch clamp recordings to get a measure of current density of the 
peak tail currents from cells co-expressing HA-hERG channels and DN-Rab proteins 
(Figure 6.7.B). The results showed that both the strong dominant negative Rab11a 
(N124I) and the weak dominant negative Rab11a (S25N) significantly decreased hERG 
currents in patch clamp studies as compared to the WT-Rab11a, (see discussion). 
These data are consistent with the lack of surface expression of HA-hERG seen in the 
imaging experiments (Figure 6.6).  
 
Taken together, the data from Figure 6.6 and 6.7, it could be argued that both Rab11a 
and Rab11b are critical for normal surface expression of HA-hERG channels.  
 
  
 Figure 6.6 Effect of Rab11a and Rab11b on surface expression of HA
HEK-MSRII cells were transfected to co
indicated GFP-tagged Rab11 constructs. As control, cells expressing HA
channels alone were 
channels on cell surface was determined by staining with an
Cy3- conjugated secondary antibody. Nuclei were stained blue using DAPI. 
Representative confocal images from two 
bars: 10 µm.  
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 Figure 6.7 Effect of disruption of Rab11a and Rab11b function on HA
function and expression
the indicated GFP-tagged Rab11 proteins (green)
total channel protein was stained (red) to look for distribution of the proteins and their 
co-localisation (yellow). Representative confocal images are shown. Nuclei (N) stained 
blue with DAPI; Scale bars
hERG channel currents. Representative current families from patch clamp recordings 
of cells co-transfected with HA
density/ voltage relationships recorded from 
GFP vector (■), Rab11a WT
GFP (▲). Data points are mean ± s.e.m. (n = 4). (F) Histogram of current density 
measured from tail currents (at 
Smith). 
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6.3.6 DN-Rab11a diverts HA-hERG channels to lysosomal 
degradation 
Since the Rab11b but not Rab11a appeared to be involved in forward trafficking of HA-
hERG channels (Figure 6.7A, top panel) and (Delisle et al., 2009, Gardner et al., 2010), 
(see discussion), it was interesting to see if the loss of surface expression of the 
channels in cells expressing DN-Rab11a (N124I) was due increased recycling of the 
hERG channels to lysosomes for degradation. To achieve this, cells co-expressing HA-
hERG and DN-Rab11b (S25N) and DN-Rab11a (N124I) were treated with or without 
leupeptin to block lysosomal degradation. Following internalisation, the HA-hERG 
channels expressed on cell surface and internalised there from were stained.  
 
Leupeptin is a protease inhibitor drug used to inhibit lysosomal degradation (Wildenthal 
et al., 1980, Manna et al., 2010). The rationale behind this experiment was that if 
disruption of Rab11 function by co-expression of dominant negative isoforms of 
Rab11a and Rab11b was causing lysosomal degradation of HA-hERG, then leupeptin 
treatment would prevent the channels from being degraded. In cells expressing the 
Rab11a (N124I), there was a striking increase in the number of channels stained in 
cells treated with leupeptin while the drug did not appear to affect the appearance of 
internalised channels in the cells expressing Rab11b (S25N), see Figure 6.8.A. These 
data suggested that Rab11a but not Rab11b was required to prevent HA-hERG from 
being diverted to the lysosomes for degradation following internalisation.  
 
Moreover the loss of channels internalised from the cell surface in the time course 
experiment (Figure 6.3.C) could be prevented in cells expressing HA-hERG by 
treatment with leupeptin (Figure 6.8.B). Taken together, these data showed that HA-
hERG channels is destined to lysosomal degradation after some cycles of endosomal 
recycling after internalisation from cell surface. Block of Rab11a function appears to 
accelerate the degradation of the channels resulting in a substantial decrease in 
surface channel density (Figure 6.6), presumably by increasing the flux of internalised 
hERG channels towards the degradative pathway.  
 
Since Rab11a has been implicated in endosomal recycling of proteins (Grant and 
Donaldson, 2009), it is possible that disruption of Rab11a activity was preventing 
channel recycling leading to reduced surface density and the non-recycled channels 
were being diverted to lysosomes for degradation. To check if this hypothesis was 
correct, firstly, the effect of leupeptin was tested on cells expressing HA-hERG 
channels alone. Confocal images showed that following recycling (used in Figure 6.2), 
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there was an increase in the amount of non-recycled channels when lysosomal 
degradation was blocked (Figure 6.9). Similarly, in cells co-expressing HA-hERG 
channels and the DN-Rab11a (N124I), there was a significant increase in the non-
recycled channel pool when lysosomal degradation was inhibited by leupeptin 
treatment (Figure 6.10).  
 
Taken together these data indicated that Rab11a activity decides the fate of hERG 
channels as to whether they recycle back to the cell surface or undergo degradation 
and this mechanism presents itself to be critical for altering the cell surface density of 
hERG channels. 
  
 Figure 6.8 DN-Rab11a causes the channels to undergo 
(A) HeLa cells co-expressing HA
constructs (green) were treated with or without leupeptin (100
to and during internalisation step (see methods). The channels expressed on cell 
surface and internalised for 60 min, at 37°C were stained (red). Nuclei stained blue with 
DAPI. (B) A set of cells w
on cell surface were 
a set of cells each was incubated at 37°C for the indicated time points as in Figure 
6.3.C. Cells were fixed, pe
antibody to label HA
from Figure 6.3.C. Representative confocal images of three independent experiments 
are shown; Scale bars
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6.4 Discussion 
 
Human ether-a-go-go-related gene (hERG) potassium channels play an important role 
in cardiac action potential repolarisation, and disruption of hERG channel function can 
cause cardiac arrhythmias (Anderson et al., 2006). Moreover, recent evidence 
suggests a role for the hERG channels in the proliferation and progression of multiple 
types of cancers, Interestingly the hERG channels have been found to express in 
cancer tissue which did not express the channel in non-cancerous states (Cherubini et 
al., 2000) making it an attractive target for cancer therapy (Ganapathi et al., 2010). 
Hence, understanding how hERG channel trafficking regulates or alters their surface 
density is as important as studying how the channel properties might be regulated. 
Towards this, the mechanisms of hERG trafficking (forward trafficking and endosomal 
recycling) need to be studied.  
 
Having investigated the mechanism of hERG internalisation in Chapter 5, this study 
aimed at investigating the post endocytic itinerary of the HA-hERG channel. Most 
proteins that undergo internalisation either recycle back to the cell surface or are 
diverted to lysosomes for degradation (Grant and Donaldson, 2009). Using the 
recycling assay described in figure 6.1, it was demonstrated that internalised HA-hERG 
channels are able to rapidly recycle back to the cell surface (Figure 6.2).  
 
Time course experiment to look at the turnover of the internalised pool of channels into 
the recycled channel pool (Figure 6.2) showed that non-recycled channel pool rapidly 
disappeared in about 30-60 min indicating that most of the internalised channels might 
be recycled back to the cell surface.  
 
The recycled channel pool increased over the first few minutes but by 120-150 min the 
recycled channels became sparse indicating that the channels might be undergoing 
degradation (Figure 6.2). The fate of the internalised HA-hERG channels to get 
degraded could be reversed if channel internalisation was blocked using AlF treatment 
(Chapter 5), (Figure 6.3.B). Since in this experiment, a pool of channels were labelled 
on cell surface and then allowed to internalise, the channels coming from the synthetic 
pathway were not stained (Figure 6.3.A). Thus the assay (Figure 6.3) was able to show 
exclusively the fate of channels expressed on the cell surface at a given point of time 
and then internalised there from.  
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Such rapid degradation of an internalised channel pool is uncommon (Maxfield and 
McGraw, 2004). For example, internalised pancreatic HA-KATP channels do not 
degrade for 4 hours or more (Manna et al., 2010) in HEK cells. Since both HA-KATP and 
HA-hERG were over-expressed in HEK-MSRII cells, it does not seem likely that the 
rapid degradation of HA-hERG is merely a result of over expression. These results 
raised two interesting questions:  
• What is the mechanism behind recycling of HA-hERG channels? 
• What is the mechanism behind degradation of internalised HA-hERG? 
 
A group (Chapman et al., 2005) investigating regulation of surface density of hERG 
reported that ceramide evokes a time-dependent decrease in hERG current which they 
claimed was not due to a change in gating properties of the channel. The rapid decline 
in hERG protein after ceramide stimulation was attributed by the authors to protein 
ubiquitinylation and its association with lysosomes leading to lysosomal degradation. 
The authors stained the entire pool of channels expressed within the cell and showed 
increase in co-localisation of the channels with lysosomal marker protein LAMP1. 
However, when co-localisation of internalised HA-hERG with lysosomal markers 
(LAMP1 or CD63) was examined, (Figure 6.4), there appeared to be no drastic 
increase in co-localisation of the channels with the lysosomal markers following 
treatment of cells with ceramide. This could be because the distribution of the total 
channel pool as seen by Chapman et al. (2005) could be different than and mask the 
distribution of the internalised surface channels. 
 
Ceramide is a sphingolipid, which due to its pro-apoptotic properties has shown 
promising results in animal models as an anticancer agent. Ceramide can be formed in 
the cell membrane from sphingomyelin as a result of various cellular stresses, including 
reactive oxygen species (ROS), radiation, ischemia reperfusion injury, or treatment with 
chemotherapeutic or pro-arrhythmic agents (Hannun, 1996). It has also been implicated 
in the formation/ stabilisation of lipid-rafts affecting the membrane localization of ion 
channels and their function (Holopainen et al., 1998). A recent finding (Ganapathi et al., 
2010) states that ceramide is responsible for recruiting hERG channels to caveolin-
enriched lipid-rafts which affects the voltage-dependent gating parameters of the 
channel inducing inhibition of hERG currents. The authors also use surface 
biotinylation experiments to label channels on cell surface to show that incubation with 
C6-ceramide (10 µM) does not alter the surface channel density over a period of 5 min 
to 24 hours which is in contradiction to the report that ceramide treatment causes 
increased degradation of the hERG channels leading to reduced surface expression of 
the channels (Chapman et al., 2005). The data (Figure 6.4) showed that in untreated 
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cells the hERG channels enter Lamp1 and CD63 positive lysosomal compartments and 
the co-localisation of the HA-hERG channels with lysosomes did not increase after 
treatment with ceramide which indicates that although internalised channels are 
diverted to lysosomes, treatment with ceramide has little effect on lysosomal targeting 
of hERG channels.  
 
Moreover, following internalisation, HA-hERG showed complete co-localisation with 
GFP-GPI-AP (Chapter 5, Figure 5.9A). The GFP-GPI-AP is known to internalise to 
GPI-AP-enriched early endosomal compartments (GEECs) in a dynamin and clathrin 
independent, CDC42- or ARF6-mediated pathways (Mayor and Pagano, 2007, Chadda 
et al., 2007). These data indicated that HA-hERG might be internalised mostly to 
GEECs. The channels showed some co-localisation with EE marker EEA1 but co-
localisation of the channels with GFP-Rab5 (DN) could not be seen (Figure 6.5). Rab5 
is known to regulate the fusion between endocytic vesicles that are generally derived 
from CME and EE as well as the homotypic fusion between early endosomes 
(Olkkonen and Stenmark, 1997, Grant and Donaldson, 2009). Taking into account the 
data from Figure 6.5 it could not be determined if the hERG channels can enter the EE 
after internalisation. Considering that most hERG channels are internalised by CI 
mechanisms, it is possible that hERG channels do not enter EE.  
 
The channels co-localise with recycling endosomal marker proteins Rab11a and Rme1 
(Figure 6.5). The channels also enter lysosomes as seen by co-localisation with 
lysosomal markers Lamp1 and CD63 (Figure 6.4). These data suggested that after 
internalisation HA-hERG channels enter the endosomal recycling compartments (ERC) 
and lysosomes. The Rab11 GTPase is known to be involved in recycling of proteins 
such as the transferrin receptor and GLUT4 receptor from the recycling endosomal 
compartments (Grant and Donaldson, 2009, Maxfield and McGraw, 2004). Disruption 
of activity of both the Rab11 isoforms by the DN isoform over-expression approach led 
to a drastic decrease in surface channel density and thereby the net channel activity 
(Figure 6.6). In the patch clamp studies, in cells co-expressing Rab11a (N124I) there 
was nearly complete absence of hERG currents (Figure 6.7.B). In the imaging, Figure 
6.6, in cells showing less fluorescence of GFP-Rab11a (N124I), some HA-hERG 
staining was seen on cell surface compared to none in cells expressing more of the 
GFP-Rab11a (N124I). Since, in patch clamp studies, highly fluorescent cells would be 
selected for the experiment, these cells express very few to no HA-hERG channels on 
cell surface as is reflected by the complete absence of hERG (Figure 6.7.B).  
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When Rab11b function was disrupted, very few internalised channels could be seen by 
immunofluorescence imaging with or without block of lysosomal degradation indicating 
that the loss of staining was not due to degradation of the internalised channels, but 
due to lack of internalised channels to begin with. These results were in agreement 
with the report that Rab11b is required for forward trafficking of the channel (Delisle et 
al., 2009). However, in cells transfected with DN-Rab11a treatment with leupeptin 
prevented degradation of internalised channels (Figure 6.8A). The channels appeared 
to undergo lysosomal degradation within a few minutes after internalisation (Figure 
6.8B) and disruption of activity of Rab11a accelerated channel degradation thereby 
reducing surface channel density.  
 
The differential roles of the two Rab11 isoforms in regulating endosomal recycling have 
been reported before; for example Rab11b, but not Rab11a, is involved in apical 
recycling of the cystic fibrosis transmembrane conductance regulator in polarized 
intestinal epithelial cells (Silvis et al., 2009, Lapierre et al., 2003). However, the 
regulation of surface density of HA-hERG by two isoforms of the same GTPase by two 
very different processes is a novel and interesting finding.  
 
Also ARF6 has been shown to be involved in recycling of CI endocytic cargo such as 
MHCI (Donaldson and Williams, 2009). Although HA-hERG has been found to 
internalise by the ARF6 dependent pathway like MHCI, the channels did not show 
extensive co-localisation with MHCI after internalisation (Chapter 5, Figure 5.9.A); 
therefore ARF6 may not have a role in endosomal recycling of HA-hERG. 
 
Since Rab11a has been implicated in endosomal recycling, it could be said that when 
HA-hERG reaches recycling endosomes after internalisation, Rab11a mediates 
recycling of the channels back to the cell surface and disruption of Rab11a function 
prevents channel recycling and diverts the channels to lysosomes where they get 
degraded. Thus the activity status of Rab11a in a cell could be a determinant of cell 
surface density of hERG channels. This hypothesis was supported by the reduced 
disappearance of non-recycled channels when the cells were treated with leupeptin to 
block lysosomal degradation prior to and during recycling (see methods). The number 
of recycled channels has also increased as they were protected from degradation 
(Figure 6.9). Although this experiment cannot give an idea of the number of recycling 
events that the HA-hERG channels can undergo before being degraded, it does 
support that the channels present on the cell surface at a given point of time are all 
degraded by 60 min after internalisation (Figure 6.8.B). It also shows that most of the 
channels internalised from the cell surface are recycled back to cell surface within 30-
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60 min (Figure 6.8.B). Channels internalised from the cell surface also degrade (Figure 
6.9). Thus recycling/degradation of hERG channels appear to occur rapidly.  
 
Half-life of the hERG channels after synthesis and assembly has been reported to be 
~12 hrs (McDonald et al., 1997, Ficker et al., 2003, Chen et al., 2009). The post-
endocytic fate of the channels from the experiments described in this chapter suggest 
that the channels expressed on the cell surface undergo several rounds of 
internalisation and recycling before being diverted to slow degradation.  
 
The experiments investigating the alternate pathway of hERG internalisation (chapter 
5, Figure 5.20) show that there is minimal co-localisation of the channels with the 
clathrin cargo transferrin. However, when the ARF6 function was disrupted with DN-
ARF6 to block ARF6-mediated internalisation of the hERG channels, co-localisation 
with transferrin has significantly increased. Transferrin has been shown to undergo 
endosomal recycling in a Rab4 (van der Sluijs et al., 1992) and Rab11 (Schlierf et al., 
2000, Ren et al., 1998) dependent manner and if hERG also recycles in a Rab11a 
dependent manner (section 6.2.5 of this chapter), the cargoes should show significant 
co-localisation. This lack of significant co-localisation could be due to the nature of 
vesicles transporting the cargoes to the recycling endosomal compartments. Cargoes 
of CME are located on different regions of the membrane than the CI cargoes which 
are localised to cholesterol rich raft domains (Lingwood and Simons, 2010). Existence 
of such micro-domains in the recycling endosomal compartments or even the existence 
of different kinds of recycling endosomes (Sonnichsen et al., 2000), would explain the 
lack of co-localisation between transferrin and the HA-hERG channels. The increased 
co-localisation of HA-hERG with transferrin on co-expression of DN-ARF6 can be 
attributed to the proteins being packed together in the endocytic CCV. It would be 
interesting to investigate the mechanism of endosomal recycling of HA-hERG 
internalised via this CME pathway and to see if the mode of internalisation alters the 
fate of the channels to undergo lysosomal degradation.  
 
The conclusions from this study could be strengthened if a biochemical approach is 
used to follow the degradation of HA-hERG channels internalised from cell surface as 
described for the KATP channel (Manna et al., 2010). Also, it would be interesting to 
investigate if Rab7 which plays a role in the transport of proteins from late endosomes 
to lysosomes (Maxfield and McGraw, 2004) affects trafficking of HA-hERG.  
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6.5 Summary 
 
While forward trafficking pathways affect expression of the proteins on the cell surface, 
pathways of endosomal trafficking can rapidly alter the surface density of the proteins 
(Grant and Donaldson, 2009, Doherty and McMahon, 2009). Co-localisation studies in 
this chapter and results from co-localisation with marker proteins in chapter 5 indicate 
that immediately after ARF6 and lipid raft mediated internalisation, HA-hERG channels 
enter non-clathrin derived structures, likely GEECs, instead of the early endosomal 
compartments which are generally the destinations of cargoes of CME after which the 
channels may briefly enter early endosomes like the other CIE cargoes such as MHCI, 
GPI-AP and Tac (Weigert et al., 2004). From here, the channels can proceed to late 
endosomes/ lysosomes for degradation or are recycled back to the plasma membrane. 
Although both Rab11b and Rab11a are required for normal expression of the hERG 
channels on cell surface, Rab11b plays a role in forward trafficking of the channels 
(Delisle et al., 2009) while Rab11a is required for channel recycling. Block of Rab11a 
function diverts channels for degradation, which could be prevented by blocking 
internalisation. Disruption of Rab11a function results in decreased surface density of 
the channels. The effect of block of Rab11a function is reflected in the lack of functional 
hERG currents in HEK cells transiently expressing the channels. This is a novel report 
of differential regulation of an ion channel trafficking by the Rab11 isoforms. 
 
Both, internalisation and endosomal recycling are the mechanisms by which surface 
density of hERG can be regulated in health and disease. The mechanism of 
endosomal trafficking of hERG determined from this study is summarized in the 
following schematic (Figure 6.11). 
  
  
Figure 6.11 Schematic to summarise 
hERG channels are expressed on the cell surface in a Rab11b
internalised via ARF6
(EE) compartments. 
they are recycled back to the cell surface. Recycling is mediated by Rab11a. The 
channels also traffic to late endosomes (LE) for transport to lysosomes for degradation. 
Lysosomal degradation is i
function.  
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endosomal trafficking of hERG
-dependent manner and 
-mediated pathway to GPI-AP rich GEECs or early endosomal 
The channels then enter recycling endosomes (RE) from where 
ncreased when DN-Rab11a disrupts the normal Rab11a 
 
 channels. 
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CHAPTER 7 
General discussion
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7.1 Overview 
 
The aim of the current study was to understand the trafficking pathways of two 
physiologically important potassium channels, the pancreatic KATP and the cardiac 
hERG. Since channel function is controlled by the channel open probability and the 
number of channels expressed on the cell surface, it was attempted to a achieve better 
understanding of the three key trafficking processes (forward trafficking, internalisation 
and endosomal recycling) that are known to regulate surface density of membrane 
proteins. Forward trafficking of the proteins was studied with respect to the ER export 
mechanisms which represent a key step in the biosynthetic delivery of proteins to the 
plasma membrane.  
 
Firstly, the mechanistic link between the CHI causing mutation E282K in the Kir6.2 
subunit of the KATP channels was investigated (discussed in Chapter 3). The study 
established the existence of a previously unreported diacidic ER exit motif (280DLE282) 
on the Kir6.2 subunit which regulates the Sar1-GTPase dependent ER exit of the 
channels in COPII vesicles and that abrogation of the signal underlies the disease. The 
study revealed that the complete assembly of KATP subunits likely occurs after ER exit. 
Based on the mechanistic information derived from this study, the use of cell 
penetrating peptides to alter KATP channel surface expression was explored. A peptide 
corresponding to the ER exit motif of Kir6.2 was able to prevent the ER exit of the 
channel, presumably by blocking the recognition of the DLE motif by the Sec24 
component of the COPII machinery. 
 
Secondly, the ER exit mechanism of hERG channels was investigated (discussed in 
Chapter 4). The channels were found to follow Sar1 dependent ER exit of the channel 
in COPII vesicles like the KATP channels. However, a functional diacidic ER exit motif 
was found to be absent on the distal C-terminal of the channel. Interestingly though, 
peptides that disrupted the ER exit of the KATP channels were found to inhibit surface 
expression of the hERG channels, indicating a role for Sec24 in the ER exit of the 
hERG channels. 
 
Next, the mechanisms of internalisation of the hERG channels were investigated 
(discussed in Chapter 5). The study revealed that both recombinant hERG and native 
ERG channels (expressed in neonatal rat cardiac myocytes) are localised to lipid-rafts 
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and are internalised from the cell surface. Most of the channels were found to undergo 
internalisation in a cholesterol- and ARF6-dependent manner. This pathway of 
internalisation appears to be unique to the hERG channels when compared to 
pathways known to be undertaken by other members of the family of potassium 
channels. Intriguingly prolonged block of channel internalisation with an ARF6 
dominant negative construct revealed that the channels can also undergo 
internalisation by an alternate pathway which is dynamin-dependent.  
 
Internalised hERG channels were found to rapidly recycle back to the cell surface and 
undergo lysosomal degradation. Degradation of the channels was enhanced when 
Rab11a activity was disrupted using dominant negative isoforms (discussed in Chapter 
6) indicating that when Rab11a is unavailable for channel recycling, they are diverted 
for degradation. The endocytic trafficking mechanisms for hERG suggested that 
endocytic processes could be critical for maintaining the surface density of the 
channels. 
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7.2 Sar1-dependent ER Exit of Pancreatic KATP 
Channels Revealed by a Mutation Causing CHI 
 
Trafficking of ion channels is often a well regulated process involving specific 
interactions between the cargo and carrier proteins through trafficking motifs and 
regulatory molecules. Mutations that disrupt these interactions have been shown to 
affect channel function and cause disease. Studies of disease causing genetic 
mutations can be very rewarding as they can provide novel insights into the molecular 
mechanisms underlying disease. In Chapter 3, the G844A heterozygous paternal 
mutation in the KCNJ11 gene of a Swedish patient with the focal form of CHI was 
studied. This mutation leads to the substitution of lysine (K) for glutamate (E) at 
position 282 of Kir6.2. The key findings of this study are: 
 
(i) The E282K mutant channels do not express on the cell surface as 
they are retained in the ER. 
(ii) The ER exit of KATP channels requires a functional diacidic ER exit 
motif (280DLE282) present on C-terminus of the Kir6.2 subunit. 
(iii) The channels enter COPII vesicles at ER exit sites in a Sar1-dependent 
manner and both the Kir6.2 and the SUR1 subunits are independently 
capable of exiting the ER to reach the ERGIC compartments. 
(iv) The interaction between the KATP channels and the Sec24 protein of the 
COPII machinery, known to recognise and bind the diacidic ER exit motif, 
can be disrupted by a peptide containing the diacidic ER exit motif.  
(v) The mutant E282K channels can be rescued to the cell surface by co-
expression with the wild type subunits. 
This study highlights the potential importance of the forward trafficking signal in the 
surface expression of KATP channels which are critical for GSIS. It provides a 
mechanistic explanation to the CHI disease phenotype of the patient. The DXE motif in 
other membrane proteins has been reported previously to be recognised by the COPII 
machinery (Nishimura and Balch, 1997, Nishimura et al., 1999, Wang et al., 2004b). 
Mutation of the motif causes ER retention resulting in complete absence of the mutant 
KATP channels on the cell surface which leads to loss of KATP currents. This results in 
membrane depolarisation and excessive insulin secretion (Ashcroft and Gribble, 1999, 
Cartier et al., 2001, Dunne et al., 2004, Ashcroft, 2006b). Misfolding and aggregation of 
newly synthesised proteins in the ER or alterations in the ER processing of cargo is 
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responsible for a broad range of diseases including cystic fibrosis, emphysema and 
neuropathies such as Alzheimer's disease (Cheng et al., 1990, Dimcheff et al., 2003). 
CHI causing mutations such as the W91R of the Kir6.2 also prevent surface expression 
of the channels, but this has been attributed to channel misfolding which could explain 
why these mutant subunits could not be rescued to the cell surface by co-expression 
with the wild type subunits (Crane and Aguilar-Bryan, 2004). The E282K mutant 
channels, studied here on the other hand, do not appear to undergo misfolding 
because co-expression of the wild type subunits with the mutant subunits could rescue 
the mutant subunits to the cell surface. Functional studies showed that the channels 
formed of wild type and E282K subunits are functional (Taneja et al., 2009). Therefore, 
the absence of the E282K mutant channels is mechanistically different from all other 
mutations reported in the literature. It also explains how the removal of the tumorous 
pancreatic sections expressing the mutant subunits alone and leaving behind the tissue 
expressing a mixed population of wild type and E282K mutant subunits (capable of 
forming functional channels) was able to cure the patient.  
 
The study also revealed that both Kir6.2 and SUR1 can exit the ER and enter 
ERGIC. These data suggested that complete assembly of the channel likely occurs 
in the ERGIC or the cis-Golgi compartment. Unassembled channel subunits, bearing 
exposed ‘RKR’ signals could be recognised by the COPI machinery, and retrieved 
to the ER via COPI vesicles (Heusser et al., 2006, Mrowiec and Schwappach, 
2006). Though the RKR motif on the KATP channel subunits was well characterised, 
previous studies could not provide experimental evidence to determine if this motif, 
which when disrupted caused accumulation of the channels in the ER, was an ER 
retention or retrieval signal. Assembly of the Kir6.2 and SUR1 subunits was 
thought to be required to mask these motifs present on both the channel subunits 
to allow exit of the channels from the ER. The present study showed that the ‘RKR’ 
signals on the KATP channel subunits are more likely to serve as retrieval signals, 
rather than retention signals because each of the channel subunits were found to be 
capable of moving out of the ER to reach the ERGIC compartments but only 
completely assembled channels were expressed on cell surface. Moreover, the 
rescue experiments suggested that the Kir6.2 subunits must dimerise or multimerise 
prior to ER exit. These findings provide a valuable mechanistic insight into the 
channel synthesis and assembly and show that the COPII machinery has an 
important role in sorting of correctly folded channels for exit out of the ER that can 
affect surface density of the channels.  
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Other potassium channels apart from the KATP channels (shown in this study) have 
been reported to have a functional diacidic ER exit motif for entry into COPII vesicles 
in humans which include TASK3, and the Kir1.1, 2.1, 3.2a and 3.4 (Ma et al., 2002, 
Heusser and Schwappach, 2005). Thus although it has been shown that the diacidic 
motif is required for ER exit in COPII vesicles, how ion channels are recruited into 
the COPII vesicles was not fully understood. Selective transport of membrane 
proteins out of the ER requires the recognition and binding of the Sec24 proteins of 
the COPII complex with cargo through the ER exit motifs localised to their cytosolic 
domains. These motifs include the diaromatic, di-hydrophobic motifs and the diacidic 
ER exit motif (Nishimura and Balch, 1997, Miller et al., 2002). The TAT-DXE 
peptides used in this study showed that if the diacidic ER exit motif binding site on 
Sec24 is saturated, the channels are not able to express on cell surface. The TAT-
DXE peptides could therefore be used to further understand the interaction between 
Sec24 and its cargoes and provide a simple tool to screen for other proteins that are 
recognised by Sec24 and exit the ER in COPII vesicles. Further, the Sec24 has 
multiple cargo binding sites (Miller et al., 2003) and therefore diverse cargoes can 
bind to it. Hence it would be interesting to study the mechanism of ER export of 
proteins that have signals other than the DXE.  
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7.3 Sar1-dependent ER Exit of hERG Channels  
 
The ER export mechanisms of the hERG potassium channels were investigated in 
Chapter 4. hERG channels were chosen in this study because the hERG channels 
are reported to be stringently processed in the ER for preventing expression of 
misfolded channels (Ficker et al., 2003). Several trafficking deficient mutant hERG 
channels have been reported that are misfolded and retained in the ER due to 
strong association with chaperones heat shock proteins (Hsp) 70 and Hsp 90 
(Ficker et al., 2003). hERG channels like the KATP channels, have been reported to 
posses the putative ER retention signal present in the C-terminus (R-G-R at 
positions 1005-1007) and the last 104 amino acids of the channel C-terminus are 
required to mask the signal and prevent ER retention of the channels (Kupershmidt 
et al., 2002). However, ER exit mechanisms used by the channels are not 
completely understood. Therefore, the ER exit of the hERG channels was 
investigated. 
 
Key findings of this study are: 
(i) ER exit of hERG channels is dependent on Sar1-GTPase. 
(ii) The channels enter COPII vesicles at ER exit sites.  
(iii) The TAT-DXE peptide treatment prevents surface expression of the 
channels which indicated that the channels must interact with the Sec24 
proteins of the COPII machinery. 
(iv) The distal C-terminus of hERG channels does not contain a functional ER 
exit motif. 
The present study showed that hERG channels follow a forward trafficking pathway 
which is dependent on Sar1-GTPase in agreement with the report (Delisle et al., 2009) 
published when the study was ongoing. Delisle et al however did not present any data 
to show if hERG channels enter COPII vesicles. Using a temperature-sensitive VSV-G 
mutant as a marker, this study showed that the channels enter the COPII vesicles at 
ERES prior to ER exit and entry into ERGIC. This mechanism of ER export of hERG 
channels appeared to be similar to that of the KATP channels. Therefore hERG C-
terminal sequence was screened for potential ER export motifs and sequential 
deletions of the distal end of hERG C-terminus were made to remove all the three 
potential DXE motifs, the LXXLE motif and three LL motifs. Truncations into the 
proximal C-terminus were not made as this region contains the cyclic nucleotide 
binding domain (CNBD- 742-842), which is important for the function of hERG 
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(Akhavan et al., 2005). The truncations did not prevent the Sar1-dependent ER exit of 
the channels. Thus none of the three diacidic ER exit motifs appeared to be involved in 
the ER exit of hERG. These results implied that the ER exit motif on the hERG 
channels may be other that the DXE sequence. 
 
A recent finding showed that glycoslyphosphatidylinositol (GPI)-anchored proteins that 
are localised to cholesterol rich lipid-raft domains of membranes are incorporated into 
COPII vesicles after synthesis for export out of the ER (Bonnon et al., 2010). They 
cannot interact directly with Sec24 since they lack a cytosolic domain and are thought 
to use membrane-spanning cargo receptors and their ability to interact with the Sec23-
Sec24 complex for entry into COPII vesicles. Moreover, the ER export of GPI-anchored 
proteins was shown to require integrity of the lipid raft domains of the ER membrane 
(Bonnon et al., 2010). When localisation of the hERG channels (discussed in Chapter 
5) was investigated, they were found to be localised to cholesterol rich membrane lipid-
rafts unlike the pancreatic KATP channels (Xia et al., 2004). Thus, it is possible that 
direct interaction of the hERG channels with Sec24 proteins does not occur. 
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7.4 Major Pathway of hERG Internalisation 
Requires Lipid-rafts and is ARF6-mediated  
 
The forward trafficking of the cardiac hERG channels presented distinct features as 
compared to the pancreatic KATP channels. Next, the endocytic mechanisms of the 
hERG channels were investigated and compared to those of the pancreatic KATP 
channels (discussed in Chapter 5). The study presented some interesting findings that 
are listed as follows: 
(i) Recombinant and native cardiac hERG channels are localised to cholesterol 
rich lipid raft micro-domains. 
(ii) The channels are internalised from the cell surface rapidly. 
(iii) Internalisation of the channels is dynamin-independent, cholesterol 
dependent and is ARF6-mediated. 
(iv) When ARF6-mediated endocytic pathway of the channels was blocked, an 
alternate endocytic pathway of the channels was revealed. 
(v) Though most channels are internalised by a lipid raft- and ARF6-mediated 
pathway, the channels are be able to also internalise via a dynamin-
dependent pathway that appears to be clathrin-mediated. 
Raft localisation of Kv channels has been reported, for example Kv2.1 and Kv1.5 
channels are localised to lipid raft micro-domains and are internalised by dynamin-
dependent internalisation in caveolar lipid-rafts (Martens et al., 2001, Martinez-Marmol 
et al., 2008, Steele et al., 2007a). There is a report that conditions that modify cell 
membrane cholesterol modulate the electrophysiological properties of Kv11.1 and IKr 
(Balijepalli et al., 2007). From the results of this study, the raft localisation of the hERG 
channels may have more physiological effects than regulation of channel function. 
 
Dynamin-independent, ARF6-mediated internalisation of hERG channels in lipid-rafts is 
novel and previously unreported for ion channels. It is a mechanism generally utilized 
by proteins such as the MHCI and viruses to gain entry into the cells (Donaldson and 
Williams, 2009, Mercer et al., 2010). This mechanism of internalisation of hERG 
channels is a complete contrast to the mechanism used by the pancreatic KATP 
channels that have been found to undergo rapid internalisation by CME via a tyrosine-
based motif, 330YSKF333 located in the C-terminus of Kir6.2 (Mankouri et al., 2006). The 
hERG channels also showed the ability to undergo internalisation by CME when the 
ARF6-mediated pathway is blocked. These findings could have important implications 
on our understanding of signalling events that regulate endocytic trafficking of the 
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channels which in turn dictate their surface density and function. hERG channel 
trafficking was found to be affected by PKC. Activation of PKC appeared to inhibit 
internalisation of the channels and increase their surface density. This is in contrast to 
the effect of PKC activation seen on the pancreatic KATP channels which show reduced 
recycling and are diverted to lysosomal degradation when treated with PKC activator 
drugs which reduces their net surface density (Manna et al., 2010). The physiological 
relevance of these findings needs to be studied. Moreover, KATP channels have been 
shown to undergo multiple rounds of internalisation and recycling (Manna et al., 2010). 
If this is also true for hERG channels remains an open question.  
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7.5 hERG Channels Recycle and Blocking Rab11a 
Function Increases Channel Degradation 
 
The post-endocytic fate of hERG channels was investigated (discussed in Chapter 6) 
and the key findings of this study are: 
(i) hERG channels that are internalised from the cell surface undergo recycling 
back to the cell surface. 
(ii) The recycled channels rapidly are diverted to lysosomes for degradation. 
(iii) Degradation of the channels is enhanced if Rab11a function is disrupted in 
the cells. 
A recent report suggested that Rab11b has a role in the forward trafficking of the hERG 
channels (Delisle et al., 2009). The present study showed that disruption of Rab11b 
activity in cells prevent expression of the hERG channels on the cell surface, but 
another isoform, Rab11a reduces surface expression of the channels as they are 
diverted to lysosomes for degradation. This can be explained by the following: Rab11a 
is ubiquitously expressed, whereas Rab11b is expressed primarily in brain and heart 
and therefore it may have distinct functions in these tissues. Moreover, the role of 
Rab11a is well established and it is known to associate with recycling endosomes and 
regulate the recycling of various proteins, such as the transferrin receptor, β-integrin, 
TRPV5/6 channels, the glucose transporter GLUT4 and the chemokine receptor 
CXCR. On the other hand Rab11b may be localised to and function distinctly to 
Rab11a (Lapierre et al., 2003, Silvis et al., 2009).  
 
The hERG channels did not appear to enter or get retained in the transferrin-positive 
early endocytic compartments. They do however enter the MHCI- and GPI-AP- positive 
compartments which could be GEECS or some recycling endosomal compartments 
that sort them for recycling back to the cell surface in a Rab11a dependent manner. If 
this recycling is blocked, most of the channels are diverted to lysosomal compartments. 
Thus the sorting of the channels would decide the fate of internalised hERG channels 
and thereby regulate their surface density.  
 
One of the most well studied membrane trafficking proteins is the glucose transporter 
GLUT4 (Bryant et al., 2002). GLUT4 is translocated to the cell surface in an insulin 
stimulated manner and is critical for glucose uptake by muscle and adipose tissues. 
Rab11a has been found to be present in GLUT4 containing vesicles after insulin 
stimulation. Rab11a is thought to be activated by the insulin signalling cascade 
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(Schwenk and Eckel, 2007). Therefore when insulin levels are low, as would be case in 
conditions such as diabetes, Rab11a activation may be depressed and this might divert 
the hERG channels for degradation. This could result in reduced hERG surface density 
and cardiac arrhythmias.  
 
It is also interesting that the hERG channels are able to undergo rapid lysosomal 
degradation after expression on the cell surface within a couple of hours and it would 
be interesting to investigate if the mode of internalisation of the channels plays a role in 
how rapidly the channels are degraded.  
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7.6 Final Summary 
 
This study has investigated and compared the trafficking mechanisms of two 
physiologically important potassium ion channels. The mechanism by which the 
diacidic (280DLE282) motif on the Kir6.2 C-terminus regulates the ER export of the KATP 
channels was determined and the molecular basis of CHI caused by the disruption of 
the motif by the mutation E282K was explained. The unique aspect of this finding is 
that the mutant channels are not misfolded but are trafficking-deficient because of 
disruption of the 280DLE282 motif. The TAT-conjugated peptides used in the study can 
be a valuable tool for investigating the interaction between the COPII and its cargo. Its 
ability to do so was tested on the hERG channel which showed Sar1-dependent 
surface expression. The study of ER exit mechanisms of the hERG channels showed 
that the channels can enter COPII vesicles at ERES although they lack the diacidic ER 
exit motifs on distal C-terminus of the channel. The hERG channels were found to be 
localised to membrane lipid-rafts and undergo internalisation from the cell membrane 
via clathrin, caveolin and dynamin-independent mechanism that was mediated by 
ARF6-GTPase. The channels were also found to be capable of using alternate 
pathway for internalisation if the major ARF6-mediated pathway was blocked. The 
mechanism of internalisation of hERG is novel to ion channels. The hERG channels 
were also found to recycle back to the cell surface and undergo lysosomal degradation 
which was enhanced when Rab11a function was disrupted. Thus this study adds to the 
understanding of KATP and hERG channel trafficking mechanisms which are important 
processes that regulate that surface levels and thereby the channel functions in health 
and disease.  
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